Id | Namn | Version | Uppdaterad | Användning (version - antal listor) |
5197
|
Abakavir + Lamivudin oralt 600 + 300 mg (ex Kivexa) tablett
|
1.1
|
2023-08-03
|
[1.1 - 5 st.]
|
4545
|
Abakavir oralt 20 mg/mL (Ziagen) oral lösning
|
1.1
|
2024-01-18
|
[1.1 - 5 st.]
|
4546
|
Abakavir oralt 300 mg (ex Ziagen) tablett
|
1.1
|
2024-05-30
|
[1.1 - 5 st.]
|
4463
|
Abatacept intravenös inf (Orencia) dos tillsätts till spädningsvätska
|
2.1
|
2025-03-06
|
[2.1 - 6 st.] [1.4 - 5 st.]
|
1411
|
Acetazolamid intravenös inj 5 mg/mL (Diamox) barn under 10 kg
|
4.3
|
2023-10-12
|
[4.3 - 6 st.]
|
4462
|
Acetazolamid intravenös inj 50 mg/mL (Diamox)
|
3.3
|
2023-10-12
|
[3.3 - 6 st.]
|
4460
|
Acetazolamid oralt 250 mg (Diamox) tablett
|
2.1
|
2022-01-13
|
[2.1 - 5 st.]
|
2513
|
Acetylcystein + Amidotrizoinsyra rektalt 25 mg/mL + 185 mg I/mL (Acetylcystein + Gastrografin) lavemang
|
3.2
|
2024-08-01
|
[3.2 - 6 st.]
|
1391
|
Acetylcystein inhalation
|
7.2
|
2025-03-05
|
[7.2 - 12 st.] [6.0 - 1 st.] [5.0 - 1 st.]
|
2938
|
Acetylcystein intravenös inf 18 mg/mL
|
1.2
|
2025-03-05
|
[1.2 - 3 st.]
|
5004
|
Acetylcystein intravenös inf 33,3 mg/mL vid paracetamolintoxikation
|
2.5
|
2025-04-16
|
[2.5 - 7 st.]
|
5003
|
Acetylcystein intravenös inf 33,3 mg/mL vid paracetamolintoxikation m. depottablett 665 mg
|
2.5
|
2025-04-16
|
[2.5 - 5 st.]
|
3211
|
Acetylcystein intravenös inf 50 mg/mL
|
6.2
|
2025-03-05
|
[6.2 - 5 st.]
|
4950
|
Acetylcystein intravenös inf 50 mg/mL vid paracetamolintoxikation
|
4.1
|
2025-04-16
|
[4.1 - 6 st.] [3.1 - 5 st.] [2.3 - 1 st.]
|
4951
|
Acetylcystein intravenös inf 50 mg/mL vid paracetamolintoxikation m. depottablett 665 mg
|
3.1
|
2025-04-16
|
[3.1 - 3 st.] [2.3 - 5 st.]
|
5007
|
Acetylcystein oralt 200 mg/mL
|
3.2
|
2024-08-01
|
[3.2 - 4 st.]
|
5172
|
Acetylcystein oralt 50 mg/mL
|
2.1
|
2024-08-01
|
[2.1 - 4 st.]
|
4540
|
Acetylcystein oralt brustablett
|
2.0
|
2021-02-04
|
[2.0 - 6 st.]
|
1392
|
Acetylcystein rektalt 100 mg/mL
|
2.2
|
2024-08-01
|
[2.2 - 10 st.]
|
2656
|
Acetylsalicylsyra oralt (ex Trombyl, Extempore) tablett/kapslar
|
4.0
|
2021-01-28
|
[4.0 - 11 st.] [1.5 - 1 st.]
|
3293
|
Aciklovir intravenös inf 5 mg/mL (ex Aciclovir Pfizer) spädning från koncentrat
|
7.6
|
2025-02-13
|
[7.6 - 11 st.]
|
4819
|
Aciklovir intravenös inf 5 mg/mL (f.d Geavir) spädning från pulver och koncentrat
|
2.8
|
2025-04-24
|
[2.8 - 13 st.] [1.6 - 1 st.]
|
2139
|
Aciklovir intravenös inf 5 mg/mL (f.d Geavir, licens) spädning från pulver
|
8.6
|
2025-03-24
|
[8.6 - 7 st.]
|
1259
|
Aciklovir konjunktivalt 30 mg/g = 3 % (ex Xorox) ögonsalva
|
2.11
|
2024-09-12
|
[2.11 - 6 st.]
|
4809
|
Aciklovir oralt 40 mg/mL (Zovirax) oral suspension
|
3.1
|
2022-03-03
|
[3.1 - 9 st.] [2.2 - 1 st.]
|
4810
|
Aciklovir oralt 80 mg/mL (Zovirax) oral suspension
|
3.0
|
2022-02-24
|
[3.0 - 9 st.] [2.2 - 1 st.]
|
3358
|
Aciklovir oralt tabletter
|
3.0
|
2022-02-24
|
[3.0 - 9 st.]
|
4782
|
Aciklovir utvärtes 5 % (ex Zovirax) kräm/stift
|
1.2
|
2022-06-27
|
[1.2 - 5 st.]
|
4694
|
Acitretin oralt 2 mg/mL (Extempore) oral vätska
|
2.4
|
2022-11-03
|
[2.4 - 6 st.]
|
4934
|
Adalimumab subkutan inj (ex Hyrimoz, Humira)
|
1.12
|
2024-02-01
|
[1.12 - 7 st.]
|
4871
|
Addex-Kalium 2 mmol/mL FÖR TILLSATS TILL INFUSIONSVÄTSKA VID T.EX. KETOACIDOS
|
2.0
|
2020-03-05
|
[2.0 - 7 st.]
|
4833
|
Addex/Addens-Kaliumklorid 2 mmol/mL FÖR TILLSATS TILL INFUSIONSVÄTSKA
|
3.2
|
2023-06-01
|
[3.2 - 7 st.]
|
4834
|
Addex/Addens-Natriumklorid 4 mmol/mL FÖR TILLSATS TILL INFUSIONSVÄTSKA
|
3.0
|
2020-03-05
|
[3.0 - 11 st.]
|
1342
|
Adenosin intravenös inj 1 mg/mL (Adenosin Life Medical)
|
7.2
|
2022-09-01
|
[7.2 - 19 st.] [6.3 - 1 st.]
|
4877
|
Adenosin intravenös inj 2,5 mg/mL (Adenosin Life Medical)
|
2.1
|
2022-09-01
|
[2.1 - 2 st.]
|
3127
|
Adenosin intravenös inj 5 mg/mL (Adenosin Life Medical)
|
6.1
|
2022-09-01
|
[6.1 - 11 st.] [5.1 - 1 st.]
|
2953
|
Adrenalin inhalation
|
8.3
|
2025-03-05
|
[8.3 - 17 st.] [7.8 - 2 st.]
|
5048
|
Adrenalin inj 0,01 mg/mL = 10 mikrog/mL flera administreringsvägar
|
2.2
|
2025-02-27
|
[2.2 - 2 st.]
|
3030
|
Adrenalin inj 0,1 mg/mL = 100 mikrog/mL flera administreringsvägar
|
6.2
|
2025-02-27
|
[6.2 - 12 st.] [5.12 - 6 st.]
|
3276
|
Adrenalin intramuskulär inj (ex EpiPen) förfylld injektionspenna
|
5.0
|
2025-03-05
|
[5.0 - 9 st.] [4.9 - 7 st.]
|
2883
|
Adrenalin intramuskulär inj 1 mg/mL
|
3.9
|
2025-03-06
|
[3.9 - 15 st.]
|
1339
|
Adrenalin intravenös inf 0,01 mg/mL = 10 mikrog/mL
|
5.1
|
2025-03-27
|
[5.1 - 6 st.] [4.4 - 1 st.]
|
4958
|
Adrenalin intravenös inf 0,02 mg/mL = 20 mikrog/mL
|
3.1
|
2025-03-27
|
[3.1 - 6 st.]
|
4618
|
Adrenalin intravenös inf 0,04 mg/mL = 40 mikrog/mL
|
3.1
|
2025-03-27
|
[3.1 - 4 st.]
|
4959
|
Adrenalin intravenös inf 0,08 mg/mL = 80 mikrog/mL
|
3.1
|
2025-03-27
|
[3.1 - 2 st.]
|
5047
|
Adrenalin intravenös inf 0,1 mg/mL = 100 mikrog/mL
|
2.1
|
2025-03-27
|
[2.1 - 3 st.]
|
4960
|
Adrenalin intravenös inf 0,16 mg/mL = 160 mikrog/mL
|
3.1
|
2025-03-27
|
[3.1 - 2 st.]
|
4949
|
Agalsidas beta intravenös inf (Fabrazyme) dos tillsätts till spädningsvätska
|
3.1
|
2024-03-21
|
[3.1 - 5 st.]
|
3180
|
Albumin intravenös inf 5 % = 50 mg/mL = 50 gram/L (ex Alburex)
|
4.4
|
2022-11-03
|
[4.4 - 16 st.]
|
3179
|
Albumin intravenös inf 20 % = 200 mg/mL = 200 gram/L (ex Alburex)
|
5.2
|
2022-11-03
|
[5.2 - 16 st.]
|
5286
|
alFENTanil intravenös inj 0,05 mg/mL = 50 mikrog/mL (ex Rapifen)
|
2.1
|
2025-02-27
|
[2.1 - 2 st.] [1.0 - 1 st.]
|
5057
|
alFENTanil intravenös inj 0,1 mg/mL = 100 mikrog/mL (ex Rapifen)
|
1.10
|
2025-02-28
|
[1.10 - 4 st.]
|
5179
|
alFENTanil intravenös inj 0,5 mg/mL = 500 mikrog/mL (ex Rapifen)
|
1.4
|
2025-02-27
|
[1.4 - 5 st.]
|
4765
|
Alginsyra + tillsatser oralt (ex Gaviscon) oral suspension
|
3.0
|
2022-06-02
|
[3.0 - 8 st.]
|
5107
|
Alginsyra + tillsatser oralt (ex Gaviscon) tuggtablett
|
2.0
|
2022-05-25
|
[2.0 - 5 st.]
|
5041
|
Alglukosidas alfa intravenös inf (Myozyme) dos tillsätts till spädningsvätska
|
3.1
|
2024-05-08
|
[3.1 - 6 st.]
|
4770
|
Alimemazin oralt (ex Nedeltran licens, f.d Theralen) kapslar/tabletter
|
5.0
|
2025-05-08
|
[5.0 - 1 st.] [4.1 - 3 st.]
|
3104
|
Alimemazin oralt 40 mg/mL (fd Theralen) orala droppar
|
8.0
|
2025-05-08
|
[8.0 - 3 st.] [7.0 - 3 st.] [6.0 - 5 st.] [5.0 - 1 st.]
|
3439
|
Allopurinol intravenös inf 6 mg/mL (Extempore)
|
3.0
|
2021-11-25
|
[3.0 - 4 st.]
|
3438
|
Allopurinol oralt (ex Zyloric) tabletter
|
5.2
|
2022-11-10
|
[5.2 - 7 st.] [1.3 - 1 st.]
|
4457
|
alPROStadil intravenös inf 0,002 mg/mL = 2 mikrog/mL (ex Prostivas)
|
6.1
|
2025-02-06
|
[6.1 - 11 st.] [5.0 - 1 st.]
|
1237
|
alPROStadil intravenös inf 0,005 mg/mL = 5 mikrog/mL (ex Prostivas)
|
6.1
|
2025-02-06
|
[6.1 - 11 st.]
|
5151
|
alPROStadil intravenös inf 0,010 mg/mL = 10 mikrog/mL (ex Prostivas)
|
1.2
|
2025-02-06
|
[1.2 - 3 st.]
|
3172
|
Alteplas instillation 1 mg/mL (ex Actilyse) i central venväg (CVK, SVP, CDK)
|
7.0
|
2024-09-19
|
[7.0 - 14 st.] [6.9 - 4 st.] [5.0 - 1 st.]
|
5034
|
Alteplas intrapleural instillation 0,1 mg/mL (Actilyse) pleuradränage
|
2.5
|
2024-09-05
|
[2.5 - 9 st.]
|
4478
|
Alteplas intravenös inf 1 mg/mL (Actilyse)
|
3.2
|
2024-04-18
|
[3.2 - 6 st.]
|
4707
|
Amfotericin B intravenös inf 0,5 mg/mL (ex AmBisome liposomal)
|
6.2
|
2024-12-12
|
[6.2 - 4 st.]
|
3163
|
Amfotericin B intravenös inf 1 mg/mL (ex AmBisome liposomal)
|
9.2
|
2024-12-12
|
[9.2 - 13 st.] [8.0 - 1 st.] [7.2 - 1 st.]
|
1408
|
Amfotericin B intravenös inf 2 mg/mL (ex AmBisome liposomal)
|
10.2
|
2024-12-12
|
[8.2 - 1 st.] [10.2 - 12 st.]
|
5169
|
Amidotrizoinsyra oralt 370 mg I/mL (Gastrografin) oral lösning
|
1.3
|
2024-02-15
|
[1.3 - 5 st.]
|
2934
|
Amikacin inhalation 250 mg/mL (ex Biklin)
|
2.1
|
2023-06-01
|
[2.1 - 5 st.]
|
2032
|
Amikacin intravenös inf/inj 10 mg/mL (ex Biklin, Extempore)
|
5.6
|
2023-06-01
|
[5.6 - 9 st.]
|
3295
|
Amikacin intravenös inf/inj 5 mg/mL (ex Biklin, Extempore)
|
5.4
|
2023-06-01
|
[5.4 - 7 st.]
|
4997
|
Amilorid oralt 5 mg (ex Midamor licens) tablett
|
1.1
|
2020-12-03
|
[1.1 - 4 st.]
|
4927
|
Aminofyllin intravenös inf 1,5 mg/mL (Teofyllamin)
|
2.1
|
2024-12-19
|
[2.1 - 5 st.]
|
2962
|
Aminofyllin intravenös inf/inj 23 mg/mL (Teofyllamin)
|
5.1
|
2024-12-19
|
[5.1 - 9 st.] [4.1 - 2 st.] [3.0 - 1 st.]
|
5012
|
Aminofyllin oralt 23 mg/mL (Teofyllamin)
|
1.1
|
2020-11-19
|
[1.1 - 2 st.]
|
3347
|
Amiodaron intravenös inf 1,5 mg/mL (ex Cordarone)
|
5.2
|
2023-10-26
|
[5.2 - 5 st.] [4.0 - 1 st.]
|
5063
|
Amiodaron intravenös inf 2,4 mg/mL (ex Cordarone)
|
1.2
|
2023-10-26
|
[1.2 - 2 st.]
|
2853
|
Amiodaron intravenös inf/inj 15 mg/mL (ex Cordarone)
|
6.3
|
2023-10-26
|
[6.3 - 11 st.] [5.0 - 1 st.]
|
4943
|
Amiodaron intravenös inf/inj 5 mg/mL (ex Cordarone)
|
3.3
|
2023-10-26
|
[3.3 - 4 st.]
|
5064
|
Amiodaron intravenös inf/inj 6 mg/mL (ex Cordarone)
|
1.3
|
2023-10-26
|
[1.3 - 1 st.]
|
4953
|
Amiodaron oralt (ex Cordarone)
|
2.0
|
2023-01-19
|
[2.0 - 5 st.]
|
4738
|
Amitriptylin (ex Saroten) tabletter
|
2.0
|
2023-02-09
|
[2.0 - 8 st.]
|
3235
|
amLODipin oralt (ex Norvasc) tabletter
|
5.5
|
2025-04-10
|
[5.5 - 7 st.] [4.2 - 1 st.]
|
4938
|
amLODipin oralt 1 mg/mL (Licens) oral lösning
|
3.3
|
2025-04-10
|
[3.3 - 10 st.] [2.1 - 1 st.]
|
3068
|
Amoxicillin + Klavulansyra oralt 50 + 13 mg/mL (Spektramox) oral suspension
|
10.0
|
2025-03-19
|
[9.5 - 7 st.] [10.0 - 9 st.]
|
4479
|
Amoxicillin + Klavulansyra oralt 500 + 125 mg (ex Bioclavid) tablett
|
7.0
|
2025-03-19
|
[7.0 - 7 st.] [6.8 - 4 st.]
|
3331
|
Amoxicillin + Klavulansyra oralt 80 + 12 mg/mL (Spektramox) oral suspension
|
7.6
|
2025-03-19
|
[7.6 - 13 st.]
|
4480
|
Amoxicillin + Klavulansyra oralt 875 + 125 mg (ex Bioclavid) tablett
|
4.10
|
2025-03-06
|
[4.10 - 8 st.]
|
4456
|
Amoxicillin oralt (ex Amimox) tabletter
|
6.1
|
2025-02-20
|
[6.1 - 11 st.] [5.15 - 1 st.] [4.5 - 1 st.]
|
4455
|
Amoxicillin oralt 100 mg/mL (ex Amimox) oral suspension
|
7.0
|
2024-10-03
|
[7.0 - 13 st.] [6.2 - 4 st.]
|
1303
|
Amoxicillin oralt 50 mg/mL (ex Amimox) oral suspension
|
7.0
|
2024-10-03
|
[7.0 - 8 st.] [6.2 - 3 st.] [4.1 - 1 st.]
|
2143
|
Ampicillin intravenös inf 20 mg/mL (ex Doktacillin, Ampitar)
|
6.2
|
2025-04-16
|
[6.2 - 10 st.] [4.6 - 1 st.]
|
2142
|
Ampicillin intravenös inf/inj 100 mg/mL (ex Doktacillin, Ampitar)
|
8.0
|
2025-04-16
|
[8.0 - 8 st.] [7.1 - 9 st.] [6.2 - 2 st.] [5.4 - 1 st.]
|
5016
|
Anakinra intravenös inj 10 mg/mL (Kineret)
|
4.2
|
2022-12-22
|
[4.2 - 13 st.] [3.0 - 1 st.]
|
5008
|
Anakinra intravenös inj 100 mg (Kineret) förfylld spruta
|
4.0
|
2022-05-05
|
[4.0 - 5 st.]
|
4595
|
Anakinra subkutan inj 100 mg/0,67 mL = 150 mg/mL (Kineret)
|
5.1
|
2022-05-19
|
[5.1 - 10 st.]
|
3343
|
Anidulafungin intravenös inf 0,7 mg/mL (ex Ecalta)
|
3.1
|
2021-12-02
|
[3.1 - 8 st.]
|
5350
|
Anifrolumab intravenös inf 3 mg/mL (Saphnelo)
|
1.0
|
2024-10-17
|
[1.0 - 5 st.]
|
5128
|
Anti-T-lymfocytimmunglobulin intravenös inf (ATGAM) häst, dos tillsätts till spädningsvätska
|
5.5
|
2023-03-30
|
[5.5 - 6 st.]
|
4473
|
Antitrombin III intravenös inf 50 E/mL (Antithrombin III Baxalta)
|
1.2
|
2021-02-04
|
[1.2 - 6 st.]
|
1300
|
Antitrombin III intravenös inf 50 E/mL (Atenativ)
|
2.2
|
2021-02-04
|
[2.2 - 8 st.]
|
3415
|
Antitymocytimmunglobulin intravenös inf 0,5 mg/mL (Thymoglobuline) kanin
|
6.0
|
2023-02-16
|
[6.0 - 5 st.]
|
3351
|
Aprepitant oralt (ex Emend) kapslar
|
7.1
|
2025-03-06
|
[7.1 - 12 st.]
|
5412
|
Aprepitant oralt 20 mg/mL (Extempore) oral suspension
|
1.1
|
2025-03-06
|
[1.1 - 5 st.]
|
4737
|
Aprepitant oralt 25 mg/mL (Emend) oral suspension
|
5.1
|
2025-03-06
|
[5.1 - 8 st.]
|
1301
|
Arginin intravenös inf 100 mg/mL (Extempore)
|
4.0
|
2022-08-10
|
[4.0 - 10 st.] [3.1 - 1 st.]
|
5173
|
Arginin oralt 100 mg/mL (Extempore) oral vätska
|
2.0
|
2024-07-11
|
[2.0 - 6 st.] [1.1 - 1 st.]
|
4679
|
Argipressin intravenös inf 0,1 E/mL = 100 mE/mL (ex Empressin)
|
5.1
|
2025-02-20
|
[5.1 - 4 st.] [4.1 - 2 st.]
|
4668
|
Argipressin intravenös inf 0,4 E/mL = 400 mE/mL (ex Empressin)
|
5.1
|
2025-02-20
|
[5.1 - 5 st.]
|
4771
|
Argipressin intravenös inf 0,5 E/mL = 500 mE/mL (ex Empressin)
|
5.1
|
2025-02-20
|
[5.1 - 1 st.] [4.1 - 1 st.]
|
5402
|
Argipressin intravenös inf 0,8 E/mL = 800 mE/mL (ex Empressin)
|
1.1
|
2025-02-20
|
[1.1 - 2 st.]
|
4772
|
Argipressin intravenös inf 1 E/mL = 1 000 mE/mL (ex Empressin)
|
5.1
|
2025-02-20
|
[5.1 - 1 st.]
|
4848
|
Aripiprazol oralt (ex Abilify) tabletter
|
1.2
|
2021-04-29
|
[1.2 - 8 st.]
|
4852
|
Aripiprazol oralt 1 mg/mL (ex Abilify) oral lösning
|
1.2
|
2021-05-20
|
[1.2 - 8 st.]
|
3230
|
Artesunat intravenös inj 10 mg/mL
|
4.3
|
2024-10-10
|
[4.3 - 5 st.]
|
4853
|
Atomoxetin oralt (f.d Strattera) kapslar
|
2.1
|
2023-09-21
|
[2.1 - 10 st.]
|
4854
|
Atomoxetin oralt 4 mg/mL (Strattera) oral lösning
|
2.1
|
2023-09-21
|
[2.1 - 8 st.]
|
5082
|
Atovakvon oralt 150 mg/mL (ex Wellvone) oral suspension
|
1.3
|
2024-05-16
|
[1.3 - 5 st.]
|
4815
|
Atrakurium intravenös inf/inj 1 mg/mL (ex Atracurium-hameln)
|
3.0
|
2022-03-10
|
[3.0 - 4 st.]
|
4816
|
Atrakurium intravenös inf/inj 10 mg/mL (ex Atracurium-hameln)
|
3.0
|
2022-03-10
|
[3.0 - 4 st.]
|
2991
|
Atrakurium intravenös inf/inj 5 mg/mL (ex Atracurium-hameln)
|
4.0
|
2022-03-10
|
[4.0 - 6 st.]
|
1299
|
Atropin 0,05 mg/mL (ex Atropin Unimedic 0,0499 mg/mL) flera administreringssätt
|
7.3
|
2022-07-28
|
[7.3 - 18 st.]
|
2684
|
Atropin 0,5 mg/mL flera administreringssätt
|
5.1
|
2022-07-28
|
[5.1 - 12 st.]
|
5304
|
Atropin intravenös inj 1 mg/mL (Licens) vid nervgasangrepp
|
1.1
|
2024-04-25
|
[1.1 - 5 st.]
|
5398
|
Avalglukosidas alfa intravenös inf (Nexviadyme) dos tillsätts till spädningsvätska
|
1.0
|
2025-02-20
|
[1.0 - 4 st.]
|
5109
|
azatioPRIN oralt (ex Imurel) tabletter
|
4.3
|
2024-03-07
|
[4.3 - 5 st.]
|
5117
|
azatioPRIN oralt 10 mg/mL (Azathioprine 50 mg/5 mL, licens) oral suspension
|
4.3
|
2024-03-07
|
[4.3 - 4 st.]
|
4991
|
azitroMYCIN intravenös inf 2 mg/mL (ex Azitromax)
|
1.4
|
2024-03-07
|
[1.4 - 7 st.]
|
4742
|
azitroMYCIN oralt (ex Azitromax) tabletter
|
3.0
|
2025-04-10
|
[3.0 - 6 st.] [2.1 - 1 st.]
|
4743
|
azitroMYCIN oralt 40 mg/mL (ex Azitromax) oral suspension
|
3.1
|
2025-04-16
|
[3.1 - 6 st.] [2.2 - 5 st.]
|
4489
|
Aztreonam intravenös inj 100 mg/mL (Azactam)
|
3.2
|
2024-08-01
|
[3.2 - 6 st.]
|
5227
|
Baloxavir oralt (Xofluza) tabletter
|
1.2
|
2023-11-23
|
[1.2 - 4 st.]
|
5175
|
Bedakilin oralt (Sirturo) tabletter
|
1.3
|
2023-11-09
|
[1.3 - 5 st.]
|
5221
|
Beklometason inhalation (ex Aerobec, Beclomet Easyhaler)
|
1.2
|
2024-02-01
|
[1.2 - 6 st.]
|
5377
|
Belimumab intravenös inf 4 mg/mL (Benlysta)
|
1.0
|
2024-11-14
|
[1.0 - 4 st.]
|
4588
|
Benelyte intravenös inf
|
1.2
|
2025-01-23
|
[1.2 - 8 st.]
|
4723
|
Bensylpenicillin intramuskulär inj 250 mg/mL (ex Penicryl)
|
5.4
|
2024-08-22
|
[5.4 - 3 st.]
|
2144
|
Bensylpenicillin intravenös inf/inj 100 mg/mL (ex Penicryl)
|
8.3
|
2024-08-22
|
[8.3 - 19 st.] [7.0 - 2 st.]
|
3116
|
Betain oralt (Cystadane) oralt pulver
|
1.1
|
2025-01-30
|
[1.1 - 5 st.]
|
1291
|
Betametason intravenös inj 0,1 mg/mL (ex Betapred)
|
9.1
|
2023-04-27
|
[9.1 - 6 st.]
|
4699
|
Betametason intravenös inj 0,4 mg/mL (ex Betapred)
|
6.1
|
2023-04-27
|
[6.1 - 3 st.]
|
4465
|
Betametason intravenös inj 0,5 mg/mL (ex Betapred)
|
7.1
|
2023-04-27
|
[7.1 - 3 st.]
|
1292
|
Betametason intravenös inj 1 mg/mL (ex Betapred)
|
9.1
|
2023-04-27
|
[9.1 - 12 st.]
|
2688
|
Betametason intravenös/intramuskulär inj 4 mg/mL (ex Betapred)
|
11.1
|
2023-04-27
|
[6.2 - 1 st.] [11.1 - 14 st.] [10.3 - 1 st.]
|
1293
|
Betametason oralt 0,1 mg/mL (ex Betapred) oral lösning från tablett
|
5.1
|
2024-10-03
|
[5.1 - 10 st.]
|
2445
|
Betametason oralt 0,5 mg (ex Betapred) tablett
|
5.4
|
2024-10-03
|
[5.4 - 18 st.] [3.3 - 1 st.]
|
4466
|
Betametason oralt 0,5 mg/mL (ex Betapred) oral lösning från tablett
|
3.1
|
2024-10-03
|
[3.1 - 3 st.]
|
5199
|
Biktegravir + Emtricitabin + Tenofoviralafenamid (Biktarvy) tabletter
|
2.0
|
2024-05-23
|
[2.0 - 5 st.]
|
1290
|
Biotin intravenös inj 5 mg/mL (Vitamin B7, ex Medebiotin Fuerte licens)
|
2.5
|
2024-01-18
|
[2.5 - 8 st.]
|
4891
|
Biotin oralt (Vitamin B7, licens) tabletter
|
1.3
|
2022-08-18
|
[1.3 - 6 st.]
|
3126
|
Biperiden intramuskulär/intravenös inj 0,4 mg/mL (Akineton)
|
2.0
|
2022-02-10
|
[2.0 - 4 st.]
|
3058
|
Biperiden intramuskulär/intravenös inj 5 mg/mL (Akineton)
|
2.0
|
2022-02-10
|
[2.0 - 4 st.]
|
1287
|
Bosentan oralt (ex Tracleer) kapslar/tabletter
|
3.10
|
2022-09-15
|
[3.10 - 8 st.]
|
5015
|
Botulinumtoxin typ A intramuskulär inj 10 E/mL (Botox)
|
2.0
|
2022-10-27
|
[2.0 - 5 st.]
|
4814
|
Botulinumtoxin typ A intramuskulär inj 50 E/mL (Botox)
|
2.0
|
2022-10-27
|
[2.0 - 4 st.]
|
4827
|
Botulinumtoxin typ A intramuskulär inj 100 E/mL (Botox)
|
2.0
|
2022-10-27
|
[2.0 - 5 st.]
|
4828
|
Botulinumtoxin typ A intramuskulär inj 100 E/mL (Dysport)
|
2.0
|
2022-10-27
|
[2.0 - 3 st.]
|
4829
|
Botulinumtoxin typ A intramuskulär inj 200 E/mL (Dysport)
|
2.0
|
2022-10-27
|
[2.0 - 4 st.]
|
4775
|
Bromhexin + EFEdrin oralt 0,5 + 1 mg/mL (ex Mollipect) oral lösning
|
1.3
|
2025-02-27
|
[1.3 - 6 st.]
|
1289
|
Bromhexin oralt 0,8 mg/mL (ex Bisolvon) oral lösning
|
3.3
|
2023-11-30
|
[3.3 - 7 st.]
|
4698
|
Bromhexin oralt 1,6 mg/mL (ex Bisolvon) oral lösning
|
1.3
|
2023-11-30
|
[1.3 - 6 st.]
|
2511
|
Bromhexin oralt 2 mg/mL (Bisolvon licens) orala droppar
|
1.2
|
2023-10-05
|
[1.2 - 3 st.]
|
2933
|
Bromhexin oralt 8 mg (ex Bisolvon) tablett
|
3.4
|
2023-10-05
|
[3.4 - 6 st.]
|
2801
|
Budesonid inhalation (ex Pulmicort)
|
7.3
|
2025-04-10
|
[7.3 - 16 st.] [6.0 - 1 st.] [5.5 - 3 st.]
|
5321
|
Budesonid lokalt (ex Pulmicort)
|
1.3
|
2025-01-09
|
[1.3 - 6 st.]
|
5300
|
Budesonid lokalt (Jorveza) munsönderfallande tablett
|
2.2
|
2024-03-07
|
[2.2 - 6 st.]
|
4759
|
Budesonid nasalt (ex Desonix) nässpray
|
1.8
|
2022-10-20
|
[1.8 - 5 st.]
|
3177
|
Budesonid oralt (ex Entocort)
|
2.3
|
2025-05-08
|
[2.3 - 5 st.]
|
5215
|
Bupropion oralt (ex Voxra) tabletter med modifierad frisättning
|
2.2
|
2024-02-15
|
[2.2 - 5 st.]
|
4493
|
C1-esterashämmare intravenös inf/inj (ex Berinert)
|
2.2
|
2019-08-15
|
[2.2 - 8 st.]
|
4983
|
cefADROXil oralt (ex Cefamox löslig) kapsel/tablett
|
2.0
|
2023-11-23
|
[2.0 - 11 st.]
|
4821
|
cefADROXil oralt 100 mg/mL oral suspension
|
2.0
|
2023-11-23
|
[2.0 - 11 st.]
|
5229
|
Cefiderokol intravenös inf 20 mg/mL (Fetcroja)
|
1.0
|
2024-10-10
|
[1.0 - 5 st.]
|
5129
|
cefIXim oralt (ex Suprax licens) tabletter
|
2.6
|
2024-04-25
|
[2.6 - 10 st.]
|
3436
|
cefIXim oralt 100 mg/5 mL = 20 mg/mL (ex InfectoOpticef licens) oral suspension
|
3.3
|
2024-04-25
|
[3.3 - 18 st.]
|
5154
|
cefOTAXim intramuskulär inj 250 mg/mL (f.d Claforan)
|
2.1
|
2024-11-28
|
[2.1 - 4 st.]
|
1379
|
cefOTAXim intravenös inf/inj 100 mg/mL (f.d Claforan)
|
7.2
|
2025-01-30
|
[7.2 - 17 st.] [6.2 - 4 st.]
|
5228
|
cefTAZidim + Avibaktam intravenös inf 20 + 5 mg/mL (Zavicefta)
|
1.1
|
2025-02-20
|
[1.1 - 5 st.]
|
1264
|
cefTAZidim intravenös inf/inj 100 mg/mL (ex Fortum)
|
5.2
|
2024-02-08
|
[5.2 - 17 st.] [4.3 - 3 st.]
|
2561
|
cefTIBUten oralt 36 mg/mL (Isocef licens) oral suspension
|
4.2
|
2020-08-20
|
[4.2 - 18 st.]
|
3330
|
cefTIBUten oralt 400 mg (ex Wincef licens) tablett/kapsel
|
4.1
|
2022-08-04
|
[4.1 - 12 st.] [3.3 - 1 st.]
|
1401
|
cefTRIAXon intramuskulär inj 250 mg/mL spädning med lidokain
|
5.2
|
2024-05-08
|
[5.2 - 4 st.] [4.12 - 1 st.]
|
1227
|
cefTRIAXon intravenös inf/inj 100 mg/mL (f.d Rocephalin)
|
8.1
|
2024-03-14
|
[8.1 - 11 st.] [7.7 - 3 st.]
|
4700
|
cefTRIAXon intravenös inf/inj 20 mg/mL (f.d Rocephalin)
|
3.1
|
2024-03-14
|
[3.1 - 13 st.] [2.7 - 1 st.]
|
2969
|
cefTRIAXon intravenös inf/inj 50 mg/mL (f.d Rocephalin)
|
7.1
|
2024-03-14
|
[7.1 - 5 st.] [6.7 - 1 st.]
|
2157
|
cefUROXim intravenös inf/inj 100 mg/mL (ex Zinacef)
|
7.1
|
2024-06-27
|
[7.1 - 13 st.] [6.0 - 4 st.]
|
3167
|
Celecoxib oralt (ex Celebra) kapslar
|
2.1
|
2025-03-27
|
[2.1 - 9 st.]
|
2450
|
Cetirizin oralt 10 mg (ex Zyrlex) tablett
|
1.6
|
2021-12-22
|
[1.6 - 7 st.]
|
5116
|
Cidofovir intravenös inf 3 mg/mL
|
4.0
|
2024-08-29
|
[4.0 - 6 st.]
|
5220
|
Ciklesonid inhalation (ex Alvesco) inhalationsspray
|
1.0
|
2025-03-27
|
[1.0 - 4 st.]
|
3396
|
Ciklosporin intravenös inf (Sandimmun) barn under 20 kg, 50 mL
|
2.2
|
2023-11-16
|
[2.2 - 3 st.]
|
4543
|
Ciklosporin intravenös inf (Sandimmun) barn över 20 kg, 100 mL
|
2.2
|
2023-11-16
|
[2.2 - 3 st.]
|
4597
|
Ciklosporin intravenös inf 2,5 mg/mL (Sandimmun)
|
2.1
|
2025-02-27
|
[2.1 - 4 st.] [1.1 - 1 st.]
|
2902
|
Ciklosporin oralt (ex Sandimmun Neoral) kapslar
|
4.0
|
2024-09-19
|
[4.0 - 11 st.]
|
3409
|
Ciklosporin oralt 100 mg/mL (ex Sandimmun Neoral) oral lösning
|
4.0
|
2024-09-19
|
[4.0 - 10 st.] [2.5 - 1 st.]
|
4739
|
Ciprofloxacin + Fluocinolon aurikulärt 3 + 0,25 mg/mL (Cetraxal Comp) örondroppar
|
1.5
|
2022-09-01
|
[1.5 - 5 st.]
|
4734
|
Ciprofloxacin aurikulärt 2 mg/mL (Cetraxal) örondroppar
|
1.4
|
2022-09-01
|
[1.4 - 5 st.]
|
4733
|
Ciprofloxacin aurikulärt 3 mg/mL (Ciloxan) örondroppar
|
1.4
|
2022-09-01
|
[1.4 - 5 st.]
|
2158
|
Ciprofloxacin intravenös inf 2 mg/mL
|
4.5
|
2025-04-30
|
[4.5 - 14 st.]
|
3377
|
Ciprofloxacin oralt 100 mg/mL (Ciproxin) oral suspension
|
6.0
|
2025-03-13
|
[6.0 - 9 st.] [5.0 - 2 st.]
|
3238
|
Ciprofloxacin oralt 50 mg/mL (Ciproxin) oral suspension
|
5.0
|
2025-03-13
|
[5.0 - 7 st.] [4.0 - 5 st.]
|
3237
|
Ciprofloxacin oralt tabletter
|
4.0
|
2025-03-13
|
[4.0 - 8 st.] [3.5 - 5 st.] [2.3 - 1 st.]
|
5120
|
Cocillana + Etylmorfin + Senegaextrakt oralt (Cocillana-Etyfin) oral lösning
|
1.1
|
2021-08-19
|
[1.1 - 6 st.]
|
3175
|
Cyanokobalamin oralt 1 mg (Vitamin B12, ex Betolvex) tablett
|
3.1
|
2024-07-11
|
[3.1 - 6 st.]
|
4459
|
Cyklopentolat + Fenylefrin konjunktivalt 0,2 + 1 % (Cyclomydril licens) ögondroppar
|
2.0
|
2023-07-27
|
[2.0 - 5 st.]
|
1374
|
Cyklopentolat + Fenylefrin konjunktivalt 0,5 + 0,5 % (Extempore) barn UNDER 1 år
|
1.4
|
2022-06-27
|
[1.4 - 15 st.]
|
2916
|
Cyklopentolat + Fenylefrin konjunktivalt 0,85 + 1,5 % (Extempore) barn ÖVER 1 år
|
1.4
|
2022-06-27
|
[1.4 - 8 st.]
|
5397
|
Dalbavancin intravenös inf 4 mg/mL (Xydalba)
|
1.0
|
2025-03-05
|
[1.0 - 3 st.]
|
5119
|
Dalteparin subkutan inj 625 E/mL (Fragmin) lämplig för doser i intervallet 60 - 250 E
|
2.0
|
2024-12-12
|
[2.0 - 7 st.] [1.0 - 1 st.]
|
5088
|
Dalteparin subkutan inj 10 000 E/mL (Fragmin) lämplig för doser i intervallet 400 - 4 000 E
|
4.0
|
2024-12-12
|
[4.0 - 12 st.] [3.1 - 1 st.] [1.0 - 1 st.]
|
5087
|
Dalteparin subkutan inj 2 500 E/mL (Fragmin) lämplig för doser i intervallet 100 - 450 E
|
3.1
|
2024-12-12
|
[3.1 - 15 st.]
|
2584
|
Dalteparin subkutan inj förfyllda sprutor (Fragmin) lämplig för fasta doser från 2 500 E/spruta
|
2.0
|
2024-12-12
|
[2.0 - 11 st.]
|
5083
|
Dapson oralt (Licens) tabletter
|
1.0
|
2022-08-18
|
[1.0 - 5 st.]
|
3454
|
Daptomycin intravenös inf 7 mg/mL (ex Cubicin)
|
2.7
|
2024-04-18
|
[2.7 - 12 st.]
|
2885
|
Darbepoetin alfa intravenös/subkutan inj (Aranesp)
|
3.4
|
2023-06-15
|
[3.4 - 5 st.]
|
4846
|
Deferasirox oralt (ex Exjade) tabletter
|
2.3
|
2022-05-05
|
[2.3 - 7 st.]
|
4758
|
Deferipron oralt (ex Ferriprox) tabletter
|
1.5
|
2024-02-08
|
[1.5 - 5 st.]
|
4845
|
Deferipron oralt 100 mg/mL (Ferriprox) oral lösning
|
1.0
|
2020-06-25
|
[1.0 - 5 st.]
|
4844
|
Deferoxamin intravenös inf 10 mg/mL (ex Desferal)
|
2.3
|
2025-04-10
|
[2.3 - 10 st.]
|
4843
|
Deferoxamin subkutan inf/intramuskulär inj 100 mg/mL (ex Desferal)
|
1.3
|
2025-04-10
|
[1.3 - 7 st.]
|
4559
|
Defibrotid intravenös inf 20 mg/mL (Defitelio)
|
2.1
|
2022-11-03
|
[2.1 - 3 st.]
|
4928
|
Defibrotid intravenös inf 4 mg/mL (Defitelio)
|
2.1
|
2022-11-03
|
[2.1 - 5 st.] [1.1 - 1 st.]
|
4933
|
Defibrotid intravenös inf 5 mg/mL (Defitelio)
|
2.1
|
2022-11-03
|
[2.1 - 2 st.]
|
3076
|
Deflazakort oralt tabletter
|
4.1
|
2024-01-11
|
[4.1 - 5 st.]
|
4594
|
Desloratadin oralt (ex Aerius) tabletter
|
4.3
|
2025-02-06
|
[4.3 - 18 st.] [3.3 - 1 st.]
|
4593
|
Desloratadin oralt 0,5 mg/mL (ex Aerius) oral lösning
|
4.3
|
2023-12-21
|
[4.3 - 15 st.] [3.0 - 2 st.]
|
2741
|
Desmopressin intravenös inf (Octostim) dos tillsätts till spädningsvätska
|
3.4
|
2020-08-13
|
[3.4 - 8 st.]
|
5056
|
Desmopressin intravenös inj 0,2 mikrog/mL (Minirin)
|
1.1
|
2023-03-30
|
[1.1 - 5 st.]
|
4464
|
Desmopressin intravenös inj 4 mikrog/mL (Minirin)
|
3.1
|
2023-03-30
|
[3.1 - 6 st.]
|
4785
|
Desmopressin oralt (ex Minirin) tabletter
|
2.5
|
2025-01-09
|
[2.5 - 13 st.] [1.1 - 1 st.]
|
3285
|
dexAMETason intravenös inj 4 mg/mL (ex Dexavit)
|
5.2
|
2023-08-03
|
[5.2 - 7 st.]
|
1366
|
dexAMETason konjunktivalt 1 mg/mL (ex Opnol) ögondroppar
|
3.2
|
2023-08-03
|
[3.2 - 7 st.]
|
3268
|
dexAMETason oralt 0,4 mg/mL (Licens) oral lösning
|
4.2
|
2023-08-03
|
[4.2 - 11 st.]
|
3373
|
dexAMETason oralt 2 mg/mL (Licens) oral lösning
|
4.2
|
2023-08-03
|
[4.2 - 5 st.]
|
3269
|
dexAMETason oralt tabletter
|
4.4
|
2025-02-27
|
[4.4 - 8 st.] [3.0 - 1 st.]
|
4855
|
Dexamfetamin oralt (Attentin) tablett
|
1.11
|
2025-02-27
|
[1.11 - 7 st.]
|
4710
|
dexmedeTOMidin intravenös inf 16 mikrog/mL (ex Dexdor)
|
1.2
|
2025-02-06
|
[1.2 - 3 st.]
|
3224
|
dexmedeTOMidin intravenös inf 4 mikrog/mL (ex Dexdor)
|
4.3
|
2025-02-27
|
[4.3 - 8 st.]
|
3225
|
dexmedeTOMidin intravenös inf 8 mikrog/mL (ex Dexdor)
|
6.3
|
2025-02-27
|
[6.3 - 8 st.]
|
3317
|
dexmedeTOMidin nasalt 100 mikrog/mL (ex Dexdor)
|
15.1
|
2025-02-06
|
[15.1 - 16 st.] [14.0 - 1 st.]
|
3086
|
Dialys: Peritonealdialyslösning med tillsatser
|
2.7
|
2025-03-06
|
[2.7 - 3 st.]
|
1217
|
Diazepam intravenös/intramuskulär inj 5 mg/mL (ex Diazepam-Lipuro licens)
|
6.3
|
2025-01-09
|
[6.3 - 16 st.] [5.3 - 1 st.] [4.0 - 1 st.]
|
3434
|
Diazepam oralt (ex Stesolid) tabletter
|
2.6
|
2025-01-09
|
[2.6 - 12 st.]
|
3419
|
Diazepam rektalt (ex Stesolid) rektallösning
|
10.0
|
2025-04-24
|
[9.3 - 7 st.] [7.1 - 1 st.] [10.0 - 9 st.]
|
1239
|
Diazoxid oralt 50 mg/mL (Proglycem licens) oral suspension
|
3.1
|
2020-12-10
|
[3.1 - 13 st.]
|
1445
|
Dicykloverin oralt 2 mg/mL (ex Dicyclomine, licens) oral lösning
|
2.6
|
2023-07-06
|
[2.6 - 4 st.]
|
1283
|
Digoxin intravenös inj 0,01 mg/mL = 10 mikrog/mL
|
2.4
|
2024-03-27
|
[2.4 - 7 st.]
|
4617
|
Digoxin intravenös inj 0,025 mg/mL = 25 mikrog/mL
|
1.3
|
2024-03-21
|
[1.3 - 6 st.]
|
1332
|
Digoxin oralt 0,05 mg/mL = 50 mikrog/mL (ex Digoxin Aspen Pharma licens, f.d Lanoxin) oral lösning
|
4.5
|
2024-03-21
|
[4.5 - 13 st.]
|
5102
|
Digoxin oralt tabletter
|
1.1
|
2024-03-21
|
[1.1 - 5 st.]
|
4495
|
Dihydralazin intravenös inj 12,5 mg/mL (Nepresol licens)
|
1.1
|
2020-01-09
|
[1.1 - 5 st.]
|
3394
|
Dihydrotestosteron utvärtes 2,5 % (Andractim Licens) gel
|
2.1
|
2022-06-27
|
[2.1 - 3 st.]
|
3407
|
Diklofenak oralt (ex Voltaren) tabletter
|
2.11
|
2023-10-26
|
[2.11 - 10 st.] [1.0 - 1 st.]
|
3403
|
Diklofenak rektalt (ex Voltaren) suppositorier
|
3.10
|
2023-10-26
|
[3.10 - 8 st.] [2.1 - 1 st.]
|
4940
|
Dimetikon utvärtes (ex Linicin) lösning/spraygel
|
1.0
|
2023-10-19
|
[1.0 - 4 st.]
|
5072
|
Dimetylsulfoxid utvärtes 990 mg/mL = 99 % (Extempore)
|
1.1
|
2022-06-27
|
[1.1 - 6 st.]
|
4911
|
DOBUTamin intravenös inf 0,5 mg/mL = 500 mikrog/mL
|
2.3
|
2025-04-30
|
[2.3 - 6 st.]
|
4623
|
DOBUTamin intravenös inf 1 mg/mL = 1000 mikrog/mL
|
3.4
|
2025-04-30
|
[3.4 - 14 st.]
|
3223
|
DOBUTamin intravenös inf 2 mg/mL = 2000 mikrog/mL
|
3.4
|
2025-04-30
|
[3.4 - 8 st.]
|
2464
|
Dokusatnatrium + Sorbitol rektalt 1 + 250 mg/mL (Klyx)
|
2.7
|
2025-02-20
|
[2.7 - 17 st.]
|
4728
|
DOPamin intravenös inf 0,5 mg/mL = 500 mikrog/mL (Giludop licens)
|
5.0
|
2025-03-19
|
[5.0 - 3 st.] [4.2 - 3 st.]
|
4683
|
DOPamin intravenös inf 1 mg/mL = 1000 mikrog/mL (Giludop licens)
|
6.0
|
2025-03-19
|
[6.0 - 9 st.] [5.1 - 7 st.]
|
4680
|
DOPamin intravenös inf 2 mg/mL = 2000 mikrog/mL (Giludop licens)
|
6.0
|
2025-03-19
|
[6.0 - 4 st.] [5.1 - 3 st.]
|
4761
|
DOPamin intravenös inf 4 mg/mL = 4000 mikrog/mL (Giludop licens)
|
5.0
|
2025-03-19
|
[5.0 - 2 st.]
|
2517
|
Dornas alfa, inhalation 1 mg/mL (Pulmozyme)
|
3.5
|
2024-08-22
|
[3.5 - 5 st.] [1.5 - 1 st.]
|
5190
|
Dornas alfa, intrapleural instillation (Pulmozyme) pleuradränage, dos tillsätts till spädningsvätska
|
1.0
|
2024-09-05
|
[1.0 - 5 st.]
|
4490
|
Doxycyklin intravenös inf 1 mg/mL (Doxyferm)
|
1.3
|
2022-09-22
|
[1.3 - 10 st.]
|
4542
|
Doxycyklin oralt 10 mg/mL (ex Vibranord licens) oral suspension
|
2.1
|
2024-11-14
|
[2.1 - 11 st.]
|
4541
|
Doxycyklin oralt 100 mg (ex Doxyferm) tablett
|
3.1
|
2025-03-06
|
[3.1 - 13 st.]
|
5376
|
Droperidol intramuskulär inj 2,5 mg/mL (ex Dridol)
|
2.0
|
2024-10-31
|
[2.0 - 4 st.]
|
4624
|
Droperidol intravenös inj 0,25 mg/mL = 250 mikrog/mL (ex Dridol)
|
3.0
|
2024-10-24
|
[3.0 - 4 st.]
|
5381
|
Droperidol intravenös inj 0,5 mg/mL = 500 mikrog/mL (ex Dridol)
|
1.0
|
2024-10-24
|
[1.0 - 4 st.]
|
5214
|
Duloxetin oralt (ex Cymbalta) kapslar
|
1.0
|
2024-10-03
|
[1.0 - 7 st.]
|
4773
|
EFEdrin + Etylmorfin oralt (Lepheton) oral lösning
|
1.2
|
2025-02-20
|
[1.2 - 5 st.]
|
4972
|
Emicizumab subkutan inj 150 mg/mL (Hemlibra)
|
1.0
|
2020-06-25
|
[1.0 - 3 st.]
|
4890
|
Emicizumab subkutan inj 30 mg/mL (Hemlibra)
|
1.0
|
2020-06-25
|
[1.0 - 3 st.]
|
5198
|
Emtricitabin + Tenofoviralafenamid oralt (Descovy) tabletter
|
1.0
|
2022-10-06
|
[1.0 - 5 st.]
|
3239
|
Enalapril oralt (ex Renitec) tabletter/kapslar
|
2.4
|
2023-07-27
|
[2.4 - 11 st.] [1.3 - 1 st.]
|
2974
|
Enalaprilat intravenös inj 0,025 mg/mL = 25 mikrog/mL (Enap licens)
|
5.1
|
2023-03-02
|
[5.1 - 6 st.]
|
1359
|
Enoxaparinnatrium subkutan inj 1 000 E/mL = 10 mg/mL (ex Klexane)
|
5.2
|
2023-08-31
|
[5.2 - 6 st.]
|
4625
|
Enoxaparinnatrium subkutan inj 2 000 E/mL = 20 mg/mL (ex Klexane)
|
4.2
|
2023-08-31
|
[4.2 - 2 st.]
|
5255
|
Epoetin alfa intravenös/subkutan inj (Eprex)
|
1.0
|
2023-06-29
|
[1.0 - 3 st.]
|
5256
|
Epoetin beta intravenös/subkutan inj (NeoRecormon)
|
1.1
|
2023-07-06
|
[1.1 - 5 st.]
|
3009
|
Epoetin beta intravenös/subkutan inj för doser upp till 2000 E (NeoRecormon)
|
4.0
|
2023-06-29
|
[4.0 - 6 st.]
|
4867
|
Epoetin zeta intravenös/subkutan inj (Retacrit)
|
1.1
|
2023-07-06
|
[1.1 - 4 st.]
|
1412
|
epoPROSTenol intravenös inf 1 mikrog/mL (ex Veletri licens)
|
4.0
|
2023-12-14
|
[4.0 - 7 st.]
|
4701
|
epoPROSTenol intravenös inf 2 mikrog/mL (ex Veletri licens)
|
3.0
|
2023-12-14
|
[3.0 - 5 st.]
|
3271
|
Ertapenem intravenös inf 20 mg/mL (ex Invanz)
|
4.0
|
2025-02-27
|
[4.0 - 9 st.] [3.4 - 4 st.]
|
3043
|
Erytromycin intravenös inf 5 mg/mL (ex Abboticin)
|
8.1
|
2024-06-27
|
[8.1 - 15 st.] [7.0 - 1 st.] [6.2 - 3 st.]
|
5345
|
Erytromycin intravenös inf 10 mg/mL (ex Abboticin) vid vätskerestriktion
|
1.2
|
2024-06-27
|
[1.2 - 4 st.]
|
4471
|
Erytromycin oralt (ex Abboticin)
|
9.0
|
2025-04-10
|
[9.0 - 7 st.] [8.3 - 7 st.] [6.1 - 1 st.]
|
4467
|
Erytromycin oralt 100 mg/mL (Ery-Max) oral suspension
|
8.0
|
2025-04-10
|
[8.0 - 7 st.] [7.3 - 8 st.] [5.1 - 1 st.]
|
1269
|
Erytromycin oralt 50 mg/mL (Ery-Max) från dospåse
|
6.0
|
2025-04-10
|
[6.0 - 6 st.] [5.4 - 5 st.] [4.4 - 1 st.]
|
4788
|
Escitalopram oralt (ex Cipralex) tabletter
|
1.9
|
2023-01-26
|
[1.9 - 8 st.]
|
4856
|
Escitalopram oralt 20 mg/mL (Cipralex) orala droppar
|
1.1
|
2020-02-27
|
[1.1 - 6 st.]
|
2658
|
Esketamin intravenös inf, 1 mL = 100 mikrog/kg (ex Ketanest) individuell spädning
|
7.0
|
2024-06-05
|
[7.0 - 3 st.]
|
5182
|
Esketamin intravenös inf/inj 0,15 mg/mL (ex Ketanest)
|
3.1
|
2024-06-13
|
[3.1 - 3 st.]
|
1360
|
Esketamin intravenös inf/inj 0,5 mg/mL (ex Ketanest)
|
6.1
|
2024-06-13
|
[6.1 - 3 st.]
|
4639
|
Esketamin intravenös inf/inj 1 mg/mL (ex Ketanest)
|
4.1
|
2024-06-13
|
[4.1 - 8 st.]
|
3129
|
Esketamin intravenös inf/inj 2 mg/mL (ex Ketanest)
|
6.1
|
2024-06-13
|
[6.1 - 5 st.]
|
5053
|
Esketamin intravenös inf/inj 5 mg/mL (ex Ketanest)
|
3.1
|
2024-06-13
|
[3.1 - 4 st.]
|
3007
|
Esketamin nasalt 25 mg/mL (ex Ketanest)
|
3.1
|
2024-10-10
|
[3.1 - 8 st.]
|
3016
|
Esketamin oralt 25 mg/mL (ex Ketanest)
|
3.1
|
2024-10-10
|
[3.1 - 4 st.]
|
4502
|
esMOLol intravenös inf/inj 1 mg/mL (Brevibloc)
|
1.10
|
2024-03-07
|
[1.10 - 3 st.]
|
4926
|
esMOLol intravenös inf/inj 10 mg/mL (Brevibloc)
|
1.10
|
2024-03-07
|
[1.10 - 4 st.]
|
1446
|
Esomeprazol intravenös inf 0,4 mg/mL (ex Nexium)
|
2.8
|
2025-04-10
|
[2.8 - 10 st.]
|
4818
|
Esomeprazol intravenös inf/inj 1 mg/mL (ex Nexium) kan även ges i jejunostomi
|
1.12
|
2025-04-10
|
[1.12 - 7 st.]
|
2634
|
Esomeprazol intravenös inf/inj 8 mg/mL (ex Nexium) kan även ges i jejunostomi
|
2.10
|
2025-04-10
|
[2.10 - 19 st.]
|
3313
|
Esomeprazol oralt (ex Nexium) enterokapslar/enterotabletter
|
5.7
|
2025-04-10
|
[5.7 - 16 st.]
|
2671
|
Esomeprazol oralt 10 mg/15 mL (ex Nexium) oral suspension
|
7.2
|
2025-04-16
|
[7.2 - 18 st.] [6.4 - 2 st.]
|
3207
|
Etakrynsyra intravenös inj 1 mg/mL (Reomax, Edecrin licens)
|
4.0
|
2021-12-16
|
[4.0 - 4 st.]
|
5014
|
Etakrynsyra intravenös inj 2,5 mg/mL (Reomax licens)
|
2.1
|
2021-12-16
|
[2.1 - 2 st.]
|
4528
|
Etambutol oralt (ex EMB-Fatol licens) tabletter/kapslar
|
2.1
|
2024-02-15
|
[2.1 - 6 st.]
|
4813
|
Etanercept subkutan inj (ex Enbrel, Benepali) förfyllda sprutor/injektionspenna
|
1.2
|
2023-10-05
|
[1.2 - 7 st.]
|
5278
|
Etanercept subkutan inj 10 mg/mL (Enbrel)
|
2.1
|
2023-11-23
|
[2.1 - 5 st.]
|
5287
|
Etanercept subkutan inj 25 mg/mL (Enbrel)
|
1.0
|
2023-10-12
|
[1.0 - 5 st.]
|
4948
|
Etosuximid oralt 250 mg kapsel
|
2.3
|
2024-06-05
|
[2.3 - 7 st.]
|
4947
|
Etosuximid oralt 50 mg/mL (ex Suxinutin) oral lösning
|
1.6
|
2021-12-16
|
[1.6 - 8 st.]
|
3242
|
FELodipin oralt (ex Plendil) depottabletter
|
2.5
|
2025-02-13
|
[2.5 - 7 st.]
|
1266
|
Fenobarbital intravenös inf/inj 20 mg/mL (ex Extempore)
|
6.1
|
2025-04-30
|
[6.1 - 8 st.] [5.1 - 12 st.] [3.2 - 1 st.]
|
4708
|
Fenobarbital intravenös inf/inj 200 mg/mL (ex Luminal licens)
|
4.1
|
2025-04-30
|
[4.1 - 3 st.]
|
3359
|
Fenobarbital oralt (ex Aphenylbarbit licens) tabletter/kapslar
|
1.12
|
2025-04-24
|
[1.12 - 5 st.]
|
1267
|
Fenobarbital oralt 5 mg/mL (Extempore) oral lösning
|
3.2
|
2025-04-24
|
[3.2 - 21 st.]
|
2943
|
Fenoximetylpenicillin oralt 50 mg/mL (ex Kåvepenin) oral suspension/lösning
|
8.0
|
2024-09-25
|
[8.0 - 9 st.] [7.4 - 3 st.] [4.4 - 1 st.]
|
2718
|
Fenoximetylpenicillin oralt (ex Kåvepenin) tabletter
|
6.0
|
2024-09-25
|
[6.0 - 14 st.] [5.7 - 3 st.] [3.1 - 1 st.]
|
1349
|
Fenoximetylpenicillin oralt 100 mg/mL (ex Kåvepenin) oral suspension
|
8.0
|
2024-09-25
|
[8.0 - 14 st.] [7.3 - 4 st.] [4.1 - 1 st.]
|
3324
|
Fenoximetylpenicillin oralt 250 mg/mL (ex Kåvepenin) orala droppar/oral lösning
|
7.0
|
2024-09-25
|
[7.0 - 10 st.] [6.5 - 2 st.]
|
5045
|
fentaNYL intravenös inf/inj 10 mikrog/mL (ex Leptanal)
|
2.0
|
2025-02-20
|
[2.0 - 1 st.]
|
2037
|
fentaNYL intravenös inf/inj 5 mikrog/mL (ex Extempore)
|
8.0
|
2025-02-20
|
[8.0 - 12 st.] [7.1 - 1 st.] [6.9 - 2 st.]
|
4472
|
fentaNYL intravenös inf/inj 50 mikrog/mL (ex Leptanal)
|
4.0
|
2025-02-20
|
[4.0 - 4 st.] [3.1 - 1 st.]
|
3297
|
FentaNYL nasalt 50 mikrog/mL (ex Leptanal)
|
2.2
|
2022-11-10
|
[2.2 - 8 st.]
|
3335
|
fentaNYL utvärtes (ex Durogesic, Matrifen) depotplåster
|
5.5
|
2025-03-06
|
[5.5 - 8 st.]
|
4745
|
fenylEFRIN intravenös inf/inj 0,1 mg/mL = 100 mikrog/mL
|
2.0
|
2022-11-10
|
[2.0 - 4 st.]
|
3194
|
fenylEFRIN intravenös inf/inj 0,2 mg/mL = 200 mikrog/mL
|
2.0
|
2022-11-10
|
[2.0 - 2 st.]
|
5207
|
fenylEFRIN intravenös inf/inj 0,5 mg/mL = 500 mikrog/mL
|
2.0
|
2022-11-10
|
[2.0 - 2 st.]
|
1252
|
Fibrinogen intravenös inf/inj 20 mg/mL (ex Fibryga)
|
2.7
|
2021-04-08
|
[2.7 - 10 st.]
|
5394
|
Fidaxomicin oralt 200 mg (Dificlir) tablett
|
1.0
|
2025-03-13
|
[1.0 - 4 st.]
|
5191
|
Fidaxomicin oralt 40 mg/mL (Dificlir) oral suspension
|
1.0
|
2025-03-13
|
[1.0 - 4 st.]
|
3446
|
Filgrastim intravenös inf 0,006 mg/mL = 6 mikrog/mL (ex Zarzio)
|
2.2
|
2020-10-15
|
[2.2 - 2 st.]
|
4676
|
Filgrastim intravenös inf 0,015 mg/mL = 15 mikrog/mL (ex Zarzio) från biosimilar
|
1.2
|
2020-10-15
|
[1.2 - 4 st.]
|
3286
|
Filgrastim intravenös inf 0,015 mg/mL = 15 mikrog/mL (Neupogen)
|
4.3
|
2021-10-21
|
[4.3 - 7 st.]
|
3380
|
Filgrastim subkutan inj 0,3 mg/mL = 30 ME/mL = 300 mikrog/mL (Neupogen)
|
5.1
|
2024-06-13
|
[5.1 - 9 st.] [4.1 - 1 st.]
|
3395
|
Filgrastim subkutan inj 0,6 mg/mL = 60 ME/mL = 600 mikrog/mL (ex Nivestim)
|
4.1
|
2024-06-13
|
[4.1 - 8 st.]
|
3404
|
Filgrastim subkutan inj 0,96 mg/mL = 96 ME/mL = 960 mikrog/mL (ex Nivestim)
|
4.1
|
2024-06-13
|
[4.1 - 6 st.]
|
4505
|
Flekainid oralt (ex Tambocor) tablett/kapsel
|
3.2
|
2025-01-09
|
[3.2 - 7 st.]
|
4736
|
Flekainid oralt 5 mg/mL (Licens) oral lösning
|
3.0
|
2024-03-27
|
[3.0 - 5 st.]
|
3455
|
Flukloxacillin oralt (ex Heracillin) tabletter
|
6.0
|
2022-10-06
|
[6.0 - 14 st.]
|
1398
|
Flukloxacillin oralt 50 mg/mL (Heracillin) oral suspension
|
6.0
|
2022-10-06
|
[6.0 - 15 st.] [3.0 - 1 st.]
|
2165
|
Flukonazol intravenös inf 2 mg/mL (f.d Diflucan)
|
4.0
|
2022-12-01
|
[4.0 - 18 st.] [3.1 - 1 st.]
|
3243
|
Flukonazol oralt (ex Diflucan) kapslar/tablett
|
3.16
|
2024-08-22
|
[3.16 - 13 st.]
|
1284
|
Flukonazol oralt 10 mg/mL (Diflucan) oral suspension
|
4.6
|
2024-12-12
|
[4.6 - 13 st.]
|
3244
|
Flukonazol oralt 40 mg/mL (ex Diflucan) oral suspension
|
4.8
|
2025-01-09
|
[4.8 - 16 st.]
|
4681
|
Flumazenil intravenös inf 9 mikrog/mL (f.d Lanexat)
|
1.3
|
2021-07-08
|
[1.3 - 4 st.]
|
2827
|
Flumazenil intravenös inj 100 mikrog/mL = 0,1 mg/mL (f.d Lanexat)
|
3.3
|
2021-07-08
|
[3.3 - 18 st.]
|
4790
|
Fluoxetin oralt (ex Fontex) tablett/kapsel
|
1.3
|
2024-05-30
|
[1.3 - 9 st.]
|
4791
|
Fluoxetin oralt 4 mg/mL (Fontex) oral lösning
|
1.3
|
2024-05-30
|
[1.3 - 6 st.]
|
3093
|
Flutikason inhalation (ex Flutide, Icsori)
|
6.7
|
2024-11-28
|
[6.7 - 13 st.] [4.0 - 1 st.] [3.4 - 1 st.]
|
5322
|
Flutikason lokalt (ex Flutide, Icsori)
|
1.6
|
2024-11-28
|
[1.6 - 6 st.]
|
2496
|
FlutikasonFUROAT nasalt 27,5 mikrog/spraydos (Avamys) nässpray
|
2.0
|
2020-01-16
|
[2.0 - 6 st.]
|
4963
|
FlutikasonPROPIONAT nasalt 50 mikrog/spraydos (ex Flutikason) nässpray
|
1.4
|
2025-01-09
|
[1.4 - 6 st.]
|
4628
|
Folsyra oralt 0,1 mg/mL (Extempore) oral lösning
|
3.2
|
2023-01-19
|
[3.2 - 9 st.]
|
5225
|
Folsyra oralt 10 mg/mL (Folix) orala droppar
|
1.1
|
2023-01-19
|
[1.1 - 6 st.]
|
4748
|
Folsyra oralt tabletter
|
3.2
|
2023-01-12
|
[3.2 - 7 st.]
|
5121
|
Fomepizol intravenös inf 5 mg/mL (Fomepizole SERB)
|
1.2
|
2023-10-12
|
[1.2 - 5 st.]
|
4706
|
Fosaprepitant intravenös inf 1 mg/mL (Ivemend)
|
4.1
|
2022-11-24
|
[4.1 - 9 st.] [3.2 - 1 st.]
|
4629
|
Fosfat intravenös inf 0,1 mmol/mL (Glycophos)
|
3.1
|
2023-12-21
|
[3.1 - 5 st.]
|
3228
|
Fosfat intravenös inf 0,12 mmol/mL (Glycophos)
|
4.1
|
2023-12-21
|
[4.1 - 6 st.]
|
4692
|
Fosfat intravenös inf 0,5 mmol/mL (Glycophos)
|
3.2
|
2023-12-21
|
[3.2 - 5 st.]
|
1263
|
Fosfat oralt 60 mg/mL = 0,63 mmol/mL (Extempore) oral lösning
|
2.3
|
2024-05-16
|
[2.3 - 16 st.]
|
5326
|
Fosfat oralt 120 mg/mL = 1,26 mmol/mL (Extempore) oral lösning
|
1.0
|
2024-05-16
|
[1.0 - 4 st.]
|
3245
|
Fosfat oralt 30,4 mg = 0,32 mmol (Extempore) kapsel
|
2.1
|
2024-05-16
|
[2.1 - 7 st.]
|
4609
|
Fosfenytoin intravenös inj 7,5 mg/mL = 5 mg FE/mL (Pro-Epanutin) dos i mg fosfenytoin
|
5.5
|
2025-04-30
|
[5.5 - 4 st.]
|
3453
|
Fosfenytoin intravenös inj 15 mg/mL = 10 mg FE/mL (Pro-Epanutin) dos i mg fosfenytoin
|
4.5
|
2025-04-30
|
[4.5 - 3 st.]
|
2749
|
Fosfenytoin intravenös inj 25 mg FE/mL = 37,5 mg/mL (Pro-Epanutin) doseras i mg FE
|
9.6
|
2025-04-30
|
[9.6 - 16 st.]
|
4868
|
Fosfenytoin intravenös inj 37,5 mg/mL = 25 mg FE/mL (Pro-Epanutin) dos i mg fosfenytoin
|
3.5
|
2025-04-30
|
[3.5 - 2 st.]
|
3327
|
Foskarnet intravenös inf 12 mg/mL (ex Virafosc)
|
6.0
|
2023-11-23
|
[6.0 - 8 st.]
|
3137
|
Foskarnet intravenös inf 24 mg/mL (ex Virafosc) via central infart
|
7.1
|
2023-11-23
|
[7.1 - 8 st.]
|
4586
|
Furosemid intravenös inf/inj 1 mg/mL (ex Furix)
|
7.1
|
2024-05-08
|
[7.1 - 4 st.] [6.0 - 1 st.] [5.1 - 1 st.]
|
1262
|
Furosemid intravenös inf/inj 10 mg/mL (ex Furix)
|
9.1
|
2024-05-08
|
[9.1 - 17 st.] [8.2 - 3 st.]
|
3363
|
Furosemid intravenös inf/inj 2 mg/mL (ex Furix)
|
13.1
|
2024-05-08
|
[13.1 - 8 st.]
|
1370
|
Furosemid oralt 10 mg/mL (ex Impugan) orala droppar
|
3.0
|
2020-10-22
|
[3.0 - 17 st.] [2.4 - 1 st.]
|
2122
|
Fusidinsyra konjunktivalt 1 % (Fucithalmic) ögonsalva/droppar
|
2.6
|
2025-02-27
|
[2.6 - 14 st.]
|
4774
|
Fusidinsyra utvärtes 2 % (ex Fucidin) kräm/salva
|
1.8
|
2024-07-11
|
[1.8 - 7 st.]
|
4930
|
Fysostigmin intravenös inf/inj 0,4 mg/mL (Anticholium 2 mg/5 mL licens)
|
3.0
|
2023-10-19
|
[3.0 - 5 st.]
|
1351
|
Fytomenadion intramuskulär/intravenös inj 10 mg/mL (Vitamin K, Konakion Novum)
|
6.2
|
2024-07-11
|
[6.2 - 14 st.] [5.3 - 3 st.]
|
4678
|
Fytomenadion intravenös inj 1 mg/mL (Vitamin K, Konakion Novum)
|
3.1
|
2024-05-08
|
[3.1 - 5 st.]
|
3354
|
Fytomenadion oralt 1 mg (Vitamin K, NeoKay licens) kapsel
|
1.5
|
2024-04-25
|
[1.5 - 12 st.]
|
5337
|
Fytomenadion oralt 10 mg (Vitamin K, Vitacon licens) tablett
|
1.0
|
2024-04-25
|
[1.0 - 3 st.]
|
1352
|
Fytomenadion oralt 10 mg/mL (Vitamin K, Konakion Novum)
|
2.4
|
2024-04-25
|
[2.4 - 10 st.]
|
1440
|
Fytomenadion oralt 20 mg/mL (Vitamin K, Ka-Vit Tropfen licens) orala droppar
|
1.6
|
2024-08-22
|
[1.6 - 12 st.]
|
4675
|
Gabapentin oralt (ex Neurontin) kapslar/tabletter
|
1.34
|
2024-03-14
|
[1.34 - 13 st.]
|
4674
|
Gabapentin oralt 50 mg/mL (ex Neurontin licens) oral lösning
|
1.6
|
2024-08-29
|
[1.6 - 8 st.]
|
5033
|
Galsulfas intravenös inf (Naglazyme) dos tillsätts till spädningsvätska
|
2.0
|
2023-12-14
|
[2.0 - 5 st.]
|
1410
|
Ganciklovir intravenös inf 10 mg/mL (ex Cymevene)
|
5.2
|
2024-08-22
|
[5.2 - 15 st.] [4.2 - 2 st.]
|
1434
|
Gentamicin intravenös inf/inj 10 mg/mL (ex Gensumycin)
|
6.1
|
2023-04-27
|
[6.1 - 16 st.] [2.1 - 1 st.]
|
2170
|
Gentamicin intravenös inf/inj 40 mg/mL (Gensumycin)
|
2.2
|
2023-04-27
|
[2.2 - 11 st.] [1.2 - 1 st.]
|
2525
|
Glukagon inj 1 mg/mL (Glucagon) flera administreringsvägar
|
2.7
|
2025-02-27
|
[2.7 - 18 st.]
|
5176
|
Glukagon nasalt 3 mg (Baqsimi) näspulver
|
1.4
|
2025-03-13
|
[1.4 - 8 st.]
|
3300
|
Glukarpidas intravenös inf/inj 1000 E/mL (Voraxaze licens)
|
2.3
|
2023-06-01
|
[2.3 - 7 st.]
|
4585
|
Glukos buckalt 400 mg/mL = 40 % (ex Extempore) munhålegel
|
3.5
|
2025-04-30
|
[3.5 - 16 st.] [1.2 - 1 st.]
|
5204
|
Glukos buffrad intravenös inf 50 mg/mL med eller utan tillsats
|
1.2
|
2022-11-10
|
[1.2 - 4 st.]
|
2591
|
Glukos buffrad intravenös inf 25 mg/mL med eller utan tillsats
|
1.0
|
2022-11-10
|
[1.0 - 7 st.]
|
5188
|
Glukos intravenös inf 50 mg/mL (+ 40 Na + 20 K) (ex Glucose-Na-K Baxter 50 mg/mL)
|
1.1
|
2022-10-27
|
[1.1 - 4 st.]
|
4835
|
Glukos intravenös inf 50 mg/mL med eller utan tillsats
|
4.0
|
2022-10-20
|
[4.0 - 7 st.] [3.2 - 1 st.]
|
4996
|
Glukos intravenös inf 100 mg/mL (+ 100 Na + valfri mängd K) vid diabetes ketoacidos
|
1.1
|
2020-06-04
|
[1.1 - 3 st.]
|
3334
|
Glukos intravenös inf 100 mg/mL (+ 140 Na + 40 K) vid diabetes ketoacidos
|
2.1
|
2020-06-04
|
[2.1 - 3 st.]
|
5189
|
Glukos intravenös inf 100 mg/mL (+ 40 Na + 20 K) (ex Glucose-Na-K Baxter 100 mg/mL)
|
1.1
|
2022-10-27
|
[1.1 - 4 st.]
|
4836
|
Glukos intravenös inf 100 mg/mL med eller utan tillsats
|
3.0
|
2022-10-20
|
[3.0 - 8 st.]
|
5177
|
Glukos intravenös inf 120 mg/mL
|
1.0
|
2022-10-20
|
[1.0 - 1 st.]
|
5114
|
Glukos intravenös inf 150 mg/mL
|
2.1
|
2023-10-05
|
[2.1 - 8 st.]
|
5208
|
Glukos intravenös inf 200 mg/mL (ex Glucos Fresenius Kabi)
|
1.0
|
2022-10-20
|
[1.0 - 6 st.]
|
3333
|
Glukos intravenös inf 50 mg/mL (+ 140 Na + 40 K) vid diabetes ketoacidos
|
2.1
|
2020-06-04
|
[2.1 - 3 st.]
|
1254
|
Glukos oralt 300 mg/mL = 30 %
|
4.0
|
2025-01-30
|
[4.0 - 13 st.] [3.3 - 5 st.]
|
5142
|
Glukoslösning oralt 75 g/200 mL (TopStar) oral lösning
|
1.2
|
2023-06-29
|
[1.2 - 5 st.]
|
3273
|
Glukospolymer enteralt/oralt (Resource Energipulver/Fantomalt)
|
3.5
|
2021-08-12
|
[3.5 - 3 st.]
|
4524
|
Glyceryltrinitrat utvärtes kräm/salva
|
1.4
|
2022-06-27
|
[1.4 - 5 st.]
|
4638
|
Glycin oralt (L-glycin, extempore) kapslar
|
2.1
|
2022-09-15
|
[2.1 - 5 st.]
|
4766
|
Glykopyrronium oralt 320 mikrog/mL (Sialanar) oral lösning
|
1.4
|
2025-01-16
|
[1.4 - 6 st.]
|
4931
|
Glykopyrroniumbromid intravenös inj 0,2 mg/mL = 200 mikrog/mL (ex Robinul)
|
2.2
|
2023-02-23
|
[2.2 - 7 st.]
|
3274
|
Granisetron intravenös inf/inj 1 mg/mL (f.d Kytril)
|
4.0
|
2020-09-17
|
[4.0 - 5 st.] [3.4 - 1 st.]
|
5011
|
Granisetron oralt (f.d Kytril) tabletter
|
4.3
|
2022-10-13
|
[4.3 - 5 st.] [2.1 - 1 st.]
|
4793
|
Guanfacin oralt (Intuniv) depottabletter
|
1.4
|
2024-03-14
|
[1.4 - 9 st.]
|
4789
|
Haloperidol intramuskulär inj 5 mg/mL (Haldol)
|
1.0
|
2019-06-27
|
[1.0 - 5 st.]
|
2893
|
Heparin instillation 100 E/mL (HeparinLÅS)
|
2.0
|
2021-01-21
|
[2.0 - 9 st.]
|
2894
|
Heparin instillation 20 E/mL (HeparinLÅS)
|
2.0
|
2021-01-21
|
[2.0 - 7 st.]
|
2876
|
Heparin intravenös inf 100 E/mL (ex Extempore)
|
8.2
|
2025-01-16
|
[8.2 - 6 st.]
|
4633
|
Heparin intravenös inf 25 E/mL
|
3.3
|
2022-06-30
|
[3.3 - 3 st.]
|
5411
|
Heparin intravenös inf 400 E/mL
|
1.0
|
2025-01-23
|
[1.0 - 2 st.]
|
1248
|
Heparin intravenös inf 5 E/mL (Heparin APL) vid katetervård och koagulationsrubbning
|
1.4
|
2020-07-30
|
[1.4 - 5 st.]
|
4632
|
Heparin intravenös inf 50 E/mL (ex Extempore)
|
2.2
|
2022-06-30
|
[2.2 - 2 st.]
|
1247
|
Hepatit B-immunglobulin intramuskulär inj 180 E/mL (Umanbig)
|
2.2
|
2020-03-26
|
[2.2 - 8 st.]
|
3326
|
Hyaluronidas subkutan inj 1500 E/mL (ex Hylase Dessau licens)
|
2.1
|
2020-06-25
|
[2.1 - 6 st.]
|
5112
|
Hydrokortison + Lidokain rektalt (Xyloproct) salva/suppositorium
|
2.2
|
2024-02-22
|
[2.2 - 6 st.]
|
4777
|
Hydrokortison + Mikonazol utvärtes 10 + 20 mg/g (Cortimyk, Daktacort) kräm
|
2.2
|
2022-06-27
|
[2.2 - 4 st.]
|
4740
|
Hydrokortison + Oxitetracyklin + Polymyxin B lokalt (Terracortril med Polymyxin B) droppar/salva
|
2.2
|
2022-03-10
|
[2.2 - 7 st.]
|
1222
|
Hydrokortison intravenös inf/inj 5 mg/mL (ex Solu-Cortef)
|
14.3
|
2023-02-16
|
[14.3 - 15 st.] [11.1 - 1 st.]
|
5165
|
Hydrokortison intravenös inj 0,5 mg/mL (ex Solu-Cortef)
|
1.2
|
2022-03-10
|
[1.2 - 3 st.]
|
5171
|
Hydrokortison intravenös inj 1 mg/mL (ex Solu-Cortef)
|
3.0
|
2023-03-09
|
[3.0 - 3 st.]
|
2754
|
Hydrokortison intravenös/intramuskulär inj 50 mg/mL (ex Solu-Cortef)
|
11.3
|
2023-03-09
|
[8.1 - 1 st.] [11.3 - 17 st.]
|
2474
|
Hydrokortison kutant 1 % (ex Mildison Lipid) kräm/salva
|
3.0
|
2025-02-20
|
[3.0 - 4 st.] [2.1 - 3 st.]
|
4757
|
Hydrokortison oralt (ex Alkindi) tabletter/kapslar
|
3.8
|
2024-07-04
|
[3.8 - 12 st.]
|
5078
|
Hydrokortison oralt 1 mg/mL (Extempore) oral suspension
|
3.1
|
2023-02-16
|
[3.1 - 9 st.]
|
4989
|
Hydroxiklorokin oralt 200 mg (Plaquenil) tablett
|
3.0
|
2024-02-22
|
[3.0 - 5 st.]
|
4857
|
Hydroxizin oralt (ex Atarax) tabletter
|
2.0
|
2025-03-27
|
[2.0 - 6 st.] [1.10 - 6 st.]
|
2911
|
Hydroxizin oralt 2 mg/mL (Atarax) oral lösning
|
3.0
|
2025-03-27
|
[3.0 - 6 st.] [2.5 - 5 st.]
|
1297
|
Hydroxokobalamin intramuskulär inj 1 mg/mL (Vitamin B12, f.d Behepan)
|
4.2
|
2025-01-23
|
[4.2 - 11 st.] [2.1 - 1 st.]
|
5362
|
Hydroxokobalamin intramuskulär inj 5 mg/mL (Vitamin B12, ex Hydroxocobalamine Acetate Sterop, licens)
|
1.0
|
2024-11-28
|
[1.0 - 4 st.]
|
5152
|
Hydroxokobalamin intravenös inf 25 mg/mL (Cyanokit)
|
1.1
|
2021-12-22
|
[1.1 - 6 st.]
|
3316
|
Högflödesgrimma (ex Optiflow, Airvo)
|
3.1
|
2024-02-08
|
[3.1 - 7 st.]
|
5103
|
Ibuprofen intravenös inf 4 mg/mL
|
2.4
|
2025-02-06
|
[2.4 - 5 st.]
|
4910
|
Ibuprofen intravenös inf 6 mg/mL
|
2.4
|
2025-02-06
|
[2.4 - 4 st.]
|
1243
|
Ibuprofen intravenös inf/inj 5 mg/mL (Pedea)
|
8.2
|
2025-02-06
|
[8.2 - 16 st.]
|
3431
|
Ibuprofen oralt (ex Ipren) tabletter/kapsel
|
4.3
|
2023-10-26
|
[4.3 - 18 st.] [3.4 - 1 st.]
|
3432
|
Ibuprofen oralt 20 mg/mL (ex Ipren) oral suspension
|
4.6
|
2023-10-26
|
[4.6 - 20 st.] [3.0 - 1 st.]
|
4612
|
Ibuprofen oralt 40 mg/mL (ex Nurofen Apelsin) oral suspension
|
3.0
|
2023-10-26
|
[3.0 - 6 st.] [2.5 - 1 st.]
|
3435
|
Ibuprofen rektalt (ex Ipren) suppositorier
|
5.0
|
2023-12-14
|
[5.0 - 15 st.] [4.1 - 1 st.] [3.3 - 1 st.] [2.4 - 1 st.]
|
4895
|
Idursulfas intravenös inf (Elaprase) dos tillsätts till spädningsvätska
|
2.0
|
2023-12-14
|
[2.0 - 8 st.]
|
1371
|
Iloprost inhalation 0,5 mikrog/mL (Ilomedin)
|
2.1
|
2020-07-02
|
[2.1 - 4 st.]
|
4544
|
Iloprost inhalation 2 mikrog/mL (Ilomedin)
|
1.2
|
2020-07-02
|
[1.2 - 9 st.]
|
4564
|
Iloprost inhalation 2,5 mikrog/mL (Ilomedin)
|
4.0
|
2020-07-02
|
[4.0 - 2 st.]
|
3232
|
Imiglukeras intravenös inf (Cerezyme) dos tillsätts till spädningsvätska
|
1.1
|
2024-08-29
|
[1.1 - 5 st.]
|
1212
|
Imipenem + Cilastatin intravenös inf 5 + 5 mg/mL (ex Tienam)
|
3.4
|
2021-10-07
|
[3.4 - 17 st.]
|
4812
|
Immunglobulin intramuskulär/subkutan inj 160 mg/mL (Beriglobin)
|
2.0
|
2024-03-27
|
[2.0 - 5 st.]
|
3039
|
Immunglobulin intravenös inf 100 mg/mL (ex Kiovig, Privigen)
|
7.3
|
2025-01-23
|
[7.3 - 16 st.] [5.0 - 3 st.]
|
5115
|
Immunglobulin subkutan inj 200 mg/mL (ex Cuvitru)
|
1.1
|
2024-04-04
|
[1.1 - 6 st.]
|
5338
|
Indocyaningrönt intravenös inj 5 mg/mL (Verdye)
|
1.0
|
2024-08-29
|
[1.0 - 4 st.]
|
2891
|
Infliximab intravenös inf (ex Remicade) dos tillsätts till spädningsvätska
|
6.0
|
2024-03-21
|
[6.0 - 12 st.] [5.4 - 3 st.]
|
5257
|
Insulin: Direktverkande subkutan inj 200 E/mL (Humalog KwikPen) förfylld penna
|
1.1
|
2023-09-21
|
[1.1 - 5 st.]
|
5238
|
Insulin: Långverkande subkutan inj 100 E/mL (ex Lantus, Levemir, Tresiba)
|
1.1
|
2023-07-06
|
[1.1 - 11 st.]
|
5149
|
Insulin: Långverkande subkutan inj 200 E/mL (Tresiba)
|
1.1
|
2023-07-06
|
[1.1 - 5 st.]
|
5239
|
Insulin: Långverkande subkutan inj 300 E/mL (Toujeo)
|
1.1
|
2023-07-06
|
[1.1 - 4 st.]
|
5010
|
Insulin: Snabb- alt. direktverkande intravenös inf/inj 0,05 E/mL (ex Actrapid Penfill)
|
2.0
|
2023-06-15
|
[2.0 - 3 st.]
|
4556
|
Insulin: Snabb- alt. direktverkande intravenös inf/inj 0,1 E/mL (ex Extempore, Actrapid Penfill)
|
6.0
|
2023-06-15
|
[6.0 - 5 st.]
|
3386
|
Insulin: Snabb- alt. direktverkande intravenös inf/inj 0,2 E/mL (ex Actrapid Penfill)
|
6.0
|
2023-06-15
|
[6.0 - 7 st.]
|
4603
|
Insulin: Snabb- alt. direktverkande intravenös inf/inj 0,2 E/mL (ex Extempore) bl.a. spädning från 10 E/mL
|
4.0
|
2023-06-15
|
[4.0 - 3 st.] [3.3 - 1 st.]
|
1426
|
Insulin: Snabb- alt. direktverkande intravenös inf/inj 1 E/mL (ex Actrapid Penfill)
|
10.0
|
2023-06-15
|
[9.2 - 2 st.] [10.0 - 13 st.]
|
5148
|
Insulin: Snabb- alt. direktverkande subkutan inj 100 E/mL (ex Actrapid Penfill, Humalog)
|
1.2
|
2023-09-28
|
[1.2 - 8 st.]
|
4999
|
Intralipid intravenös inf/inj 200 mg/mL Vid hjärtstillestånd orsakat av lokalanestetika
|
2.0
|
2024-03-21
|
[2.0 - 5 st.]
|
1298
|
Ipratropiumbromid inhalation (ex Atrovent)
|
10.0
|
2024-12-12
|
[9.0 - 1 st.] [7.6 - 3 st.] [6.6 - 1 st.] [10.0 - 12 st.]
|
4750
|
Isavukonazol intravenös inf 0,8 mg/mL (Cresemba)
|
2.0
|
2024-11-14
|
[2.0 - 5 st.]
|
4909
|
Isoniazid intravenös inj 50 mg/mL (Extempore)
|
2.0
|
2023-11-02
|
[2.0 - 4 st.]
|
4527
|
Isoniazid oralt (ex Tibinide) tabletter
|
2.0
|
2023-11-02
|
[2.0 - 6 st.]
|
5019
|
Isoniazid oralt 20 mg/mL (Extempore) oral lösning
|
2.0
|
2023-11-02
|
[2.0 - 7 st.]
|
5138
|
Isoprenalin intravenös inf 0,01 mg/mL = 10 mikrog/mL (ex Isoprenaline)
|
3.1
|
2022-09-08
|
[3.1 - 8 st.]
|
5139
|
Isoprenalin intravenös inf 0,02 mg/mL = 20 mikrog/mL (ex Isoprenaline)
|
2.3
|
2022-09-08
|
[2.3 - 2 st.]
|
5140
|
Isoprenalin intravenös inf 0,05 mg/mL = 50 mikrog/mL (ex Isoprenaline)
|
3.1
|
2022-09-08
|
[3.1 - 4 st.]
|
5141
|
Isoprenalin intravenös inf 0,08 mg/mL = 80 mikrog/mL (ex Isoprenaline)
|
2.3
|
2022-09-08
|
[2.3 - 3 st.]
|
3176
|
Isoton aminosyralösning + Heparin 0,2 E/mL intraarteriell inf ocklusionsförebyggande spoldropp
|
2.3
|
2023-09-21
|
[2.3 - 2 st.]
|
5196
|
Isoton aminosyralösning + Heparin 2 E/mL intraarteriell inf ocklusionsförebyggande spoldropp
|
1.3
|
2023-09-21
|
[1.3 - 3 st.]
|
3024
|
Isoton aminosyralösning intraarteriell inf (Vaminolac) ocklusionsförebyggande spoldropp
|
2.2
|
2023-09-21
|
[2.2 - 6 st.]
|
5110
|
Ispaghula oralt (ex Vi-Siblin)
|
2.1
|
2021-06-17
|
[2.1 - 5 st.]
|
5183
|
Ivakaftor + Tezakaftor + Elexakaftor oralt (Kaftrio) tabletter/granulat
|
2.1
|
2024-03-07
|
[2.1 - 5 st.]
|
5213
|
Ivakaftor oralt (Kalydeco) tabletter/granulat
|
2.0
|
2025-04-30
|
[2.0 - 4 st.] [1.2 - 1 st.]
|
3309
|
Johexol intravenös inj 300 mg I/mL (Omnipaque) för iohexolclearance
|
3.2
|
2022-03-31
|
[3.2 - 5 st.]
|
2479
|
Järn(II)sulfat oralt 100 mg Fe2+ (ex Niferex)
|
3.5
|
2024-09-05
|
[3.5 - 10 st.]
|
1307
|
Järn(II)sulfat oralt 30 mg Fe2+/mL (Glutaferro licens, f.d Niferex) oral lösning/orala droppar
|
6.0
|
2024-10-10
|
[6.0 - 14 st.] [5.6 - 3 st.] [4.8 - 1 st.]
|
4994
|
Järn(III)derisomaltos intravenös inf 5 mg Fe/mL (MonoFer)
|
3.4
|
2024-11-28
|
[3.4 - 4 st.]
|
3027
|
Järn(III)karboximaltos intravenös inf (ex Ferinject) dos tillsätts till spädningsvätska
|
4.7
|
2025-01-09
|
[4.7 - 11 st.] [3.2 - 3 st.]
|
4977
|
Järn(III)karboximaltos intravenös inf 5 mg Fe/mL (ex Ferinject)
|
2.8
|
2025-01-09
|
[2.8 - 5 st.] [1.2 - 1 st.]
|
5306
|
Järnsackaros intravenös inf (Venofer) dos tillsätts till spädningsvätska
|
1.2
|
2024-11-20
|
[1.2 - 2 st.]
|
2817
|
Järnsackaros intravenös inf 1 mg Fe/mL (Venofer)
|
4.3
|
2024-11-20
|
[4.3 - 10 st.] [3.0 - 1 st.]
|
4967
|
Järnsackaros intravenös inj 20 mg Fe/mL (Venofer)
|
3.2
|
2024-01-11
|
[3.2 - 3 st.]
|
3085
|
Kalcitriol oralt 1 mikrog/mL (Rocaltrol licens) oral lösning
|
1.1
|
2025-01-30
|
[1.1 - 4 st.]
|
4558
|
Kalcium oralt 15 mg (Extempore) kapsel
|
1.1
|
2021-11-11
|
[1.1 - 9 st.]
|
1364
|
Kalcium oralt 7 mg/mL (Extempore) oral lösning
|
2.1
|
2021-11-11
|
[2.1 - 12 st.]
|
2886
|
Kalciumglukonat intravenös inf/inj 0,223 mmol Ca/mL (Zeltacin)
|
8.0
|
2025-02-06
|
[8.0 - 15 st.] [7.3 - 4 st.]
|
4642
|
Kalciumklorid intravenös inf 0,1 mmol Ca/mL (Extempore)
|
2.0
|
2024-05-08
|
[2.0 - 1 st.]
|
4582
|
Kalciumklorid intravenös inf/inj 0,45 mmol Ca/mL (Extempore)
|
2.0
|
2024-05-08
|
[2.0 - 1 st.]
|
1365
|
Kaliumcitrat oralt 0,85 mmol K/mL (Kajos) oral lösning
|
7.0
|
2022-06-02
|
[7.0 - 19 st.]
|
5218
|
Kaliumcitrat oralt 0,93 mmol K/mL (Kaliumcitrat APL 100mg/mL, extempore) oral lösning
|
1.0
|
2022-12-01
|
[1.0 - 6 st.]
|
3364
|
Kaliumjodid oralt 65 mg
|
2.2
|
2023-12-07
|
[2.2 - 3 st.]
|
3325
|
Kaliumkanrenoat intravenös inj 10 mg/mL (ex Aldactone licens)
|
4.1
|
2024-11-28
|
[4.1 - 3 st.] [3.2 - 1 st.]
|
4631
|
Kaliumkanrenoat intravenös inj 20 mg/mL (ex Aldactone licens)
|
3.2
|
2024-11-28
|
[3.2 - 5 st.]
|
1346
|
Kaliumklorid intravenös inf 0,2 mmol/mL (från ex Addex-Kaliumklorid)
|
7.1
|
2024-12-19
|
[7.1 - 4 st.]
|
5022
|
Kaliumklorid intravenös inf 0,3 mmol/mL (från ex Addex-Kaliumklorid)
|
5.1
|
2024-12-19
|
[5.1 - 2 st.] [3.0 - 1 st.]
|
4640
|
Kaliumklorid intravenös inf 0,5 mmol/mL (från ex Addex-Kaliumklorid)
|
6.1
|
2024-12-19
|
[6.1 - 2 st.]
|
4641
|
Kaliumklorid intravenös inf 1 mmol/mL (från ex Addex-Kaliumklorid)
|
7.1
|
2024-12-19
|
[7.1 - 5 st.] [5.1 - 2 st.]
|
4719
|
Kaliumklorid intravenös inf 2 mmol/mL (ex Addex-Kaliumklorid)
|
1.1
|
2024-12-19
|
[1.1 - 2 st.]
|
1386
|
Kaliumklorid oralt 2 mmol/mL (ex Extempore) oral vätska
|
2.0
|
2024-05-08
|
[2.0 - 9 st.] [1.4 - 1 st.]
|
4883
|
Kandesartan oralt (ex Atacand) tabletter
|
2.3
|
2025-03-06
|
[2.3 - 5 st.]
|
4677
|
Kaptopril oralt (ex Extempore) tabletter/kapslar
|
5.3
|
2024-08-01
|
[5.3 - 5 st.]
|
1394
|
Kaptopril oralt 0,2 mg/mL oral lösning
|
1.1
|
2022-01-20
|
[1.1 - 4 st.]
|
4636
|
Kaptopril oralt 1 mg/mL (ex Noyada 5mg/5mL licens) oral lösning
|
7.1
|
2022-10-13
|
[7.1 - 9 st.]
|
5032
|
Kaptopril oralt 5 mg/mL (ex Noyada 25 mg/5 mL licens) oral lösning
|
5.2
|
2022-10-13
|
[5.2 - 5 st.]
|
4894
|
Karayagummi oralt (Inolaxol)
|
2.2
|
2024-11-28
|
[2.2 - 5 st.]
|
4897
|
Karbamazepin oralt (ex Tegretol) tabletter
|
1.2
|
2024-12-05
|
[1.2 - 6 st.]
|
4898
|
Karbamazepin oralt 20 mg/mL (Tegretol) oral suspension
|
1.0
|
2023-10-26
|
[1.0 - 6 st.]
|
4787
|
Karbomer konjunktivalt (ex Viscotears) ögongel
|
1.2
|
2022-06-27
|
[1.2 - 6 st.]
|
4621
|
Kargluminsyra oralt 200 mg (ex Carbaglu) dispergerbar tablett
|
2.3
|
2020-12-10
|
[2.3 - 8 st.]
|
5281
|
Karperitid intravenös inf 10 mikrog/mL (hANP, licens)
|
1.1
|
2023-12-14
|
[1.1 - 2 st.]
|
5246
|
Karperitid intravenös inf 25 mikrog/mL (hANP, licens)
|
1.1
|
2023-12-14
|
[1.1 - 3 st.]
|
4637
|
Karperitid intravenös inf 100 mikrog/mL (hANP, licens)
|
1.1
|
2023-12-14
|
[1.1 - 4 st.]
|
4876
|
Kaspofungin intravenös inf 0,2 mg/mL (ex Cancidas)
|
3.7
|
2024-01-25
|
[3.7 - 1 st.]
|
3164
|
Kaspofungin intravenös inf 0,4 mg/mL (ex Cancidas)
|
6.6
|
2024-01-25
|
[6.6 - 5 st.]
|
4584
|
Kaspofungin intravenös inf 0,5 mg/mL (ex Cancidas)
|
6.7
|
2024-01-25
|
[6.7 - 14 st.]
|
4566
|
Ketamin intravenös inf/inj 10 mg/mL (ex Ketalar)
|
3.0
|
2024-09-12
|
[3.0 - 3 st.]
|
4682
|
Ketobemidon intravenös inf, 1 mL = 10 mikrog/kg (f.d Ketogan Novum) individuell spädning
|
3.0
|
2024-09-12
|
[3.0 - 2 st.]
|
3337
|
Ketobemidon intravenös inf, 1 mL = 20 mikrog/kg (f.d Ketogan Novum) individuell spädning
|
4.0
|
2024-09-12
|
[4.0 - 3 st.]
|
5393
|
Ketobemidon intravenös inf/inj 0,02 mg/mL = 20 mikrog/mL (f.d Ketogan Novum)
|
1.0
|
2025-03-27
|
[1.0 - 2 st.]
|
2085
|
Ketobemidon intravenös inf/inj 0,05 mg/mL = 50 mikrog/mL (f.d Ketogan Novum)
|
8.0
|
2024-09-12
|
[8.0 - 3 st.] [7.0 - 1 st.]
|
4690
|
Ketobemidon intravenös inf/inj 0,1 mg/mL = 100 mikrog/mL (f.d Ketogan Novum)
|
6.0
|
2024-09-12
|
[6.0 - 3 st.]
|
4915
|
Ketobemidon intravenös inf/inj 0,2 mg/mL = 200 mikrog/mL (f.d Ketogan Novum)
|
5.0
|
2024-09-12
|
[5.0 - 2 st.]
|
2822
|
Ketobemidon intravenös inf/inj 1 mg/mL (ex Ketobemidon Unimedic)
|
9.0
|
2024-09-12
|
[9.0 - 13 st.]
|
2898
|
Ketorolak intravenös inj 3 mg/mL (ex Toradol)
|
3.7
|
2025-02-27
|
[3.7 - 8 st.]
|
2763
|
Klemastin intravenös/intramuskulär inj 1 mg/mL (ex Tavegyl licens)
|
6.0
|
2022-11-17
|
[6.0 - 8 st.] [4.0 - 3 st.]
|
2765
|
Klemastin oralt 1 mg (Tavegyl) tablett
|
3.4
|
2022-12-08
|
[3.4 - 9 st.]
|
2172
|
Klindamycin intravenös inf 5 mg/mL (ex Dalacin)
|
7.2
|
2025-03-13
|
[7.2 - 14 st.] [6.1 - 1 st.] [5.6 - 1 st.]
|
5043
|
Klindamycin intravenös inf 6 mg/mL (ex Dalacin)
|
3.2
|
2025-03-13
|
[3.2 - 3 st.]
|
3418
|
Klindamycin intravenös inf 10 mg/mL (ex Dalacin)
|
5.2
|
2025-03-13
|
[5.2 - 6 st.] [3.6 - 2 st.]
|
5044
|
Klindamycin intravenös inf 12 mg/mL (ex Dalacin)
|
3.2
|
2025-03-13
|
[3.2 - 6 st.]
|
4747
|
Klindamycin oralt (ex Dalacin) kapslar
|
4.2
|
2025-03-13
|
[4.2 - 13 st.] [2.4 - 2 st.] [1.3 - 1 st.]
|
2573
|
Klindamycin oralt 15 mg/mL (ex Dalacin) oral lösning
|
6.3
|
2025-03-19
|
[6.3 - 17 st.] [4.5 - 3 st.]
|
2705
|
kloBAzam oralt 10 mg (ex Frisium licens) tablett
|
2.6
|
2025-03-27
|
[2.6 - 9 st.]
|
4893
|
Klobetasolpropionat utvärtes (ex Dermovat)
|
2.2
|
2025-01-23
|
[2.2 - 5 st.]
|
5241
|
Klofazimin oralt (ex Lamprene licens) kapslar/tablett
|
1.0
|
2024-10-24
|
[1.0 - 5 st.]
|
2709
|
kloNAzepam intravenös inj 0,5 mg/mL (Rivotril licens)
|
4.4
|
2024-10-17
|
[4.4 - 10 st.]
|
3360
|
kloNAzepam oralt (ex Iktorivil) tabletter
|
5.5
|
2024-10-17
|
[5.5 - 10 st.]
|
3105
|
kloNAzepam oralt 2,5 mg/mL (Iktorivil) orala droppar
|
5.6
|
2025-05-08
|
[5.6 - 9 st.]
|
5039
|
Klonidin intravenös inf, 1 mL = 0,5 mikrog/kg (ex Catapresan) individuell spädning
|
2.0
|
2024-06-05
|
[2.0 - 2 st.]
|
3298
|
Klonidin intravenös inf/inj 0,5 mikrog/mL (ex Catapresan)
|
7.0
|
2024-06-05
|
[7.0 - 5 st.]
|
3410
|
Klonidin intravenös inf/inj 1 mikrog/mL (ex Catapresan)
|
8.0
|
2024-06-05
|
[8.0 - 7 st.]
|
4762
|
Klonidin intravenös inf/inj 5 mikrog/mL (ex Catapresan)
|
4.0
|
2024-06-05
|
[4.0 - 2 st.] [2.10 - 1 st.]
|
5046
|
Klonidin intravenös inf/inj 7,5 mikrog/mL (ex Catapresan)
|
3.0
|
2024-06-05
|
[3.0 - 2 st.]
|
3440
|
Klonidin intravenös inf/inj 10 mikrog/mL (ex Catapresan)
|
6.0
|
2024-06-05
|
[6.0 - 9 st.] [4.9 - 1 st.]
|
2560
|
Klonidin intravenös inf/inj 15 mikrog/mL (ex Catapresan, Extempore)
|
9.0
|
2024-06-05
|
[9.0 - 13 st.] [7.10 - 1 st.]
|
1409
|
Klonidin intravenös inf/inj 3 mikrog/mL (ex Catapresan, Extempore)
|
11.0
|
2024-06-05
|
[9.10 - 1 st.] [11.0 - 14 st.]
|
1358
|
Klonidin oralt 5 mikrog/mL (Extempore) oral lösning
|
8.0
|
2024-06-05
|
[8.0 - 8 st.]
|
2692
|
Klonidin oralt (ex Catapresan licens) tabletter
|
8.1
|
2024-06-13
|
[8.1 - 11 st.] [4.1 - 1 st.]
|
3441
|
Klonidin oralt 10 mikrog/mL (ex Catapresan)
|
7.0
|
2024-06-05
|
[7.0 - 2 st.]
|
3357
|
Klonidin oralt 20 mikrog/mL (ex Extempore) oral lösning
|
8.0
|
2024-06-05
|
[8.0 - 16 st.] [6.2 - 2 st.] [3.3 - 1 st.]
|
2951
|
Kloralhydrat oralt 140 mg/mL (Extempore) oral lösning
|
5.0
|
2021-06-03
|
[5.0 - 3 st.]
|
1356
|
Kloralhydrat oralt 70 mg/mL (Extempore) oral lösning
|
5.0
|
2021-06-03
|
[5.0 - 14 st.]
|
1357
|
Kloralhydrat rektalt 200 mg/mL (Extempore) rektal lösning
|
7.0
|
2021-06-03
|
[7.0 - 5 st.] [1.0 - 1 st.]
|
4587
|
Kloralhydrat rektalt 70 mg/mL (Extempore)
|
3.0
|
2021-06-03
|
[3.0 - 4 st.]
|
1380
|
Kloramfenikol konjunktivalt 10 mg/g = 1 % ögonsalva
|
3.1
|
2022-06-27
|
[3.1 - 11 st.]
|
2972
|
Kloramfenikol konjunktivalt 5 mg/mL ögondroppar
|
3.2
|
2024-08-01
|
[3.2 - 15 st.]
|
5410
|
Klorokin oralt (ex Resochin licens) tabletter
|
2.1
|
2025-04-16
|
[2.1 - 4 st.]
|
4990
|
Klorokinfosfat oralt 15 mg/mL (Extempore) oral suspension
|
4.0
|
2024-10-17
|
[4.0 - 5 st.]
|
1282
|
Klortiazid oralt 50 mg/mL (Diuril licens) oral suspension
|
2.0
|
2019-12-12
|
[2.0 - 11 st.]
|
1385
|
Klotrimazol utvärtes 1 % (Canesten) kräm
|
3.1
|
2022-06-27
|
[3.1 - 8 st.]
|
4687
|
Kloxacillin intravenös inf 10 mg/mL (f.d Ekvacillin)
|
5.2
|
2024-04-04
|
[5.2 - 6 st.]
|
1274
|
Kloxacillin intravenös inf 20 mg/mL (f.d Ekvacillin)
|
7.2
|
2024-04-04
|
[7.2 - 16 st.]
|
4596
|
Kloxacillin intravenös inf 25 mg/mL (f.d Ekvacillin)
|
6.2
|
2024-04-04
|
[6.2 - 4 st.]
|
3069
|
Kloxacillin intravenös inf/inj 50 mg/mL (f.d Ekvacillin)
|
7.2
|
2024-04-04
|
[7.2 - 14 st.]
|
4485
|
Koagulationsfaktor IX intravenös inj plasmaderivat, hel ampull
|
2.1
|
2022-03-31
|
[2.1 - 4 st.]
|
4484
|
Koagulationsfaktor IX intravenös inj rekombinant, hel ampull
|
2.2
|
2024-03-14
|
[2.2 - 5 st.]
|
4483
|
Koagulationsfaktor VIIa intravenös inj (Novoseven) rekombinant, AKTIVERAD, hel ampull
|
1.3
|
2019-05-23
|
[1.3 - 5 st.]
|
2100
|
Koagulationsfaktor VIIa intravenös inj 1 mg/mL (Novoseven) rekombinant, aktiverat, nyfödda
|
4.3
|
2019-08-20
|
[4.3 - 6 st.]
|
4494
|
Koagulationsfaktor VIII + von Willebrandfaktor intravenös inj (Haemate)
|
1.3
|
2019-08-21
|
[1.3 - 7 st.]
|
1337
|
Koagulationsfaktor VIII intravenös inj 100 E/mL (ex Kovaltry) rekombinant
|
1.1
|
2019-01-17
|
[1.1 - 4 st.]
|
4577
|
Koagulationsfaktor VIII intravenös inj 125 E/mL (ex Advate) rekombinant
|
1.4
|
2024-08-15
|
[1.4 - 5 st.]
|
4578
|
Koagulationsfaktor VIII intravenös inj 200 E/mL rekombinant, nyfödda
|
1.5
|
2024-08-15
|
[1.5 - 5 st.]
|
4581
|
Koagulationsfaktor VIII intravenös inj 250 E/mL rekombinant, nyfödda
|
1.3
|
2024-08-15
|
[1.3 - 4 st.]
|
4580
|
Koagulationsfaktor VIII intravenös inj 62,5 E/mL (ex NovoEight) rekombinant
|
1.2
|
2019-01-24
|
[1.2 - 4 st.]
|
4486
|
Koagulationsfaktor VIII intravenös inj plasmaderivat
|
1.6
|
2024-08-15
|
[1.6 - 4 st.]
|
4476
|
Koagulationsfaktor VIII intravenös inj rekombinant
|
1.8
|
2024-08-15
|
[1.8 - 6 st.]
|
4487
|
Koagulationsfaktor VIII intravenös inj rekombinant, långverkande
|
1.8
|
2024-08-15
|
[1.8 - 6 st.]
|
3291
|
Koffeincitrat intravenös inf 10 mg/mL (Gencebok, Peyona)
|
2.0
|
2022-09-15
|
[2.0 - 5 st.]
|
3283
|
Koffeincitrat intravenös inf/inj 20 mg/mL (Peyona)
|
2.1
|
2022-09-15
|
[2.1 - 14 st.]
|
1354
|
Koffeincitrat oralt 10 mg/mL (Peyona, Gencebok, extempore)
|
3.0
|
2022-09-15
|
[3.0 - 5 st.]
|
4709
|
Koffeincitrat oralt 20 mg/mL (Peyona)
|
3.1
|
2022-09-29
|
[3.1 - 17 st.]
|
4901
|
Kolekalciferol oralt (Vitamin D3, ex Divisun) tabletter/kapslar
|
1.7
|
2024-01-18
|
[1.7 - 6 st.]
|
5023
|
Kolekalciferol oralt 20 000 E/mL (Vitamin D3, ex Detremin) orala droppar
|
1.1
|
2021-01-21
|
[1.1 - 5 st.]
|
2055
|
Kolekalciferol oralt 80 E/droppe (Vitamin D3, ex D-vitamin ACO) orala droppar
|
5.6
|
2024-01-25
|
[5.6 - 17 st.]
|
3355
|
Kolistimetat intravenös inf 20 000 E/mL (Tadim) prodrug till kolistin
|
1.4
|
2022-11-10
|
[1.4 - 8 st.]
|
2941
|
Kreatin oralt (Extempore) dospulver/kapslar
|
1.0
|
2022-03-10
|
[1.0 - 4 st.]
|
5217
|
Kvetiapin oralt (ex Quetiapine Accord, Seroquel Depot) tabletter/depottabletter
|
1.2
|
2024-09-19
|
[1.2 - 5 st.]
|
4635
|
laBETalol intravenös inf/inj 1 mg/mL (ex Trandate)
|
2.1
|
2025-03-27
|
[2.1 - 3 st.] [1.3 - 1 st.]
|
4781
|
laBETalol intravenös inf/inj 5 mg/mL (ex Trandate)
|
2.1
|
2025-03-27
|
[2.1 - 4 st.] [1.4 - 2 st.]
|
2989
|
Lactobacillus reuteri oralt (Protectis) tuggtablett
|
1.2
|
2019-10-24
|
[1.2 - 3 st.]
|
2990
|
Lactobacillus reuteri oralt (Semper magdroppar)
|
1.2
|
2019-10-24
|
[1.2 - 10 st.]
|
5122
|
Lakosamid intravenös inf 10 mg/mL (ex Vimpat)
|
1.1
|
2025-03-13
|
[1.1 - 4 st.]
|
4649
|
Lakosamid oralt (ex Vimpat) tabletter
|
1.1
|
2025-03-13
|
[1.1 - 5 st.]
|
3253
|
Lakosamid oralt 10 mg/mL (Vimpat) sirap
|
1.1
|
2025-03-13
|
[1.1 - 5 st.]
|
1275
|
Laktulos oralt 670 mg/mL (ex Duphalac) oral lösning
|
4.0
|
2024-03-07
|
[4.0 - 16 st.] [3.5 - 4 st.]
|
4684
|
Lamivudin oralt (ex Epivir) tabletter
|
1.1
|
2022-09-29
|
[1.1 - 5 st.]
|
1271
|
Lamivudin oralt 10 mg/mL (Epivir) oral lösning
|
3.0
|
2022-09-29
|
[3.0 - 10 st.]
|
4794
|
Lamotrigin oralt (ex Lamictal) tabletter
|
2.8
|
2025-05-08
|
[2.8 - 12 st.]
|
1331
|
LANSOprazol oralt (ex Lanzo) tabletter/kapslar
|
3.5
|
2024-10-10
|
[3.5 - 9 st.] [2.1 - 1 st.]
|
5040
|
Laronidas intravenös inf (Aldurazyme) dos tillsätts till spädningsvätska
|
2.0
|
2023-12-14
|
[2.0 - 5 st.]
|
2850
|
leveTIRacetam intravenös inf (ex Keppra) dos tillsätts till spädningsvätska
|
9.0
|
2025-02-13
|
[9.0 - 2 st.] [8.0 - 1 st.]
|
4534
|
leveTIRacetam intravenös inf 5 mg/mL (ex Keppra, Kevesy)
|
8.1
|
2025-02-13
|
[8.1 - 5 st.]
|
4614
|
leveTIRacetam intravenös inf 10 mg/mL (ex Keppra, Kevesy)
|
9.0
|
2025-02-13
|
[9.0 - 8 st.] [8.0 - 4 st.]
|
4533
|
leveTIRacetam intravenös inf 15 mg/mL (ex Keppra)
|
11.0
|
2025-02-13
|
[11.0 - 5 st.] [10.0 - 4 st.]
|
2713
|
leveTIRacetam oralt (ex Keppra) tabletter
|
5.0
|
2025-02-13
|
[5.0 - 9 st.] [4.10 - 5 st.] [3.1 - 1 st.] [2.15 - 1 st.]
|
2714
|
leveTIRacetam oralt 100 mg/mL (ex Keppra) oral lösning
|
7.0
|
2025-02-13
|
[7.0 - 9 st.] [6.0 - 6 st.] [5.1 - 1 st.] [2.2 - 1 st.]
|
3349
|
levoBUPivakain + Klonidin inf 0,625 mg/mL + 1 mikrog/mL (f.d Chirocaine + ex Catapresan) flera administreringssätt
|
5.4
|
2025-02-20
|
[5.4 - 3 st.]
|
3350
|
levoBUPivakain + Klonidin inf 1,25 mg/mL + 1 mikrog/mL (f.d Chirocaine + ex Catapresan) flera administreringssätt
|
5.3
|
2025-02-20
|
[5.3 - 4 st.]
|
2833
|
levoBUPivakain 2,5 mg/mL (f.d Chirocaine) sårkateter
|
4.0
|
2025-02-20
|
[4.0 - 3 st.] [3.2 - 1 st.]
|
1382
|
levoBUPivakain inf/inj 0,625 mg/mL (f.d Chirocaine) flera administreringssätt
|
6.0
|
2025-02-20
|
[6.0 - 3 st.] [5.3 - 2 st.] [2.1 - 1 st.]
|
2570
|
levoBUPivakain inf/inj 1,25 mg/mL (f.d Chirocaine) flera administreringssätt
|
5.1
|
2025-02-20
|
[5.1 - 3 st.] [4.2 - 2 st.] [2.4 - 1 st.]
|
2929
|
Levofloxacin intravenös inf 5 mg/mL (Tavanic)
|
3.4
|
2024-12-19
|
[3.4 - 6 st.]
|
5185
|
Levofloxacin oralt 25 mg/mL (licens) oral lösning
|
1.1
|
2024-03-14
|
[1.1 - 5 st.]
|
4688
|
Levofloxacin oralt tabletter
|
4.0
|
2023-11-02
|
[4.0 - 5 st.]
|
1384
|
levoKARNitin intravenös inf/inj 50 mg/mL (ex Carnitene licens)
|
3.3
|
2025-02-27
|
[3.3 - 8 st.] [2.1 - 1 st.]
|
4610
|
levoKARNitin intravenös inf/inj 200 mg/mL (ex Carnitene licens)
|
2.3
|
2025-02-27
|
[2.3 - 6 st.] [1.1 - 1 st.]
|
1362
|
levoKARNitin oralt 200 mg/mL (ex Carnitene licens) oral lösning
|
2.4
|
2025-02-27
|
[2.4 - 10 st.]
|
5130
|
levoKARNitin oralt 300 mg/mL (ex Carnitene licens) oral lösning
|
1.2
|
2025-02-27
|
[1.2 - 4 st.]
|
4477
|
levoSIMendan intravenös inf 0,025 mg/mL = 25 mikrog/mL (ex Simdax)
|
2.9
|
2025-02-13
|
[2.9 - 3 st.] [1.2 - 1 st.]
|
3443
|
levoSIMendan intravenös inf 0,05 mg/mL = 50 mikrog/mL (ex Simdax)
|
2.9
|
2025-02-13
|
[2.9 - 5 st.]
|
2468
|
levoTYROxin oralt (ex Levaxin) tabletter
|
3.5
|
2025-02-27
|
[3.5 - 13 st.]
|
4526
|
Lidokain + Adrenalin + Tetrakain utvärtes 4 + 0,05 + 0,5 % (LAT-gel, extempore) gel
|
1.3
|
2024-01-11
|
[1.3 - 8 st.]
|
1273
|
Lidokain + Prilokain utvärtes (ex EMLA) kräm, plåster
|
2.7
|
2024-10-31
|
[2.7 - 19 st.]
|
3219
|
Lidokain + Tetrakain utvärtes (Rapydan, Pliaglis licens) kräm, plåster
|
2.1
|
2025-03-27
|
[2.1 - 12 st.] [1.4 - 1 st.]
|
4929
|
Lidokain intravenös inf/inj 10 mg/mL (ex Xylocain utan konserveringsmedel)
|
4.0
|
2025-04-30
|
[4.0 - 2 st.] [3.1 - 2 st.] [2.7 - 1 st.]
|
4634
|
Lidokain intravenös inf/inj 2 mg/mL (ex Xylocain)
|
5.0
|
2025-04-30
|
[5.0 - 2 st.] [4.0 - 1 st.] [3.6 - 2 st.]
|
1196
|
Lidokain intravenös inf/inj 20 mg/mL (Xylocard)
|
6.0
|
2025-04-30
|
[6.0 - 6 st.] [5.1 - 8 st.]
|
4563
|
Lidokain lokalbedövning 10 mg/mL (ex Xylocain utan konserveringsmedel)
|
2.6
|
2024-01-11
|
[2.6 - 12 st.]
|
2685
|
Lidokain lokalbedövning 8,33 mg/mL (ex Xylocain utan kons.) buffrad med Natriumbikarbonat
|
5.7
|
2024-04-04
|
[5.7 - 8 st.]
|
1198
|
Lidokain lokalbedövning av yta (Xylocain) spray 10 mg/dos = 100 mg/mL
|
4.1
|
2022-06-27
|
[4.1 - 7 st.]
|
4839
|
Lidokain utvärtes 40 mg/g (LidoGalen licens) kräm
|
2.1
|
2023-02-09
|
[2.1 - 9 st.] [1.5 - 1 st.]
|
1199
|
Lidokain utvärtes gel 2 % = 20 mg/mL (ex Xylocain)
|
4.2
|
2024-12-19
|
[4.2 - 14 st.]
|
2930
|
Linezolid intravenös inf 2 mg/mL (ex Zyvoxid)
|
4.3
|
2024-01-11
|
[4.3 - 13 st.]
|
4469
|
Linezolid oralt 20 mg/mL (Zyvoxid) oral suspension
|
3.1
|
2024-01-11
|
[3.1 - 7 st.] [2.4 - 1 st.]
|
4468
|
Linezolid oralt 600 mg (ex Zyvoxid) tablett
|
3.2
|
2024-01-11
|
[3.2 - 6 st.] [2.0 - 1 st.]
|
4519
|
Liotyronin intravenös inf/inj 20 mikrog/mL (ex Thyrotardin licens)
|
2.0
|
2019-09-26
|
[2.0 - 1 st.]
|
4795
|
Lisdexamfetamin oralt (Elvanse) kapslar
|
1.7
|
2022-08-18
|
[1.7 - 10 st.]
|
4796
|
Litium oralt 42 mg (Lithionit) depottablett
|
2.0
|
2020-10-01
|
[2.0 - 9 st.]
|
4905
|
Loperamid oralt 2 mg (ex Dimor) kapsel/tablett
|
2.4
|
2023-06-08
|
[2.4 - 6 st.]
|
1363
|
Lopinavir + Ritonavir oralt 80 + 20 mg/mL (Kaletra) oral lösning
|
4.0
|
2025-04-24
|
[4.0 - 4 st.] [3.5 - 3 st.]
|
2862
|
Loratadin oralt 1 mg/mL (Clarityn) sirap
|
5.1
|
2021-09-23
|
[5.1 - 4 st.]
|
2863
|
Loratadin oralt 10 mg (ex Clarityn) tablett
|
5.1
|
2023-08-17
|
[5.1 - 8 st.]
|
4916
|
Lorazepam intramuskulär inj 4 mg/mL
|
2.2
|
2023-08-03
|
[2.2 - 5 st.]
|
3417
|
Lorazepam intravenös inj 1 mg/mL (ex Ativan licens)
|
5.0
|
2024-05-08
|
[5.0 - 4 st.]
|
3416
|
Lorazepam intravenös inj 2 mg/mL
|
7.0
|
2024-05-08
|
[7.0 - 6 st.] [5.2 - 1 st.]
|
4643
|
Lorazepam oralt/sublingualt 1 mg (ex Temesta) tablett/munsönderfallande tablett/resoriblett
|
1.3
|
2024-03-27
|
[1.3 - 5 st.]
|
4881
|
Losartan oralt (ex Cozaar) tabletter
|
2.6
|
2024-08-22
|
[2.6 - 5 st.]
|
4955
|
Losartan oralt 10 mg/mL (Extempore) oral suspension
|
1.3
|
2023-09-14
|
[1.3 - 5 st.]
|
5224
|
Lumakaftor + Ivakaftor oralt (Orkambi) tabletter/granulat
|
2.0
|
2024-01-11
|
[2.0 - 5 st.]
|
5216
|
Lurasidon oralt (Latuda) tabletter
|
2.2
|
2025-05-08
|
[2.2 - 5 st.]
|
3284
|
Magnesium intravenös inf/inj 0,1 mmol/mL
|
14.1
|
2025-01-30
|
[9.2 - 1 st.] [14.1 - 13 st.] [12.1 - 2 st.]
|
5194
|
Magnesium intravenös inf/inj 0,3 mmol/mL
|
1.1
|
2025-01-30
|
[1.1 - 2 st.]
|
4565
|
Magnesium intravenös inf/inj 0,5 mmol/mL
|
10.2
|
2025-01-30
|
[10.2 - 4 st.]
|
3120
|
Magnesium oralt 2,4 mg/mL = 0,1 mmol/mL
|
3.0
|
2024-06-13
|
[3.0 - 5 st.]
|
3292
|
Magnesium oralt 12 mg/mL = 0,5 mmol/mL (ex Extempore) oral lösning
|
4.0
|
2024-06-13
|
[4.0 - 8 st.]
|
2733
|
Makrogol + elektrolyter oralt (ex Movicol Junior Neutral)
|
5.7
|
2023-07-06
|
[5.7 - 18 st.]
|
4695
|
Makrogol + elektrolyter oralt (ex Movicol Junior Neutral) barn under 6 mån
|
2.9
|
2023-07-06
|
[2.9 - 9 st.]
|
2477
|
Makrogol + elektrolyter oralt (ex Movicol)
|
5.11
|
2023-07-06
|
[5.11 - 18 st.]
|
5170
|
Makrogol + elektrolyter oralt (Laxabon)
|
2.2
|
2023-07-06
|
[2.2 - 7 st.]
|
4696
|
Makrogol oralt (ex Forlax Junior)
|
4.2
|
2024-05-08
|
[4.2 - 16 st.]
|
4697
|
Makrogol oralt (ex Forlax)
|
3.4
|
2024-05-08
|
[3.4 - 16 st.]
|
3320
|
Mannitol intravenös inf 150 mg/mL
|
4.0
|
2022-11-03
|
[4.0 - 7 st.] [2.2 - 2 st.]
|
5356
|
Mebendazol oralt 100 mg (Vermox) tablett
|
1.0
|
2025-03-05
|
[1.0 - 4 st.]
|
5347
|
Mebendazol oralt 20 mg/mL (Vermox) oral suspension
|
1.0
|
2025-03-05
|
[1.0 - 4 st.]
|
3111
|
Medicinskt kol oralt (Carbomix) oral suspension
|
2.0
|
2023-05-17
|
[2.0 - 11 st.] [1.2 - 2 st.]
|
4995
|
Medicinskt kol oralt 150 mg/mL (Kolsuspension) oral suspension
|
2.0
|
2023-05-17
|
[2.0 - 6 st.] [1.2 - 1 st.]
|
2472
|
Melatonin oralt (ex Aritonin, Mellozzan)
|
7.2
|
2025-01-09
|
[7.2 - 12 st.] [6.14 - 3 st.]
|
5113
|
Melatonin oralt 1 mg/mL (ex Mellozzan) oral lösning
|
3.0
|
2024-11-28
|
[3.0 - 11 st.] [2.8 - 2 st.]
|
4946
|
Merkaptopurin oralt 20 mg/mL (Xaluprine) oral suspension
|
4.0
|
2021-11-25
|
[4.0 - 11 st.]
|
3170
|
Merkaptopurin oralt 50 mg (ex Puri-nethol) tablett
|
5.1
|
2022-03-03
|
[5.1 - 10 st.] [1.1 - 1 st.]
|
4592
|
Meropenem intravenös inf 10 mg/mL (ex Meronem)
|
7.2
|
2024-06-27
|
[7.2 - 5 st.] [4.6 - 2 st.]
|
4921
|
Meropenem intravenös inf 20 mg/mL (ex Meronem)
|
6.2
|
2024-06-27
|
[6.2 - 3 st.]
|
2176
|
Meropenem intravenös inf/inj 50 mg/mL (ex Meronem)
|
15.2
|
2024-06-27
|
[15.2 - 17 st.] [13.0 - 1 st.] [12.1 - 2 st.] [10.3 - 1 st.]
|
2897
|
Mesna intravenös inj 100 mg/mL (Uromitexan)
|
1.1
|
2025-05-08
|
[1.1 - 4 st.]
|
5417
|
Mesna oralt (Uromitexan) tabletter
|
1.1
|
2025-05-08
|
[1.1 - 4 st.]
|
3379
|
Metadon intravenös inf/inj 1 mg/mL
|
4.1
|
2024-12-19
|
[4.1 - 5 st.] [3.4 - 1 st.] [2.5 - 1 st.]
|
5180
|
Metadon intravenös inj/inf 0,075 mg/mL = 75 mikrog/mL
|
2.1
|
2024-12-19
|
[2.1 - 3 st.] [1.4 - 1 st.]
|
4557
|
Metadon oralt 1 mg/mL (ex Extempore) oral lösning
|
2.2
|
2024-12-19
|
[2.2 - 6 st.] [1.4 - 1 st.]
|
3406
|
Metadon oralt tabletter
|
3.1
|
2024-12-19
|
[3.1 - 5 st.] [2.9 - 1 st.]
|
3382
|
Metoklopramid intravenös inj 5 mg/mL (ex Primperan)
|
3.4
|
2023-03-30
|
[3.4 - 11 st.] [2.0 - 1 st.]
|
2748
|
Metoklopramid oralt 10 mg (ex Primperan) tablett
|
5.5
|
2022-06-23
|
[5.5 - 10 st.]
|
4644
|
Metolazon oralt (ex Metolazon Abcur) tablett/kapsel
|
1.1
|
2024-11-14
|
[1.1 - 5 st.]
|
4645
|
Metoprolol intravenös inj/inf 1 mg/mL (ex Seloken)
|
2.2
|
2024-08-22
|
[2.2 - 6 st.]
|
5080
|
Metoprolol oralt 1 mg/mL (Extempore) oral lösning
|
2.3
|
2024-07-11
|
[2.3 - 4 st.]
|
4514
|
Metoprolol oralt (ex Seloken, extempore) tablett/kapsel/depottabletter
|
3.4
|
2024-07-11
|
[3.4 - 6 st.]
|
5236
|
Metoprolol oralt 5 mg/mL (Extempore) oral lösning
|
2.3
|
2024-07-11
|
[2.3 - 4 st.]
|
4755
|
Metotrexat oralt (ex Metotab) tabletter
|
3.0
|
2024-10-24
|
[3.0 - 8 st.]
|
5145
|
Metotrexat oralt 2 mg/mL (Jylamvo) oral lösning
|
2.1
|
2024-12-19
|
[2.1 - 6 st.] [1.1 - 1 st.]
|
5259
|
Metotrexat subkutan inj 50 mg/mL (ex Metoject, Metojectpen) förfyllda sprutor/injektionspennor
|
2.0
|
2024-11-07
|
[2.0 - 6 st.]
|
3012
|
Metronidazol intravenös inf 5 mg/mL (f.d Flagyl)
|
8.1
|
2023-06-01
|
[8.1 - 18 st.] [7.0 - 3 st.]
|
3361
|
Metronidazol oralt (ex Flagyl) tabletter
|
3.1
|
2021-11-25
|
[3.1 - 12 st.] [1.4 - 1 st.]
|
1437
|
Metronidazol oralt 40 mg/mL (Flagyl) oral suspension
|
4.0
|
2021-11-18
|
[4.0 - 18 st.] [3.1 - 1 st.]
|
4720
|
Metylfenidat oralt (ex Concerta) tabletter/kapslar
|
2.37
|
2023-12-07
|
[2.37 - 10 st.]
|
4925
|
Metylnaltrexonbromid subkutan inj 12 mg/0,6 mL = 20 mg/mL (Relistor)
|
1.1
|
2020-08-27
|
[1.1 - 3 st.]
|
2755
|
Metylprednisolon intravenös inf/inj 10 mg/mL (Solu-Medrol)
|
13.0
|
2025-04-10
|
[13.0 - 8 st.] [12.0 - 2 st.] [11.1 - 3 st.] [10.9 - 4 st.]
|
3299
|
Metylprednisolon intravenös inf/inj 40 mg/mL (Solu-Medrol)
|
11.0
|
2025-04-10
|
[8.5 - 3 st.] [7.5 - 1 st.] [11.0 - 4 st.] [10.0 - 1 st.]
|
4753
|
Metylprednisolon intravenös inf/inj 62,5 mg/mL (Solu-Medrol)
|
9.0
|
2025-04-10
|
[9.0 - 4 st.] [7.4 - 2 st.] [5.4 - 1 st.]
|
4522
|
Metyltionin intravenös inf/inj 5 mg/mL (Methylthioninium chloride Proveblue)
|
2.2
|
2021-08-19
|
[2.2 - 9 st.]
|
2918
|
Midazolam buckalt 5 mg/mL (ex Buccolam)
|
7.1
|
2024-10-31
|
[7.1 - 15 st.] [6.0 - 1 st.] [5.1 - 1 st.] [4.0 - 1 st.]
|
5211
|
Midazolam intramuskulär inj 5 mg/mL (f.d Dormicum)
|
1.5
|
2024-12-19
|
[1.5 - 4 st.]
|
5104
|
Midazolam intravenös inf/inj 0,1 mg/mL (f.d Dormicum)
|
4.1
|
2024-12-19
|
[4.1 - 2 st.]
|
2978
|
Midazolam intravenös inf/inj 0,2 mg/mL (f.d Dormicum)
|
9.1
|
2024-12-19
|
[9.1 - 5 st.] [7.1 - 2 st.] [6.2 - 1 st.]
|
4647
|
Midazolam intravenös inf/inj 0,5 mg/mL (f.d Dormicum)
|
5.1
|
2024-12-19
|
[5.1 - 3 st.] [3.1 - 1 st.] [2.2 - 1 st.]
|
2851
|
Midazolam intravenös inf/inj 1 mg/mL (f.d Dormicum)
|
14.1
|
2024-12-19
|
[14.1 - 14 st.] [13.0 - 1 st.] [12.0 - 2 st.] [11.0 - 1 st.] [10.1 - 2 st.]
|
4730
|
Midazolam intravenös inf/inj 5 mg/mL (f.d Dormicum)
|
3.1
|
2024-12-19
|
[3.1 - 5 st.]
|
4650
|
Midazolam nasalt (ex Midazolam HCl licens)
|
2.1
|
2024-10-31
|
[2.1 - 6 st.]
|
4599
|
Midazolam oralt 1 mg/mL (ex Extempore)
|
3.2
|
2024-12-19
|
[3.2 - 12 st.] [2.2 - 3 st.]
|
4714
|
Midazolam rektalt 1 mg/mL (ex Extempore)
|
1.2
|
2024-10-31
|
[1.2 - 4 st.]
|
4600
|
Midazolam rektalt 3 mg/mL (ex Extempore) rektalgel
|
2.5
|
2024-10-31
|
[2.5 - 9 st.]
|
3450
|
Mikafungin intravenös inf 0,5 mg/mL (ex Mycamine)
|
2.6
|
2023-08-03
|
[2.6 - 6 st.]
|
4842
|
Mikafungin intravenös inf 2 mg/mL (ex Mycamine)
|
2.5
|
2023-08-03
|
[2.5 - 5 st.]
|
2973
|
Milrinon intravenös inf 100 mikrog/mL = 0,1 mg/mL (ex Corotrop)
|
5.0
|
2020-06-18
|
[5.0 - 7 st.]
|
3389
|
Milrinon intravenös inf 200 mikrog/mL = 0,2 mg/mL (ex Corotrop)
|
3.0
|
2020-04-23
|
[3.0 - 9 st.]
|
4954
|
Milrinon intravenös inf 400 mikrog/mL = 0,4 mg/mL (ex Corotrop)
|
1.0
|
2020-04-23
|
[1.0 - 2 st.]
|
3319
|
Minoxidil oralt (ex Loniten licens) tabletter
|
2.3
|
2020-01-09
|
[2.3 - 5 st.]
|
4797
|
Mirtazapin oralt (ex Mirtin) tabletter
|
1.10
|
2025-05-08
|
[1.10 - 9 st.]
|
3397
|
Montelukast oralt (ex Singulair) tabletter/granulat
|
3.4
|
2025-04-10
|
[3.4 - 12 st.] [2.7 - 3 st.]
|
4574
|
Morfin intravenös inf, 1 mL = 10 mikrog/kg individuell spädning
|
3.0
|
2024-06-05
|
[3.0 - 2 st.]
|
3321
|
Morfin intravenös inf, 1 mL = 20 mikrog/kg individuell spädning
|
4.0
|
2024-06-05
|
[4.0 - 3 st.]
|
5025
|
Morfin intravenös inf/inj 0,02 mg/mL = 20 mikrog/mL
|
5.1
|
2025-01-30
|
[5.1 - 2 st.]
|
1322
|
Morfin intravenös inf/inj 0,04 mg/mL = 40 mikrog/mL
|
10.2
|
2024-06-13
|
[9.1 - 2 st.] [10.2 - 7 st.]
|
5071
|
Morfin intravenös inf/inj 0,05 mg/mL = 50 mikrog/mL
|
4.0
|
2024-06-05
|
[4.0 - 4 st.]
|
4713
|
Morfin intravenös inf/inj 0,1 mg/mL = 100 mikrog/mL
|
4.1
|
2024-06-13
|
[4.1 - 12 st.] [3.1 - 1 st.]
|
4808
|
Morfin intravenös inf/inj 0,2 mg/mL = 200 mikrog/mL
|
5.1
|
2024-06-13
|
[5.1 - 3 st.]
|
1324
|
Morfin intravenös inf/inj 0,4 mg/mL = 400 mikrog/mL
|
10.1
|
2024-06-13
|
[9.1 - 1 st.] [10.1 - 9 st.]
|
2732
|
Morfin intravenös inf/inj 1 mg/mL
|
10.1
|
2024-06-13
|
[8.1 - 1 st.] [10.1 - 17 st.]
|
3028
|
Morfin oralt 0,2 mg/mL (ex Extempore) oral lösning
|
7.2
|
2024-05-30
|
[7.2 - 4 st.]
|
4760
|
Morfin oralt 0,5 mg/mL (ex Extempore) oral lösning
|
1.9
|
2024-05-23
|
[1.9 - 7 st.]
|
1323
|
Morfin oralt 2 mg/mL oral lösning
|
6.4
|
2024-05-23
|
[6.4 - 13 st.]
|
2731
|
Morfin oralt tabletter
|
4.1
|
2025-02-20
|
[4.1 - 6 st.] [3.5 - 3 st.]
|
5400
|
Morfin subkutan inf/inj 1 mg/mL
|
1.0
|
2025-05-08
|
[1.0 - 2 st.]
|
5203
|
Morfin subkutan inf/inj 10 mg/mL
|
1.0
|
2025-05-08
|
[1.0 - 2 st.]
|
5320
|
Moxifloxacin intravenös inf 1,6 mg/mL
|
1.0
|
2024-12-12
|
[1.0 - 5 st.]
|
4536
|
Moxifloxacin oralt (ex Rivomoxi) tabletter
|
1.0
|
2024-12-12
|
[1.0 - 5 st.]
|
3374
|
Multivitamin oralt (Abidec multivitamin drops, licens) orala droppar
|
3.0
|
2021-05-20
|
[3.0 - 8 st.]
|
3272
|
Multivitamin oralt (Multivitamindroppar Unimedic, Extempore) orala droppar
|
3.3
|
2021-09-02
|
[3.3 - 17 st.]
|
5060
|
Mykofenolsyra intravenöst inf 6 mg/mL (CellCept)
|
5.0
|
2024-04-25
|
[5.0 - 5 st.]
|
4508
|
Mykofenolsyra oralt (ex CellCept) tablett/kapsel
|
5.1
|
2024-12-12
|
[5.1 - 5 st.]
|
4513
|
Mykofenolsyra oralt 1 g/5 mL = 200 mg/mL (CellCept) oral suspension
|
5.0
|
2024-04-25
|
[5.0 - 5 st.]
|
5178
|
MÄRKNING ETIKETTER
|
1.0
|
2022-05-25
|
[1.0 - 2 st.]
|
4530
|
Naloxegol oralt (Moventig) tabletter
|
1.1
|
2021-08-19
|
[1.1 - 8 st.]
|
2825
|
Naloxon intravenös/intramuskulär inf/inj 0,02 mg/mL = 20 mikrog/mL
|
7.2
|
2024-12-05
|
[7.2 - 6 st.]
|
5059
|
Naloxon intravenös/intramuskulär inf/inj 0,04 mg/mL = 40 mikrog/mL
|
5.2
|
2024-12-05
|
[5.2 - 2 st.]
|
1320
|
Naloxon intravenös/intramuskulär inf/inj 0,4 mg/mL = 400 mikrog/mL
|
8.2
|
2024-12-05
|
[8.2 - 19 st.]
|
3307
|
Naloxon nasalt 0,4 mg/mL = 400 mikrog/mL
|
2.1
|
2024-07-11
|
[2.1 - 4 st.]
|
5068
|
Naloxon nasalt 1,8 mg (Nyxoid)
|
1.1
|
2021-04-29
|
[1.1 - 3 st.]
|
4481
|
Naloxon oralt 0,1 mg/mL = 100 mikrog/mL (Extempore) oral lösning
|
1.4
|
2021-09-23
|
[1.4 - 6 st.]
|
4716
|
Naloxon oralt 1 mg/mL (Extempore) oral lösning
|
1.2
|
2021-09-23
|
[1.2 - 6 st.]
|
1319
|
Naloxon oralt 10 mikrog/mL (Extempore) oral lösning
|
3.3
|
2021-09-23
|
[3.3 - 11 st.]
|
2735
|
Naloxon oralt 30 mikrog/mL (Extempore) oral lösning
|
3.2
|
2021-09-23
|
[3.2 - 11 st.]
|
5076
|
Naloxon oralt 40 mikrog/mL (Extempore) oral lösning
|
1.1
|
2021-09-23
|
[1.1 - 3 st.]
|
4939
|
Naproxen oralt (ex Pronaxen) tabletter
|
1.6
|
2024-10-24
|
[1.6 - 6 st.]
|
1317
|
Natriumbensoat intravenös inf 20 mg/mL (Extempore)
|
4.3
|
2024-10-10
|
[4.3 - 6 st.] [2.2 - 2 st.]
|
4482
|
Natriumbensoat intravenös inf 50 mg/mL (Extempore)
|
3.3
|
2024-10-10
|
[3.3 - 3 st.]
|
3449
|
Natriumbensoat oralt 100 mg/mL (Extempore) oral vätska
|
2.2
|
2022-09-08
|
[2.2 - 7 st.]
|
4646
|
Natriumcitrat + Natriumlaurylsulfoacetat rektalt (Microlax)
|
2.0
|
2023-09-28
|
[2.0 - 6 st.]
|
1314
|
Natriumdikloracetat intravenös inf 20 mg/mL (Extempore)
|
3.7
|
2025-01-30
|
[3.7 - 9 st.]
|
1315
|
Natriumdikloracetat oralt 100 mg/mL (Extempore) oral lösning
|
3.2
|
2022-09-29
|
[3.2 - 6 st.]
|
3131
|
Natriumfenylacetat + Natriumbensoat intravenös inf (Ammonul licens) dos tillsätts till spädningsvätska
|
1.1
|
2023-08-31
|
[1.1 - 2 st.]
|
3130
|
Natriumfenylbutyrat oralt (Ammonaps, Pheburane)
|
2.3
|
2023-01-12
|
[2.3 - 5 st.]
|
4648
|
Natriumfenylbutyrat oralt 100 mg/mL = 0,1 gram/mL (Ammonaps) oral lösning från tablett
|
3.3
|
2023-09-07
|
[3.3 - 5 st.]
|
5013
|
Natriumklorid + Glukos intravenös inf 4,5 + 25 mg/mL
|
1.0
|
2020-10-08
|
[1.0 - 2 st.]
|
5210
|
Natriumklorid 4,5 mg/mL + Heparin 2 E/mL ocklusionsförebyggande spoldropp, flera administreringsvägar
|
2.1
|
2023-09-14
|
[2.1 - 2 st.]
|
2121
|
Natriumklorid 9 mg/mL med heparin 1 E/mL ocklusionsförebyggande spoldropp, flera administreringsvägar
|
2.3
|
2023-09-14
|
[2.3 - 9 st.]
|
4630
|
Natriumklorid 9 mg/mL med heparin 2 E/mL ocklusionsförebyggande spoldropp, flera administreringsvägar
|
2.1
|
2023-09-14
|
[2.1 - 2 st.]
|
3082
|
Natriumklorid hyperton inhalation 30 mg/mL = 3 % (ex spädning från Addens/Addex Natriumklorid)
|
10.1
|
2025-01-23
|
[9.5 - 3 st.] [10.1 - 10 st.]
|
5026
|
Natriumklorid hyperton inhalation 40 mg/mL = 4 % (ex spädning från Addens/Addex Natriumklorid)
|
3.0
|
2024-02-08
|
[3.0 - 5 st.]
|
5147
|
Natriumklorid hyperton inhalation 45 mg/mL = 4,5 % (ex spädning från Addens/Addex Natriumklorid)
|
2.0
|
2024-02-08
|
[2.0 - 4 st.]
|
5027
|
Natriumklorid hyperton inhalation 50 mg/mL = 5 % (ex spädning från Addens/Addex Natriumklorid)
|
3.0
|
2024-02-08
|
[3.0 - 6 st.]
|
5028
|
Natriumklorid hyperton inhalation 60 mg/mL = 6 % (ex spädning från Addens/Addex Natriumklorid)
|
3.0
|
2024-02-08
|
[3.0 - 7 st.]
|
5029
|
Natriumklorid hyperton inhalation 70 mg/mL = 7 % (ex spädning från Addens/Addex Natriumklorid)
|
3.0
|
2024-02-08
|
[3.0 - 6 st.]
|
1343
|
Natriumklorid hyperton intravenös inf 0,5 mmol/mL (från Addens/Addex Natriumklorid)
|
2.3
|
2023-07-06
|
[2.3 - 6 st.] [1.1 - 1 st.]
|
4685
|
Natriumklorid intravenös inf 9 mg/mL ersättning av vätskeförlust enl. 1 %-regeln
|
1.3
|
2024-03-07
|
[1.3 - 6 st.]
|
4832
|
Natriumklorid intravenös inf 9 mg/mL med eller utan tillsats
|
3.1
|
2025-05-08
|
[3.1 - 5 st.] [2.3 - 1 st.]
|
2968
|
Natriumklorid isoton inhalation 9 mg/mL
|
8.2
|
2025-05-08
|
[8.2 - 14 st.] [7.2 - 2 st.]
|
1344
|
Natriumklorid oralt 4 mmol/mL (ex Extempore) oral vätska
|
3.0
|
2024-05-23
|
[3.0 - 14 st.] [2.4 - 2 st.]
|
5091
|
Natriumoxibat oralt 500 mg/mL = 0,5 gram/mL (ex Xyrem) oral lösning
|
1.1
|
2024-05-08
|
[1.1 - 5 st.]
|
5258
|
Natriumpikosulfat + Magnesiumcitrat oralt (Picoprep) pulver till oral lösning
|
2.1
|
2024-05-23
|
[2.1 - 4 st.]
|
4892
|
Natriumpikosulfat 7,5 mg/mL (ex Cilaxoral, Laxoberal) orala droppar
|
3.0
|
2023-02-23
|
[3.0 - 9 st.]
|
2905
|
Natriumpolystyrensulfonat oralt (Resonium)
|
3.1
|
2024-10-03
|
[3.1 - 7 st.]
|
3411
|
Natriumpolystyrensulfonat rektalt 0,15 gram/mL (Resonium)
|
2.1
|
2024-10-03
|
[2.1 - 7 st.]
|
4620
|
Natriumvätekarbonat intravenös inf/inj 50 mg/mL (Natriumbikarbonat Fresenius Kabi)
|
3.2
|
2022-08-18
|
[3.2 - 12 st.]
|
1316
|
Natriumvätekarbonat oralt 50 mg/mL = 0,6 mmol/mL (Extempore, Natriumbikarbonat) oral lösning
|
4.3
|
2025-02-27
|
[4.3 - 12 st.]
|
1377
|
Naturliga fosfolipider intratrakealt 80 mg/mL (Curosurf)
|
3.2
|
2025-01-30
|
[3.2 - 15 st.] [2.2 - 1 st.]
|
1311
|
Neostigmin inj 150 mikrog/mL flera administreringssätt
|
2.0
|
2021-10-07
|
[2.0 - 6 st.]
|
1399
|
Neostigmin oralt 150 mikrog/mL
|
2.1
|
2023-11-30
|
[2.1 - 4 st.]
|
1201
|
Nevirapin oralt 10 mg/mL (Viramune) oral suspension
|
3.0
|
2023-09-28
|
[3.0 - 9 st.] [2.2 - 1 st.]
|
3254
|
NIFEdipin oralt (ex Adalat oros) kapslar/depottabletter
|
3.6
|
2025-04-10
|
[3.6 - 5 st.]
|
2985
|
NIFEdipin oralt 20 mg/mL (Licens) orala droppar
|
5.2
|
2024-10-31
|
[5.2 - 5 st.]
|
4496
|
niMODipin intravenös inf 0,2 mg/mL = 200 mikrog/mL (Nimotop)
|
1.3
|
2025-02-27
|
[1.3 - 5 st.]
|
5036
|
Nirsevimab intramuskulär inj 100 mg/mL (Beyfortus)
|
1.2
|
2025-04-24
|
[1.2 - 7 st.]
|
3328
|
Nitrofurantoin oralt (ex Furadantin) tabletter
|
4.0
|
2021-04-15
|
[4.0 - 12 st.]
|
5062
|
Nitroprussid intravenös inf 0,12 mg/mL = 120 mikrog/mL (Nipruss)
|
2.1
|
2021-12-16
|
[2.1 - 4 st.]
|
5079
|
Nitroprussid intravenös inf 0,24 mg/mL = 240 mikrog/mL (Nipruss)
|
2.1
|
2021-12-16
|
[2.1 - 3 st.]
|
5153
|
Nitroprussid intravenös inf 0,4 mg/mL = 400 mikrog/mL (Nipruss)
|
1.1
|
2021-12-16
|
[1.1 - 4 st.]
|
5146
|
NORadrenalin intravenös inf 0,005 mg/mL = 5 mikrog/mL
|
1.1
|
2022-03-17
|
[1.1 - 3 st.]
|
5096
|
NORadrenalin intravenös inf 0,01 mg/mL = 10 mikrog/mL
|
1.2
|
2022-03-17
|
[1.2 - 10 st.]
|
5097
|
NORadrenalin intravenös inf 0,02 mg/mL = 20 mikrog/mL
|
1.2
|
2022-03-17
|
[1.2 - 6 st.]
|
5098
|
NORadrenalin intravenös inf 0,04 mg/mL = 40 mikrog/mL
|
1.2
|
2022-03-17
|
[1.2 - 7 st.]
|
5099
|
NORadrenalin intravenös inf 0,08 mg/mL = 80 mikrog/mL
|
1.3
|
2022-03-17
|
[1.3 - 3 st.]
|
5100
|
NORadrenalin intravenös inf 0,1 mg/mL = 100 mikrog/mL
|
1.3
|
2022-03-17
|
[1.3 - 2 st.]
|
5101
|
NORadrenalin intravenös inf 0,16 mg/mL = 160 mikrog/mL
|
1.3
|
2022-03-17
|
[1.3 - 2 st.]
|
4689
|
Nusinersen intratekalt 12 mg (Spinraza)
|
2.0
|
2021-11-25
|
[2.0 - 5 st.]
|
5105
|
Nutrilock instillation
|
1.0
|
2021-03-18
|
[1.0 - 5 st.]
|
1321
|
Nystatin oralt 100 000 E/mL (ex Nystimex) oral suspension
|
3.6
|
2025-05-08
|
[3.6 - 16 st.]
|
5324
|
Obidoxim intramuskulär/intravenös inf/inj 250 mg/mL = 0,25 g/mL (Toxogonin, licens) vid nervgasangrepp
|
1.1
|
2025-03-05
|
[1.1 - 5 st.]
|
4822
|
Okrelizumab intravenös inf 1,2 mg/mL (Ocrevus)
|
1.1
|
2024-08-29
|
[1.1 - 4 st.]
|
4518
|
Oktreotid intravenös inf 10 mikrog/mL (ex Sandostatin)
|
2.4
|
2024-08-01
|
[2.4 - 2 st.]
|
2048
|
Oktreotid intravenös inf/inj 1 mikrog/mL (ex Sandostatin)
|
3.5
|
2025-02-13
|
[3.5 - 7 st.]
|
3200
|
Oktreotid intravenös inf/inj 8 mikrog/mL (ex Sandostatin)
|
3.7
|
2024-10-03
|
[3.7 - 7 st.]
|
2890
|
Oktreotid subkutan inf/inj 50 mikrog/mL (ex Sandostatin)
|
2.3
|
2019-08-07
|
[2.3 - 6 st.]
|
4858
|
olanZAPIN oralt (ex Zyprexa) tabletter
|
1.12
|
2024-03-07
|
[1.12 - 10 st.]
|
3173
|
Omalizumab subkutan inj (Xolair)
|
3.0
|
2022-10-13
|
[3.0 - 5 st.] [2.1 - 2 st.]
|
2470
|
Omeprazol oralt (ex Losec) enterokapslar/enterotabletter
|
4.13
|
2025-04-30
|
[4.13 - 13 st.] [3.5 - 1 st.]
|
5252
|
Omeprazol oralt 2 mg/mL (Pedippi) oral suspension
|
1.2
|
2025-05-08
|
[1.2 - 5 st.]
|
5181
|
Omeprazol oralt 4 mg/mL (Licens) oral suspension
|
2.3
|
2023-08-10
|
[2.3 - 5 st.]
|
2638
|
Ondansetron intravenös inj/inf 2 mg/mL (f.d Zofran)
|
7.0
|
2023-03-09
|
[7.0 - 13 st.] [5.1 - 1 st.] [3.0 - 1 st.]
|
3192
|
Ondansetron oralt (ex Zofran) tabletter
|
5.8
|
2024-12-19
|
[5.8 - 17 st.] [2.5 - 1 st.]
|
5035
|
Ondansetron oralt 0,8 mg/mL (ex Zofran) oral lösning
|
4.6
|
2024-04-18
|
[4.6 - 13 st.]
|
2971
|
Oseltamivir oralt (ex Tamiflu) kapslar
|
4.5
|
2025-04-30
|
[4.5 - 13 st.]
|
3275
|
Oseltamivir oralt 6 mg/mL (ex Tamiflu) oral suspension
|
6.2
|
2025-05-08
|
[6.2 - 7 st.] [5.5 - 8 st.]
|
4859
|
oxAZEpam oralt (ex Oxascand) tabletter
|
1.8
|
2024-11-14
|
[1.8 - 8 st.]
|
2977
|
Oxibutynin intravesikal instillation 0,5 mg/mL (Oxybutynin Unimedic)
|
2.0
|
2020-12-10
|
[2.0 - 4 st.]
|
5187
|
Oxibutynin oralt 5 mg (Oxybutynin, Ditropan) tablett
|
1.1
|
2024-07-11
|
[1.1 - 5 st.]
|
4889
|
Oxikodon + Naloxon oralt (ex Targiniq) depottabletter
|
2.0
|
2024-10-10
|
[2.0 - 8 st.] [1.8 - 1 st.]
|
3345
|
Oxikodon intravenös inf, 1 mL = 20 mikrog/kg (ex OxyNorm) individuell spädning
|
2.9
|
2024-10-31
|
[2.9 - 4 st.]
|
5331
|
Oxikodon intravenös inf/inj 0,04 mg/mL = 40 mikrog/mL (ex OxyNorm)
|
1.1
|
2024-10-31
|
[1.1 - 4 st.]
|
4945
|
Oxikodon intravenös inf/inj 0,1 mg/mL = 100 mikrog/mL (ex OxyNorm)
|
2.3
|
2024-10-31
|
[2.3 - 4 st.]
|
5334
|
Oxikodon intravenös inf/inj 0,2 mg/mL = 200 mikrog/mL (ex OxyNorm)
|
2.0
|
2024-10-31
|
[2.0 - 3 st.]
|
4651
|
Oxikodon intravenös inf/inj 1 mg/mL (ex OxyNorm)
|
8.4
|
2024-10-31
|
[8.4 - 9 st.] [7.0 - 1 st.]
|
4653
|
Oxikodon oralt (ex OxyNorm, OxyContin) kapslar/tabletter/depottabletter
|
1.0
|
2024-10-10
|
[1.0 - 7 st.]
|
3445
|
Oxikodon oralt 1 mg/mL (ex OxyNorm) oral lösning
|
2.0
|
2024-10-10
|
[2.0 - 11 st.] [1.3 - 1 st.]
|
5431
|
Oxikodon subkutan inf/inj 1 mg/mL (ex Oxynorm)
|
1.0
|
2025-05-08
|
[1.0 - 2 st.]
|
5372
|
Oxikodon subkutan inf/inj 10 mg/mL (ex Oxynorm)
|
1.1
|
2025-05-08
|
[1.1 - 2 st.]
|
1308
|
Oximetazolin nasalt 0,1 mg/mL (ex Rhinox licens) näsdroppar
|
3.2
|
2021-11-04
|
[3.2 - 9 st.]
|
4872
|
Oximetazolin nasalt 0,125 mg/mL spädning från Nezeril
|
4.1
|
2023-07-27
|
[4.1 - 13 st.] [2.2 - 1 st.]
|
4718
|
Oximetazolin nasalt 0,25 mg/mL (ex Nezeril) näsdroppar/nässpray
|
2.5
|
2023-07-27
|
[2.5 - 14 st.]
|
4717
|
Oximetazolin nasalt 0,5 mg/mL (ex Nezeril) näsdroppar/nässpray
|
1.6
|
2022-12-08
|
[1.6 - 14 st.]
|
4878
|
oxKARBazepin oralt (Trileptal) tabletter
|
2.3
|
2023-06-29
|
[2.3 - 7 st.]
|
4652
|
oxKARBazepin oralt 60 mg/mL (Trileptal) oral suspension
|
2.6
|
2025-01-09
|
[2.6 - 8 st.]
|
1215
|
Palivizumab intramuskulär inj 100 mg/mL (Synagis)
|
5.0
|
2022-04-07
|
[5.0 - 19 st.] [4.3 - 1 st.]
|
3384
|
Palonosetron intravenös inf/inj 50 mikrog/mL (ex Aloxi 250 mikrog/5 mL)
|
8.2
|
2023-12-07
|
[8.2 - 13 st.] [7.3 - 2 st.]
|
3408
|
Pamidronat intravenös inf (ex Pamifos, f.d Aredia) dos tillsätts till spädningsvätska
|
2.0
|
2022-03-17
|
[2.0 - 8 st.] [1.4 - 1 st.]
|
3203
|
Pamidronat intravenös inf 0,1 mg/mL (ex Pamifos, f.d Aredia)
|
1.1
|
2020-12-10
|
[1.1 - 5 st.]
|
3047
|
Pankreatin oralt (ex Creon, Pertzye licens) kapslar
|
2.14
|
2025-04-10
|
[2.14 - 6 st.] [1.5 - 1 st.]
|
3035
|
Pankreatin oralt (ex Kreon für Kinder licens) granulat
|
3.4
|
2025-03-19
|
[3.4 - 7 st.]
|
4654
|
Pankuroniumbromid intravenös inj 0,2 mg/mL (ex Pancuronium Actavis licens)
|
1.1
|
2020-02-20
|
[1.1 - 1 st.]
|
2839
|
Pantoprazol intravenös inf/inj 4 mg/mL (ex Pantoloc) kan även ges i jejunostomi
|
3.7
|
2024-02-29
|
[3.7 - 6 st.]
|
1241
|
Paracetamol intravenös inf 10 mg/mL
|
12.1
|
2024-10-10
|
[9.2 - 1 st.] [12.1 - 17 st.] [11.0 - 1 st.] [10.2 - 1 st.]
|
3400
|
Paracetamol oralt (ex Alvedon, Panodil)
|
11.1
|
2024-04-18
|
[8.0 - 1 st.] [4.3 - 1 st.] [11.1 - 15 st.] [10.1 - 1 st.]
|
3428
|
Paracetamol oralt 24 mg/mL (ex Alvedon) oral lösning/suspension
|
13.1
|
2025-05-08
|
[13.1 - 17 st.] [12.0 - 1 st.] [11.7 - 3 st.]
|
4607
|
Paracetamol rektalt (ex Alvedon, Extempore) suppositorier
|
9.2
|
2024-08-29
|
[9.2 - 17 st.] [8.0 - 1 st.] [7.5 - 1 st.] [3.2 - 1 st.]
|
4608
|
Paracetamol rektalt 20 mg/mL (Extempore) rektalgel
|
9.0
|
2024-01-25
|
[9.0 - 6 st.]
|
4920
|
Parecoxib intravenös inf/inj 4 mg/mL (ex Dynastat)
|
3.4
|
2022-12-22
|
[3.4 - 6 st.]
|
3005
|
Parecoxib intravenös inj 20 mg/mL (ex Dynastat)
|
4.3
|
2022-12-22
|
[4.3 - 13 st.]
|
2073
|
Parenteral nutrition: Aminosyra/Glukos-baserad intravenös inf individuell komposition, extempore
|
2.0
|
2023-02-23
|
[2.0 - 3 st.]
|
2106
|
Parenteral nutrition: Lipid-baserad intravenös inf individuell komposition, extempore
|
3.0
|
2023-02-23
|
[3.0 - 3 st.]
|
3202
|
Parenteral nutrition: Numeta G13E intravenös inf standardkomposition
|
2.1
|
2023-03-30
|
[2.1 - 12 st.]
|
3213
|
Parenteral nutrition: Numeta G16E intravenös inf standardkomposition
|
3.1
|
2023-03-30
|
[3.1 - 13 st.]
|
3215
|
Parenteral nutrition: Numeta G19E intravenös inf standardkomposition
|
3.1
|
2023-03-30
|
[3.1 - 11 st.]
|
3217
|
Parenteral nutrition: Olimel N5E intravenös inf standardkomposition
|
2.0
|
2023-11-02
|
[2.0 - 3 st.]
|
5237
|
Parenteral nutrition: Olimel N7E intravenös inf standardkomposition
|
2.0
|
2023-11-02
|
[2.0 - 4 st.]
|
3218
|
Parenteral nutrition: Olimel perifer N4E intravenös inf standardkomposition
|
2.0
|
2023-11-02
|
[2.0 - 7 st.]
|
5317
|
Parenteral nutrition: Perifer Numeta G 9E intravenös inf standardkomposition, spädning från G13E
|
1.3
|
2024-02-08
|
[1.3 - 5 st.]
|
4952
|
Parenteral nutrition: Perifer Numeta G10E intravenös inf standardkomposition, spädning från G13E
|
3.1
|
2023-03-30
|
[3.1 - 6 st.] [1.1 - 1 st.]
|
5291
|
Parenteral nutrition: Perifer Numeta G11E inf standardkomposition, spädning från G16E (820 mOsm/L)
|
1.1
|
2024-04-04
|
[1.1 - 1 st.]
|
4729
|
Parenteral nutrition: Perifer Numeta G11E inf standardkomposition, spädning från G16E (880 mOsm/L)
|
3.0
|
2024-03-27
|
[3.0 - 6 st.]
|
5234
|
Parenteral nutrition: SmofKabiven intravenös inf standardkomposition
|
1.2
|
2023-03-30
|
[1.2 - 4 st.]
|
5235
|
Parenteral nutrition: SmofKabiven Perifer intravenös inf standardkomposition
|
1.2
|
2023-03-30
|
[1.2 - 5 st.]
|
2080
|
Parenteral nutrition: Start Up Neo intravenös inf standardkomposition, extempore
|
4.2
|
2024-11-14
|
[4.2 - 2 st.]
|
2108
|
Parenteral nutrition: Vaminolac + Peditrace intravenös inf standardkomposition
|
2.3
|
2023-05-11
|
[2.3 - 3 st.]
|
4602
|
Pegfilgrastim subkutan inj 10 mg/mL (ex Neulasta)
|
1.1
|
2025-02-28
|
[1.1 - 3 st.]
|
3392
|
Piperacillin + Tazobaktam intravenös inf/inj 40 + 5 mg/mL (f.d Tazocin)
|
5.5
|
2024-06-27
|
[5.5 - 10 st.] [4.2 - 2 st.]
|
2181
|
Piperacillin + Tazobaktam intravenös inf/inj 200 + 25 mg/mL (f.d Tazocin)
|
7.5
|
2024-06-27
|
[7.5 - 15 st.] [6.2 - 1 st.]
|
4604
|
Pivmecillinam oralt (ex Selexid) tabletter
|
1.2
|
2022-08-18
|
[1.2 - 12 st.]
|
4589
|
Plasmalyte GLUCOS intravenös inf
|
1.5
|
2025-01-23
|
[1.5 - 10 st.]
|
4992
|
Plasmalyte Glucos intravenös inf (+ 35 K) vid diabetes ketoacidos
|
1.1
|
2020-06-04
|
[1.1 - 5 st.]
|
4993
|
Plasmalyte intravenös inf
|
3.5
|
2025-01-23
|
[3.5 - 7 st.]
|
5359
|
Posakonazol intravenös inf 2 mg/mL (Noxafil)
|
1.0
|
2024-11-28
|
[1.0 - 5 st.]
|
4561
|
Posakonazol oralt 40 mg/mL (ex Noxafil) oral suspension
|
1.1
|
2024-11-14
|
[1.1 - 5 st.]
|
4860
|
Prazosin oralt (ex Minipress licens) tabletter/kapsel
|
2.0
|
2022-03-10
|
[2.0 - 4 st.]
|
5111
|
Prednisolon + Cinkokain rektalt (Scheriproct) salva/suppositorium
|
1.5
|
2025-04-10
|
[1.5 - 4 st.]
|
4964
|
Prednisolon oralt 1 mg/mL (pms-Prednisolone 5 mg/5 mL licens) oral lösning
|
5.0
|
2025-04-16
|
[5.0 - 3 st.] [4.0 - 1 st.]
|
3257
|
Prednisolon oralt tabletter/kapslar
|
3.0
|
2025-04-16
|
[3.0 - 6 st.] [2.0 - 5 st.]
|
2965
|
Prednisolon-natriumsuccinat intravenös inj 25 mg/mL (ex Precortalon aquosum)
|
6.0
|
2025-04-16
|
[6.0 - 5 st.] [5.3 - 4 st.]
|
2824
|
Proklorperazin intravenös inj 1 mg/mL (ex Stemetil licens)
|
4.0
|
2024-12-12
|
[4.0 - 2 st.]
|
4861
|
Prometazin intramuskulär inj 25 mg/mL (Phenergan licens)
|
1.2
|
2019-11-28
|
[1.2 - 6 st.]
|
3424
|
Prometazin intravenös inf/inj 1 mg/mL (Phenergan licens)
|
4.0
|
2020-10-15
|
[4.0 - 8 st.] [2.5 - 1 st.]
|
4862
|
Prometazin oralt (ex Lergigan) tabletter
|
2.0
|
2025-03-27
|
[2.0 - 6 st.] [1.5 - 4 st.]
|
5330
|
Prometazin oralt 1 mg/mL (Lergigan) oral lösning
|
1.0
|
2025-03-27
|
[1.0 - 4 st.]
|
4863
|
Propiomazin oralt 25 mg (ex Propavan) tablett
|
1.5
|
2025-03-27
|
[1.5 - 7 st.]
|
3133
|
Propofol intravenös inf/inj 10 mg/mL (ex Diprivan)
|
3.4
|
2024-10-10
|
[3.4 - 12 st.]
|
4656
|
Propofol intravenös inf/inj 20 mg/mL (ex Diprivan)
|
3.3
|
2023-04-20
|
[3.3 - 4 st.]
|
4657
|
Propofol intravenös inf/inj 5 mg/mL (Propofol Lipuro)
|
4.7
|
2024-10-10
|
[4.7 - 6 st.]
|
3391
|
proPRANolol oralt 3,75 mg/mL (Hemangiol) oral lösning
|
3.4
|
2025-03-06
|
[3.4 - 11 st.]
|
3365
|
Propranololhydroklorid intravenös inj 1 mg/mL = 1000 mikrog/mL (ex Dociton licens)
|
1.0
|
2023-04-05
|
[1.0 - 4 st.]
|
4537
|
Propranololhydroklorid oralt (ex Inderal) tabletter/depotkapslar
|
1.11
|
2025-02-06
|
[1.11 - 10 st.]
|
1238
|
Propranololhydroklorid oralt 1 mg/mL (Extempore) oral vätska
|
7.1
|
2022-05-19
|
[7.1 - 17 st.] [6.3 - 1 st.]
|
4520
|
Propranololhydroklorid oralt 10 mg/mL (Extempore) oral vätska
|
2.0
|
2021-07-01
|
[2.0 - 8 st.] [1.3 - 1 st.]
|
4904
|
Propylenglykol + mjölksyra utvärtes 200 + 45 mg/g (Locobase LPL) kräm
|
1.1
|
2022-08-18
|
[1.1 - 5 st.]
|
4908
|
Propylenglykol utvärtes 20 % (ex Propyderm) kräm/emulsion
|
1.3
|
2023-03-30
|
[1.3 - 5 st.]
|
1383
|
Protein C intravenös inf/inj 100 E/mL (Ceprotin)
|
3.1
|
2023-05-17
|
[3.1 - 6 st.]
|
4491
|
Protrombinkomplex AKTIVERAD intravenös inf (Feiba)
|
2.2
|
2022-07-28
|
[2.2 - 6 st.] [1.2 - 1 st.]
|
1428
|
Protrombinkomplex intravenös inf/inj 25 E/mL (ex Confidex)
|
4.1
|
2022-04-28
|
[4.1 - 8 st.]
|
4529
|
Pyrazinamid oralt (ex Pyrafat licens, extempore) kapslar/tablett
|
2.0
|
2023-11-09
|
[2.0 - 6 st.]
|
2791
|
Pyridoxal-5-fosfat oralt (Vitamin B6, Extempore) kapslar
|
5.0
|
2024-03-21
|
[5.0 - 4 st.] [4.3 - 3 st.]
|
3259
|
Pyridoxal-5-fosfat oralt 10 mg/mL (Vitamin B6, Extempore) oral lösning från kapsel
|
2.0
|
2024-03-21
|
[2.0 - 4 st.] [1.4 - 1 st.]
|
2847
|
Pyridoxin intravenös inf/inj 150 mg/mL (Vitamin B6, Extempore)
|
4.3
|
2024-03-27
|
[4.3 - 8 st.] [3.2 - 1 st.]
|
1232
|
Pyridoxin intravenös inf/inj 25 mg/mL (Vitamin B6, Extempore)
|
6.1
|
2024-03-27
|
[6.1 - 13 st.] [4.2 - 2 st.]
|
4601
|
Pyridoxin oralt (Vitamin B6, ex Extempore) tabletter/kapslar
|
5.0
|
2024-03-21
|
[5.0 - 7 st.] [4.3 - 1 st.]
|
5002
|
Pyridoxin oralt 10 mg/mL (Vitamin B6, Extempore) oral vätska
|
3.0
|
2024-03-21
|
[3.0 - 4 st.]
|
1233
|
Pyridoxin oralt 150 mg/mL (Vitamin B6, Extempore)
|
5.0
|
2024-03-21
|
[5.0 - 5 st.] [4.3 - 1 st.] [3.4 - 1 st.]
|
5001
|
Pyridoxin oralt 50 mg/mL (Vitamin B6, Extempore) oral vätska
|
3.0
|
2024-03-21
|
[3.0 - 4 st.] [2.2 - 1 st.]
|
3205
|
Pyrimetamin oralt 2 mg/mL (Extempore) oral lösning
|
1.1
|
2023-03-23
|
[1.1 - 5 st.]
|
5352
|
Pyrvinium oralt 100 mg (Pyrvin) tablett
|
1.0
|
2025-03-05
|
[1.0 - 4 st.]
|
3310
|
Rabies-immunglobulin humant, intramuskulär inj 150 E/mL (Berirab/Berirab P licens)
|
3.1
|
2024-10-10
|
[3.1 - 5 st.]
|
3336
|
Racekadotril oralt (ex Hidrasec) granulat
|
1.7
|
2025-01-23
|
[1.7 - 13 st.]
|
4763
|
Racekadotril oralt 30 mg/15 mL = 2 mg/mL (ex Hidrasec) oral suspension
|
1.3
|
2025-01-23
|
[1.3 - 9 st.]
|
3346
|
Rasburikas intravenös inf (Fasturtec) dos tillsätts till spädningsvätska
|
5.0
|
2024-11-28
|
[5.0 - 1 st.] [3.2 - 2 st.]
|
5192
|
Rasburikas intravenös inf 0,3 mg/mL (Fasturtec)
|
2.1
|
2024-11-28
|
[2.1 - 9 st.]
|
4987
|
Remdesivir intravenös inf (Veklury) dos tillsätts till spädningsvätska, barn från 40 kg
|
7.0
|
2022-04-07
|
[7.0 - 5 st.]
|
5163
|
Remdesivir intravenös inf 1 mg/mL (Veklury)
|
2.0
|
2022-03-24
|
[2.0 - 7 st.]
|
3229
|
Remifentanil intravenös inf/inj 100 mikrog/mL (ex Ultiva)
|
2.2
|
2025-04-24
|
[2.2 - 3 st.]
|
4658
|
Remifentanil intravenös inf/inj 25 mikrog/mL (ex Ultiva)
|
2.2
|
2025-02-06
|
[2.2 - 6 st.]
|
4820
|
Remifentanil intravenös inf/inj 50 mikrog/mL (ex Ultiva)
|
3.2
|
2025-02-06
|
[3.2 - 4 st.]
|
4659
|
Remifentanil intravenös inj 10 mikrog/mL (ex Ultiva)
|
3.2
|
2025-02-06
|
[3.2 - 3 st.]
|
3288
|
Retinol oralt 250 mikrog/mL (Vitamin A, extempore) oral lösning
|
3.2
|
2024-09-20
|
[3.2 - 5 st.] [2.0 - 2 st.]
|
5310
|
Retinolpalmitat oralt 30,2 mg/mL (Vitamin A, extempore) oral lösning
|
1.0
|
2024-09-05
|
[1.0 - 3 st.]
|
4660
|
Riboflavin oralt 20 mg/mL (Vitamin B2, Extempore) oral vätska
|
1.2
|
2020-09-10
|
[1.2 - 5 st.]
|
1416
|
Rifampicin intravenös inf 6 mg/mL (ex Rifadin)
|
5.2
|
2023-12-21
|
[5.2 - 9 st.] [4.7 - 1 st.] [3.1 - 1 st.]
|
4769
|
Rifampicin oralt (ex Rimactan) kapslar
|
3.2
|
2023-12-07
|
[3.2 - 6 st.]
|
1228
|
Rifampicin oralt 20 mg/mL (Rifadin) oral suspension
|
5.3
|
2023-12-21
|
[5.3 - 7 st.] [4.1 - 1 st.]
|
4837
|
Ringer-Acetat intravenös inf/inj
|
5.8
|
2025-01-23
|
[5.8 - 8 st.]
|
5391
|
Ringer-Laktat intravenös inf/inj (ex Lactated Ringer's Demo, licens)
|
1.3
|
2025-01-23
|
[1.3 - 2 st.]
|
5395
|
Ringerfundin intravenös inf/inj
|
1.2
|
2025-01-23
|
[1.2 - 2 st.]
|
5248
|
Risdiplam oralt 0,75 mg/mL (Evrysdi) oral lösning
|
1.1
|
2025-03-06
|
[1.1 - 4 st.]
|
4864
|
Risperidon oralt (ex Risperdal) tablett
|
1.8
|
2025-01-16
|
[1.8 - 10 st.]
|
4865
|
Risperidon oralt 1 mg/mL (ex Risperdal) oral lösning
|
2.0
|
2025-03-19
|
[2.0 - 5 st.] [1.3 - 1 st.]
|
4461
|
Rituximab intravenös inf (ex Mabthera) dos tillsätts till spädningsvätska
|
5.1
|
2024-11-14
|
[5.1 - 7 st.] [4.0 - 2 st.]
|
2524
|
Rituximab intravenös inf 1 mg/mL (ex Mabthera)
|
2.1
|
2024-11-14
|
[2.1 - 4 st.]
|
4590
|
Rituximab intravenös inf 2 mg/mL (ex Mabthera)
|
3.1
|
2024-11-14
|
[3.1 - 3 st.]
|
4662
|
Rokuroniumbromid intravenös inf/inj 10 mg/mL (f.d Esmeron)
|
2.0
|
2024-12-12
|
[2.0 - 6 st.]
|
5294
|
Ropivakain + Klonidin inf/inj 2 mg/mL + 1 mikrog/mL (ex Ropivacain Fresenius Kabi + ex Catapressan) flera administreringssätt
|
1.2
|
2024-09-12
|
[1.2 - 4 st.]
|
5295
|
Ropivakain inf/inj 2 mg/mL (ex Ropivacain Fresenius Kabi) flera administreringssätt
|
1.2
|
2024-09-12
|
[1.2 - 5 st.]
|
5296
|
Ropivakain inj 5 mg/mL (ex Ropivacain Fresenius Kabi) nervblockad
|
1.2
|
2024-09-12
|
[1.2 - 4 st.]
|
5297
|
Ropivakain inj 7,5 mg/mL (ex Ropivacain Fresenius Kabi) nervblockad
|
1.4
|
2024-11-20
|
[1.4 - 4 st.]
|
1335
|
Salbutamol inhalation (ex Airomir, Ventoline)
|
12.0
|
2024-12-12
|
[8.5 - 1 st.] [12.0 - 13 st.] [11.3 - 4 st.] [10.0 - 1 st.]
|
3383
|
Salbutamol oralt 0,4 mg/mL (Ventoline) oral lösning
|
3.1
|
2024-08-22
|
[3.1 - 6 st.] [2.2 - 2 st.]
|
1225
|
Salicylsyra utvärtes 1 % (Salsyvase) salva
|
2.4
|
2022-06-27
|
[2.4 - 5 st.]
|
4879
|
Salicylsyra utvärtes 2 % (f.d. Salsyvase) kräm/salva
|
1.4
|
2022-06-27
|
[1.4 - 5 st.]
|
3281
|
Saltsyra instillation 2,5 mmol/mL (Extempore) i CVK/venport
|
3.1
|
2022-04-07
|
[3.1 - 3 st.]
|
4798
|
Sertralin oralt (ex Zoloft) tabletter
|
1.12
|
2025-01-09
|
[1.12 - 10 st.]
|
4792
|
Sertralin oralt 20 mg/mL (Zoloft) koncentrat till oral lösning
|
1.7
|
2024-10-03
|
[1.7 - 7 st.]
|
4458
|
Serum mot huggormsgift intravenös inf (ex European Viper Venom Antiserum, licens) hästserum
|
3.1
|
2022-09-08
|
[3.1 - 4 st.]
|
3204
|
Serum mot huggormsgift intravenös inf (ViperaTAb licens) fårserum
|
3.3
|
2023-10-05
|
[3.3 - 7 st.] [2.2 - 1 st.]
|
4752
|
Serum mot huggormsgift intravenös inf (Viperfav licens) hästserum
|
5.0
|
2022-05-05
|
[5.0 - 6 st.] [4.2 - 1 st.]
|
3181
|
Sildenafil intravenös inf 0,16 mg/mL (Revatio)
|
3.1
|
2025-04-24
|
[3.1 - 10 st.] [2.3 - 1 st.]
|
5009
|
Sildenafil intravenös inf 0,4 mg/mL (Revatio)
|
3.1
|
2025-04-24
|
[3.1 - 2 st.]
|
3296
|
Sildenafil intravenös inf/inj 0,8 mg/mL (Revatio)
|
4.3
|
2025-04-24
|
[4.3 - 7 st.]
|
2673
|
Sildenafil oralt (ex Revatio) tablett/kapslar
|
2.1
|
2023-02-23
|
[2.1 - 5 st.] [1.2 - 1 st.]
|
3220
|
Sildenafil oralt 10 mg/mL (Revatio) oral suspension
|
4.2
|
2021-11-11
|
[4.2 - 15 st.]
|
5284
|
Silibinin intravenös inf 3,5 mg/mL (Legalon SIL licens)
|
1.0
|
2023-10-12
|
[1.0 - 5 st.]
|
1325
|
Simetikon oralt 100 mg/mL (Minifom) droppar
|
3.2
|
2023-10-26
|
[3.2 - 14 st.]
|
5279
|
Sirolimus oralt (Rapamune) tabletter
|
1.1
|
2024-02-29
|
[1.1 - 5 st.]
|
3261
|
Sirolimus oralt 1 mg/mL (Rapamune) oral lösning
|
2.0
|
2024-03-21
|
[2.0 - 6 st.]
|
2752
|
Sorbitol rektalt 8,5 gram (Resulax)
|
4.1
|
2023-10-26
|
[4.1 - 9 st.] [3.3 - 1 st.] [2.0 - 1 st.]
|
4874
|
Sotalol oralt (ex Sotacor) tabletter/kapslar
|
1.6
|
2024-10-24
|
[1.6 - 6 st.]
|
1219
|
Sotalol oralt 10 mg/mL (Extempore) oral lösning
|
3.2
|
2024-10-24
|
[3.2 - 5 st.]
|
4873
|
Sotalol oralt 5 mg/mL (Extempore) oral lösning
|
1.2
|
2024-10-24
|
[1.2 - 5 st.]
|
1218
|
Spironolakton oralt (ex Extempore) tablett/kapsel
|
5.2
|
2024-10-24
|
[5.2 - 15 st.] [4.1 - 2 st.]
|
1400
|
Spironolakton oralt 10 mg/mL (Extempore) oral suspension
|
5.3
|
2024-11-20
|
[5.3 - 13 st.] [4.3 - 2 st.]
|
4932
|
Spironolakton oralt 5 mg/mL (Extempore) oral suspension
|
2.3
|
2024-11-20
|
[2.3 - 7 st.] [1.0 - 1 st.]
|
3006
|
SUFentanil nasalt 50 mikrog/mL (ex Sufenta)
|
2.4
|
2023-02-16
|
[2.4 - 5 st.]
|
5325
|
suGAMMAdex intravenös inj 100 mg/mL (ex Bridion)
|
1.3
|
2025-02-20
|
[1.3 - 6 st.]
|
4998
|
Sukros oralt 240 mg/mL = 24 % (Algopedol-Sucrose) oral lösning
|
2.0
|
2025-01-30
|
[2.0 - 4 st.] [1.4 - 1 st.]
|
3206
|
Sulfadiazin oralt (ex extempore) tablett/kapslar
|
1.0
|
2023-03-23
|
[1.0 - 5 st.]
|
4576
|
Sumatriptan nasalt (Imigran) nässpray
|
1.0
|
2023-11-23
|
[1.0 - 5 st.]
|
4664
|
suxaMETONIUM intravenös/intramuskulär inj 5 mg/mL (Celocurin)
|
2.0
|
2025-02-27
|
[2.0 - 5 st.] [1.1 - 4 st.]
|
1403
|
suxaMETONIUM intravenös/intramuskulär inj 10 mg/mL (ex Celocurin)
|
3.0
|
2025-02-27
|
[3.0 - 6 st.] [2.2 - 2 st.]
|
3315
|
suxaMETONIUM intravenös/intramuskulär inj 50 mg/mL (Celocurin)
|
3.0
|
2025-02-27
|
[3.0 - 3 st.]
|
3266
|
Takrolimus oralt/sublingualt (ex Prograf)
|
6.21
|
2025-04-24
|
[6.21 - 9 st.] [3.22 - 1 st.]
|
4981
|
Talidomid oralt 50 mg (Thalidomide BMS) kapsel
|
2.4
|
2023-11-23
|
[2.4 - 4 st.]
|
5006
|
Taurolock instillation
|
2.1
|
2021-03-18
|
[2.1 - 10 st.]
|
3226
|
Taurolock instillation (Extempore) med heparin 70 E/mL
|
4.1
|
2021-03-18
|
[4.1 - 3 st.]
|
4665
|
Taurolock instillation (Taurolock U 25000) med urokinas 5 000 E/mL
|
3.2
|
2022-06-27
|
[3.2 - 3 st.]
|
3302
|
Taurolock instillation (TauroLockHep 100) med heparin 100 E/mL
|
5.1
|
2021-03-18
|
[5.1 - 4 st.]
|
3227
|
Taurolock instillation med heparin 20 E/mL
|
4.1
|
2021-03-18
|
[4.1 - 4 st.]
|
4962
|
Teikoplanin intravenös inf/inj 100 mg/mL (ex Targocid)
|
2.4
|
2023-12-21
|
[2.4 - 6 st.]
|
3405
|
Teikoplanin intravenös inf/inj 133,3 mg/mL (ex Targocid) spädning från 400 mg
|
4.6
|
2023-12-21
|
[4.6 - 4 st.]
|
3378
|
Teikoplanin intravenös inf/inj 67,7 mg/mL (ex Targocid) spädning från 200 mg
|
4.3
|
2023-02-23
|
[4.3 - 4 st.]
|
4899
|
Terbinafin oralt 250 mg (ex Lamisil) tablett
|
1.0
|
2024-11-20
|
[1.0 - 5 st.]
|
4900
|
Terbinafin utvärtes 1 % (ex Lamisil) kräm
|
1.0
|
2024-11-20
|
[1.0 - 5 st.]
|
5054
|
Terbutalin intravenös inf 0,02 mg/mL = 20 mikrog/mL (Bricanyl)
|
2.1
|
2024-12-19
|
[2.1 - 6 st.] [1.0 - 1 st.]
|
3301
|
Testosteron intramuskulär inj 250 mg/mL (Testoviron-Depot licens)
|
2.1
|
2021-09-02
|
[2.1 - 7 st.]
|
4924
|
Tetanus-immunglobulin humant, intramuskulär inj 250 E/mL (Tetagam P licens)
|
1.2
|
2024-03-21
|
[1.2 - 6 st.]
|
2848
|
Tetrakosaktid intramuskulär inj 1 mg/mL (ex Synacthene Retard licens)
|
3.4
|
2024-03-27
|
[3.4 - 8 st.] [2.2 - 1 st.]
|
5164
|
Tetrakosaktid intravenös inj 0,5 mikrog/mL (Synacthen)
|
1.3
|
2024-11-20
|
[1.3 - 3 st.]
|
4721
|
Tetrakosaktid intravenös/intramuskulär inj 250 mikrog/mL (Synacthen)
|
2.1
|
2024-11-20
|
[2.1 - 6 st.] [1.1 - 1 st.]
|
5223
|
Tezakaftor + Ivakaftor oralt (Symkevi) tabletter
|
1.2
|
2023-01-26
|
[1.2 - 5 st.]
|
4831
|
Tiamazol oralt 5 mg (ex Thacapzol) tablett
|
2.3
|
2022-11-03
|
[2.3 - 6 st.]
|
1294
|
Tiamin intravenös inf 50 mg/mL (Vitamin B1, ex Thiatum)
|
4.6
|
2023-06-15
|
[4.6 - 9 st.]
|
5067
|
Tiamin oralt (Vitamin B1, Benerva licens, extempore)
|
1.0
|
2021-02-11
|
[1.0 - 5 st.]
|
5066
|
Tiamin oralt 100 mg/mL (Vitamin B1, extempore) oral lösning
|
1.2
|
2021-05-27
|
[1.2 - 6 st.]
|
5070
|
Tiamin oralt 50 mg/mL (Vitamin B1, extempore) oral lösning
|
2.6
|
2023-06-15
|
[2.6 - 5 st.]
|
4598
|
Tigecyklin intravenös inf 0,5 mg/mL (ex Tygacil)
|
2.3
|
2024-01-11
|
[2.3 - 6 st.]
|
4671
|
Tiopental intravenös inf/inj 2,5 mg/mL (ex Pentocur)
|
4.3
|
2024-05-23
|
[4.3 - 5 st.]
|
1415
|
Tiopental intravenös inf/inj 5 mg/mL (ex Pentocur)
|
6.3
|
2024-05-23
|
[6.3 - 7 st.]
|
2870
|
Tiopental intravenös inf/inj 10 mg/mL (ex Pentocur)
|
5.4
|
2024-05-30
|
[5.4 - 3 st.]
|
2856
|
Tiopental intravenös inf/inj 25 mg/mL (ex Pentocur)
|
5.4
|
2024-05-30
|
[5.4 - 5 st.]
|
2518
|
Tobramycin inhalation 300 mg (ex Tobi)
|
2.1
|
2024-08-01
|
[2.1 - 5 st.]
|
1313
|
Tobramycin intravenös inf/inj 10 mg/mL (ex Nebcina)
|
6.1
|
2023-08-10
|
[6.1 - 16 st.]
|
2751
|
Tobramycin intravenös/intramuskulär inj 40 mg/mL (Nebcina)
|
3.1
|
2023-08-10
|
[3.1 - 4 st.]
|
4525
|
Tocilizumab intravenös inf (ex RoActemra) dos tillsätts till spädningsvätska
|
3.0
|
2025-05-08
|
[3.0 - 3 st.] [2.2 - 9 st.]
|
5005
|
Tocilizumab intravenös inf 2 mg/mL (ex Roactemra)
|
1.0
|
2025-05-08
|
[1.0 - 2 st.]
|
5429
|
Tocilizumab subkutan inj 162 mg (ex Roactemra) förfylld spruta/injektionspenna
|
1.0
|
2025-05-08
|
[1.0 - 3 st.]
|
3036
|
Tokoferol oralt 100 mg (Vitamin E, E-vimin) kapsel
|
1.0
|
2020-11-19
|
[1.0 - 5 st.]
|
1436
|
Tokofersolan oralt 50 mg/mL (Vitamin E, Vedrop) oral lösning
|
3.0
|
2021-06-10
|
[3.0 - 11 st.] [2.1 - 1 st.]
|
4956
|
Topiramat oralt (ex Topimax) kapslar/tabletter
|
1.5
|
2024-12-12
|
[1.5 - 7 st.]
|
5348
|
Trametinib oralt (Mekinist) tabletter
|
1.0
|
2024-05-30
|
[1.0 - 5 st.]
|
4764
|
Trametinib oralt 0,05 mg/mL (Spexotras) oral lösning
|
2.0
|
2024-05-30
|
[2.0 - 5 st.]
|
4667
|
Tranexamsyra intravenös inf/inj 20 mg/mL (ex Cyklokapron)
|
2.1
|
2022-04-28
|
[2.1 - 3 st.]
|
1376
|
Tranexamsyra intravenös inj 100 mg/mL (ex Cyklokapron)
|
4.0
|
2022-04-28
|
[4.0 - 15 st.]
|
3289
|
Trientin oralt (ex Cufence, Cuprior) kapslar/tablett
|
2.1
|
2023-08-24
|
[2.1 - 3 st.]
|
3013
|
Trimetoprim + Sulfametoxazol intravenös inf (ex Eusaprim) dos i mL koncentrat
|
9.0
|
2024-11-28
|
[9.0 - 3 st.] [8.2 - 1 st.] [7.1 - 1 st.]
|
2184
|
Trimetoprim + Sulfametoxazol intravenös inf (ex Eusaprim) vätskerestriktion, dos i mL koncentrat
|
9.0
|
2024-11-28
|
[9.0 - 2 st.] [8.2 - 1 st.] [1.0 - 1 st.]
|
4830
|
Trimetoprim + Sulfametoxazol intravenös inf 0,6 + 3,1 mg/mL (ex Eusaprim) dos i mg trimetoprim
|
3.0
|
2024-11-28
|
[3.0 - 7 st.] [2.4 - 3 st.]
|
4562
|
Trimetoprim + Sulfametoxazol intravenös inf 0,6 + 3,1 mg/mL (ex Eusaprim) dos i mL spädd lösning
|
7.0
|
2024-11-28
|
[7.0 - 6 st.] [6.2 - 1 st.] [5.1 - 1 st.]
|
3318
|
Trimetoprim + Sulfametoxazol intravenös inf 1 + 5 mg/mL (ex Eusaprim) vätskerestr, dos mg trimetoprim
|
3.0
|
2024-11-28
|
[3.0 - 4 st.] [2.4 - 1 st.]
|
4870
|
Trimetoprim + Sulfametoxazol oralt (ex Bactrim/Bactrim forte) tabletter
|
1.2
|
2020-11-12
|
[1.2 - 13 st.]
|
4869
|
Trimetoprim + Sulfametoxazol oralt 8 + 40 mg/mL (ex Bactrim) dos i mg trimetoprim, oral suspension
|
1.5
|
2022-03-24
|
[1.5 - 9 st.]
|
2686
|
Trimetoprim + Sulfametoxazol oralt 8 + 40 mg/mL (ex Bactrim) dos i mL vätska, oral suspension
|
8.0
|
2022-02-24
|
[8.0 - 10 st.]
|
3329
|
Trimetoprim oralt (Idotrim) tabletter
|
9.1
|
2024-03-07
|
[9.1 - 8 st.] [8.0 - 2 st.]
|
1405
|
Trimetoprim oralt 10 mg/mL oral suspension
|
9.1
|
2024-03-07
|
[9.1 - 13 st.] [8.0 - 2 st.]
|
1208
|
Trometamol + flera komponenter intravenös inf/inj (Tribonat)
|
3.2
|
2022-08-25
|
[3.2 - 14 st.]
|
2917
|
Tropikamid konjunktivalt 0,5 % ögondroppar
|
2.1
|
2022-06-27
|
[2.1 - 4 st.]
|
4474
|
Ubidekarenon = Q10 oralt 8 mg/mL (Extempore) oral lösning
|
2.0
|
2023-03-15
|
[2.0 - 5 st.]
|
1207
|
Ursodeoxicholsyra oralt 50 mg/mL (Ursofalk) oral suspension
|
3.1
|
2020-11-05
|
[3.1 - 15 st.]
|
3255
|
Ursodeoxicholsyra oralt (ex Ursofalk) kapsel/tablett
|
3.1
|
2021-10-28
|
[3.1 - 6 st.]
|
3421
|
UTGÅR UPPDATERAS EJ Acetylcystein intravenös inf vid paracetamolintox (barn under 30 kg) depottablett 665 mg
|
5.1
|
2020-07-30
|
[5.1 - 1 st.]
|
3420
|
UTGÅR UPPDATERAS EJ Acetylcystein intravenös inf vid paracetamolintox (barn över 30 kg) depottablett 665 mg
|
5.1
|
2020-07-30
|
[5.1 - 1 st.]
|
2919
|
UTGÅR UPPDATERAS EJ Acetylcystein intravenös inf, vid paracetamolintoxikation (barn under 30 kg)
|
6.1
|
2020-07-30
|
[6.1 - 2 st.]
|
3169
|
UTGÅR UPPDATERAS EJ Acetylcystein intravenös inf, vid paracetamolintoxikation (barn över 30 kg)
|
7.1
|
2020-07-30
|
[7.1 - 1 st.]
|
3034
|
UTGÅR UPPDATERAS EJ Acetylcystein oralt 200 mg, brustablett
|
2.0
|
2017-09-21
|
[2.0 - 1 st.]
|
1310
|
UTGÅR UPPDATERAS EJ Acitretin oralt 10 mg (Neotigason)
|
2.1
|
2020-07-30
|
[2.1 - 1 st.]
|
3387-875
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf 4 mikrog/mL
|
4.0
|
2020-02-06
|
[4.0 - 1 st.]
|
3387-876
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf 10 mikrog/mL
|
4.0
|
2019-12-19
|
[4.0 - 1 st.]
|
3387-664
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf 20 mikrog/mL
|
4.0
|
2019-12-19
|
[4.0 - 1 st.]
|
3387-888
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf 40 mikrog/mL
|
4.0
|
2019-12-19
|
[4.0 - 1 st.]
|
3387-957
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf 80 mikrog/mL
|
4.0
|
2019-12-19
|
[4.0 - 1 st.]
|
1338
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf 0,001 mg/mL = 1 mikrog/mL
|
2.1
|
2017-08-10
|
[2.1 - 1 st.]
|
3387-958
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf 160 mikrog/mL
|
4.0
|
2019-12-19
|
[4.0 - 1 st.]
|
3387
|
UTGÅR UPPDATERAS EJ Adrenalin intravenös inf, alla spädningar
|
2.1
|
2019-08-01
|
[2.1 - 1 st.]
|
4986
|
UTGÅR UPPDATERAS EJ Alteplas instillation 1 mg/mL (Actilyse) i dränage
|
2.0
|
2020-10-08
|
[2.0 - 1 st.]
|
1396
|
UTGÅR UPPDATERAS EJ Amiodaron oralt 5 mg/mL (Extempore)
|
2.0
|
2019-12-19
|
[2.0 - 1 st.]
|
3065
|
UTGÅR UPPDATERAS EJ Amoxicillin + klavulansyra oralt (ex Spektramox), tabletter
|
3.1
|
2017-12-07
|
[3.1 - 1 st.]
|
2443
|
UTGÅR UPPDATERAS EJ Amoxicillin oralt (ex Amimox, Imacillin)
|
2.1
|
2018-04-19
|
[2.1 - 1 st.]
|
3008
|
UTGÅR UPPDATERAS EJ Botulinumtoxin typ A anal inj 25 E/mL (Botox)
|
2.0
|
2021-01-14
|
[2.0 - 1 st.]
|
2512
|
UTGÅR UPPDATERAS EJ Bromhexin intravenös inj 0,4 mg/mL (Bisolvon licens)
|
2.0
|
2019-11-21
|
[2.0 - 1 st.]
|
3022
|
UTGÅR UPPDATERAS EJ C1-hämmare intravenös inj, inf 50 mg/mL (Berinert)
|
2.1
|
2019-11-04
|
[2.1 - 1 st.]
|
2864
|
UTGÅR UPPDATERAS EJ Cetirizin oralt 1 mg/mL (Zyrlex) oral lösning
|
3.0
|
2023-10-26
|
[3.0 - 2 st.]
|
3376
|
UTGÅR UPPDATERAS EJ Cetirizin oralt 10 mg/mL (Zyrlex) orala droppar
|
2.0
|
2023-08-31
|
[2.0 - 2 st.]
|
2704
|
UTGÅR UPPDATERAS EJ Dalteparin subkutan inj (Fragmin) flera olika styrkor
|
3.0
|
2021-11-11
|
[3.0 - 3 st.] [2.4 - 1 st.]
|
2927
|
UTGÅR UPPDATERAS EJ Deferoxamin flera administrationssätt (ex Desferal)
|
3.0
|
2020-06-25
|
[3.0 - 1 st.]
|
2927-562
|
UTGÅR UPPDATERAS EJ Deferoxamin intravenös inf 10 mg/mL (ex Desferal)
|
2.0
|
2020-06-25
|
[2.0 - 1 st.]
|
2927-558
|
UTGÅR UPPDATERAS EJ Deferoxamin subkutan inf, intramuskulär inj 100 mg/mL (ex Desferal)
|
2.0
|
2020-06-25
|
[2.0 - 1 st.]
|
2441
|
UTGÅR UPPDATERAS EJ Desloratadin oralt (ex Aerius)
|
2.1
|
2020-04-16
|
[2.1 - 1 st.]
|
3294
|
UTGÅR UPPDATERAS EJ Diazepam oralt, rektalt (ex Stesolid)
|
2.2
|
2020-07-30
|
[2.2 - 1 st.]
|
1373
|
UTGÅR UPPDATERAS EJ Diazepam rektalt 2 mg/mL (ex Stesolid)
|
2.1
|
2020-07-30
|
[2.1 - 1 st.]
|
3433
|
UTGÅR UPPDATERAS EJ Diazepam rektalt 5 mg/mL (Stesolid Rektal Prefill) rektallösning
|
8.0
|
2023-03-23
|
[8.0 - 6 st.] [7.1 - 1 st.] [6.1 - 1 st.]
|
1397
|
UTGÅR UPPDATERAS EJ Diazoxid intravenös inj 15 mg/mL (Eudemine licens)
|
2.1
|
2019-11-11
|
[2.1 - 1 st.]
|
2493
|
UTGÅR UPPDATERAS EJ Diklofenak oralt, rektalt (ex Voltaren, Diclofenac)
|
3.3
|
2020-07-30
|
[3.3 - 1 st.]
|
3322
|
UTGÅR UPPDATERAS EJ Dimetylsulfoxid utvärtes 500 mg/mL = 50 % (DMSO Extempore)
|
2.0
|
2020-12-17
|
[2.0 - 1 st.]
|
3072
|
UTGÅR UPPDATERAS EJ DOBUTamin intravenös inf 0,3 mg/mL
|
2.0
|
2019-06-20
|
[2.0 - 1 st.]
|
3117
|
UTGÅR UPPDATERAS EJ DOBUTamin intravenös inf 0,6 mg/mL
|
2.0
|
2019-06-20
|
[2.0 - 1 st.]
|
3118
|
UTGÅR UPPDATERAS EJ DOBUTamin intravenös inf 1,2 mg/mL
|
2.0
|
2019-06-20
|
[2.0 - 1 st.]
|
1256
|
UTGÅR UPPDATERAS EJ DOPamin intravenös inf 0,3 mg/mL (Giludop)
|
2.0
|
2019-06-20
|
[2.0 - 1 st.]
|
1257
|
UTGÅR UPPDATERAS EJ DOPamin intravenös inf 0,6 mg/mL (Giludop)
|
3.0
|
2019-06-20
|
[3.0 - 1 st.]
|
1258
|
UTGÅR UPPDATERAS EJ DOPamin intravenös inf 1,2 mg/mL (Giludop)
|
2.0
|
2019-06-20
|
[2.0 - 1 st.]
|
5021
|
UTGÅR UPPDATERAS EJ Droperidol intravenös inj 0,125 mg/mL = 125 mikrog/mL (ex Dridol)
|
3.0
|
2024-10-24
|
[3.0 - 2 st.]
|
4741
|
UTGÅR UPPDATERAS EJ Droperidol intravenös inj 1 mg/mL = 1 000 mikrog/mL (ex Dridol)
|
2.0
|
2024-10-24
|
[2.0 - 1 st.]
|
4979
|
UTGÅR UPPDATERAS EJ Esketamin intravenös inf/inj 4 mg/mL (Ketanest)
|
2.0
|
2021-12-16
|
[2.0 - 1 st.]
|
2790
|
UTGÅR UPPDATERAS EJ Etosuximid oralt (Suxinutin, Petnidan)
|
2.1
|
2020-07-30
|
[2.1 - 1 st.] [1.5 - 1 st.]
|
2595
|
UTGÅR UPPDATERAS EJ Flukloxacillin oralt (ex Heracillin)
|
2.0
|
2017-03-16
|
[2.0 - 1 st.]
|
4693
|
UTGÅR UPPDATERAS EJ Fosfat intravenös inf 0,05 mmol/mL (Glycophos)
|
4.0
|
2024-12-12
|
[4.0 - 1 st.]
|
2831
|
UTGÅR UPPDATERAS EJ Gabapentin oralt (ex Neurontin)
|
2.2
|
2020-07-30
|
[2.2 - 1 st.]
|
3332
|
UTGÅR UPPDATERAS EJ Glukos buffrad intravenös inf 25 mg/mL, vid diabetes ketoacidos
|
2.1
|
2020-07-28
|
[2.1 - 1 st.]
|
2040-580
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/ml (+ 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2040-585
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/ml (2 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2040-588
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/ml (2 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.5 - 1 st.]
|
2040-581
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/ml (2 mmol Na + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2040-587
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/ml (2 mmol Na)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
2040-586
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/ml (4 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2040-589
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/ml (4 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 2 st.] [1.5 - 1 st.]
|
2040
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 50 mg/mL, med tillsatser
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
2590-590
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/ml (+ 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2590-592
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/ml (2 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2590-595
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/ml (2 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.5 - 1 st.]
|
2590-591
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/ml (2 mmol Na + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2590-594
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/ml (2 mmol Na)/100 ml
|
3.0
|
2022-10-20
|
[3.0 - 1 st.] [2.4 - 1 st.]
|
2590-593
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/ml (4 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2590-596
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/ml (4 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 2 st.] [1.5 - 1 st.]
|
2590
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 100 mg/mL, med tillsatser
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
2115-597
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
2115-600
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml (2 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2115-603
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml (2 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.5 - 1 st.]
|
2115-599
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml (2 mmol Na + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2115-602
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml (2 mmol Na)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
2115-598
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml (20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2115-601
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml (4 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2115-604
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/ml (4 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.5 - 1 st.]
|
2115
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 120 mg/mL, med tillsatser
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.5 - 1 st.]
|
3041-619
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml
|
2.0
|
2022-10-20
|
[2.0 - 2 st.] [1.3 - 1 st.]
|
3041-605
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml (+ 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
3041-607
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml (2 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
3041-610
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml (2 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.5 - 1 st.]
|
3041-606
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml (2 mmol Na + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
3041-609
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml (2 mmol Na)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
3041-608
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml (4 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
3041-611
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/ml (4 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 2 st.] [1.5 - 1 st.]
|
3041
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 150 mg/mL, med tillsatser
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.2 - 1 st.]
|
2068-612
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/ml (+ 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2068-614
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/ml (2 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2068-617
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/ml (2 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
2068-613
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/ml (2 mmol Na + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2068-616
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/ml (2 mmol Na)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.3 - 1 st.]
|
2068-615
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/ml (4 mmol Na + 2 mmol K + 20 E heparin)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.]
|
2068-618
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/ml (4 mmol Na + 2 mmol K)/100 ml
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.4 - 1 st.]
|
2068
|
UTGÅR UPPDATERAS EJ Glukos intravenös inf 200 mg/mL, med tillsatser
|
2.0
|
2022-10-20
|
[2.0 - 1 st.] [1.2 - 1 st.]
|
5118
|
UTGÅR UPPDATERAS EJ Glykopyrronium oralt 160 mikrog/mL (Rybrila) oral lösning
|
2.0
|
2024-12-19
|
[2.0 - 2 st.]
|
5030
|
UTGÅR UPPDATERAS EJ Hydrokortison oralt 0,5 mg/mL (Extempore) oral lösning från kapsel
|
2.0
|
2021-02-11
|
[2.0 - 2 st.]
|
2447
|
UTGÅR UPPDATERAS EJ Ibuprofen oralt, rektalt (ex Brufen, Ipren)
|
2.0
|
2017-03-16
|
[2.0 - 1 st.]
|
2942
|
UTGÅR UPPDATERAS EJ Idebenon oralt 45 mg (Mnesis licens)
|
2.0
|
2022-12-15
|
[2.0 - 1 st.]
|
1246
|
UTGÅR UPPDATERAS EJ Iloprost intravenös inf 0,5 mikrog/mL (Ilomedin)
|
2.0
|
2017-08-10
|
[2.0 - 1 st.]
|
1425
|
UTGÅR UPPDATERAS EJ Insulin intravenös inf, inj 0,1 E/mL
|
2.2
|
2020-07-30
|
[2.2 - 1 st.]
|
4475
|
UTGÅR UPPDATERAS EJ Insulin subkutan inj 100 E/mL (Levemir)
|
4.0
|
2023-06-29
|
[4.0 - 2 st.]
|
3388-878
|
UTGÅR UPPDATERAS EJ Isoprenalin intravenös inf (Isuprel licens) spädning till 10 mikrog/mL
|
3.0
|
2021-10-07
|
[3.0 - 1 st.]
|
3388-879
|
UTGÅR UPPDATERAS EJ Isoprenalin intravenös inf (Isuprel licens) spädning till 20 mikrog/mL
|
3.0
|
2021-10-07
|
[3.0 - 1 st.]
|
3388-880
|
UTGÅR UPPDATERAS EJ Isoprenalin intravenös inf (Isuprel licens) spädning till 50 mikrog/mL
|
3.0
|
2021-10-07
|
[3.0 - 1 st.]
|
3388-881
|
UTGÅR UPPDATERAS EJ Isoprenalin intravenös inf (Isuprel licens) spädning till 80 mikrog/mL
|
3.0
|
2021-10-07
|
[3.0 - 1 st.]
|
3388
|
UTGÅR UPPDATERAS EJ Isoprenalin intravenös inf (Isuprel licens), alla spädningar
|
2.2
|
2020-07-30
|
[2.2 - 1 st.]
|
3050
|
UTGÅR UPPDATERAS EJ Isoprenalin intravenös inf 4 mikrog/mL (Isuprel licens)
|
2.2
|
2020-07-30
|
[2.2 - 1 st.]
|
5209
|
UTGÅR UPPDATERAS EJ Isoton aminosyralösning + Heparin 4 E/mL intraarteriell inf ocklusionsförebyggande spoldropp
|
2.0
|
2023-09-14
|
[2.0 - 1 st.]
|
3142
|
UTGÅR UPPDATERAS EJ Jodixanol instillation i silastic 270 mg I/mL (Visipaque)
|
2.0
|
2017-06-28
|
[2.0 - 1 st.]
|
3290
|
UTGÅR UPPDATERAS EJ Kaliumkanrenoat intravenös inj 100 mg/mL (Kanrenol licens, f.d Soldactone)
|
2.4
|
2024-05-08
|
[2.4 - 2 st.]
|
4978
|
UTGÅR UPPDATERAS EJ Ketobemidon intravenös inf/inj 0,04 mg/mL = 40 mikrog/mL (ex Ketogan Novum)
|
2.0
|
2024-02-29
|
[2.0 - 1 st.]
|
1413
|
UTGÅR UPPDATERAS EJ Klonazepam intravenös inj 0,05 mg/mL (Iktorivil)
|
3.0
|
2018-02-19
|
[3.0 - 1 st.] [1.0 - 1 st.]
|
4560
|
UTGÅR UPPDATERAS EJ Klonidin oralt 15 mikrog/mL (ex Catapresan)
|
5.0
|
2022-02-10
|
[5.0 - 1 st.]
|
4988
|
UTGÅR UPPDATERAS EJ Klorokinfosfat oralt 250 mg tablett
|
5.0
|
2025-01-23
|
[5.0 - 2 st.]
|
1296
|
UTGÅR UPPDATERAS EJ Koagulationsfaktor rekombinant IX intravenös inj 100 E/mL (BeneFIX)
|
3.3
|
2019-11-21
|
[3.3 - 1 st.]
|
1231
|
UTGÅR UPPDATERAS EJ Koagulationsfaktor rekombinant VIII intravenös inj 125 E/mL (ReFacto)
|
3.2
|
2020-07-30
|
[3.2 - 1 st.]
|
1251
|
UTGÅR UPPDATERAS EJ Koagulationsfaktor rekombinant VIII intravenös inj 200 E/mL (Helixate NexGen)
|
3.0
|
2019-03-07
|
[3.0 - 1 st.]
|
1197
|
UTGÅR UPPDATERAS EJ Lidokain subkutan inj 10 mg/mL (Xylocain utan konserveringsmedel)
|
2.0
|
2017-10-19
|
[2.0 - 1 st.]
|
2747
|
UTGÅR UPPDATERAS EJ Metoklopramid rektalt 10 mg (ex Primperan)
|
3.0
|
2019-12-19
|
[3.0 - 1 st.]
|
5308
|
UTGÅR UPPDATERAS EJ Metylprednisolon intravenös inf/inj 59,7 mg/mL (Solu-Medrol)
|
2.0
|
2023-12-07
|
[2.0 - 1 st.]
|
3021
|
UTGÅR UPPDATERAS EJ Metyltionin intravenös inj 10 mg/mL (Extempore)
|
2.0
|
2024-10-24
|
[2.0 - 2 st.]
|
2865
|
UTGÅR UPPDATERAS EJ Midazolam oralt, rektalt (Extempore)
|
2.1
|
2020-07-30
|
[2.1 - 1 st.]
|
4724
|
UTGÅR UPPDATERAS EJ Montelukast oralt 1 mg/mL (ex Singulair) oral lösning
|
3.0
|
2023-10-19
|
[3.0 - 5 st.] [2.5 - 1 st.]
|
3444
|
UTGÅR UPPDATERAS EJ Morfin intravenös inf/inj 0,08 mg/mL = 80 mikrog/mL
|
9.0
|
2024-04-25
|
[9.0 - 1 st.]
|
4767
|
UTGÅR UPPDATERAS EJ Morfin oralt 0,4 mg/mL
|
4.0
|
2024-04-25
|
[4.0 - 2 st.]
|
4616
|
UTGÅR UPPDATERAS EJ Naloxon intravenös/intramuskulär inf/inj 0,001 mg/mL = 1 mikrog/mL
|
6.0
|
2024-10-10
|
[6.0 - 1 st.]
|
5020
|
UTGÅR UPPDATERAS EJ Naloxon intravenös/intramuskulär inf/inj 0,8 mikrog/mL
|
5.0
|
2024-10-10
|
[5.0 - 1 st.]
|
2110
|
UTGÅR UPPDATERAS EJ Natriumklorid 4,5 mg/mL + Heparin 0,2 E/mL ocklusionsförebyggande spoldropp, flera administreringsvägar
|
3.0
|
2023-08-31
|
[3.0 - 1 st.]
|
2039
|
UTGÅR UPPDATERAS EJ Natriumklorid 9 mg/mL med heparin 0,2 E/mL ocklusionsförebyggande spoldropp, flera administreringsvägar
|
3.0
|
2023-08-31
|
[3.0 - 1 st.]
|
4499
|
UTGÅR UPPDATERAS EJ Nitroprussid intravenös inf 0,1 mg/mL = 100 mikrog/mL (Licens)
|
3.0
|
2024-03-21
|
[3.0 - 1 st.]
|
4500
|
UTGÅR UPPDATERAS EJ Nitroprussid intravenös inf 0,2 mg/mL = 200 mikrog/mL (Licens)
|
3.0
|
2024-03-21
|
[3.0 - 1 st.]
|
4711
|
UTGÅR UPPDATERAS EJ Nitroprussid intravenös inf 0,4 mg/mL = 400 mikrog/mL (Licens)
|
4.0
|
2024-03-21
|
[4.0 - 1 st.]
|
3278-481
|
UTGÅR UPPDATERAS EJ NORadrenalin intravenös inf spädning till 4 mikrog/mL
|
5.0
|
2021-03-31
|
[5.0 - 1 st.]
|
3278-482
|
UTGÅR UPPDATERAS EJ NORadrenalin intravenös inf spädning till 10 mikrog/mL
|
5.0
|
2021-03-31
|
[5.0 - 1 st.]
|
3278-827
|
UTGÅR UPPDATERAS EJ NORadrenalin intravenös inf spädning till 20 mikrog/mL
|
5.0
|
2021-03-31
|
[5.0 - 1 st.]
|
3278-483
|
UTGÅR UPPDATERAS EJ NORadrenalin intravenös inf spädning till 40 mikrog/mL
|
5.0
|
2021-03-31
|
[5.0 - 1 st.]
|
3278-484
|
UTGÅR UPPDATERAS EJ NORadrenalin intravenös inf spädning till 80 mikrog/mL
|
5.0
|
2021-03-31
|
[5.0 - 1 st.]
|
3278-485
|
UTGÅR UPPDATERAS EJ NORadrenalin intravenös inf spädning till 160 mikrog/mL
|
5.0
|
2021-03-31
|
[5.0 - 1 st.]
|
3278
|
UTGÅR UPPDATERAS EJ NORadrenalin intravenös inf, alla spädningar
|
3.0
|
2018-05-31
|
[3.0 - 1 st.]
|
5161
|
UTGÅR UPPDATERAS EJ Ondansetron oralt 0,8 mg/mL spädning från injektions/infusionsvätska
|
2.0
|
2022-01-27
|
[2.0 - 1 st.]
|
4567
|
UTGÅR UPPDATERAS EJ Oxikodon intravenös inf, 1 mL = 10 mikrog/kg (ex OxyNorm) individuell spädning
|
2.0
|
2023-10-12
|
[2.0 - 1 st.]
|
3423
|
UTGÅR UPPDATERAS EJ Oximetazolin nasalt 0,1 mg/mL (licens Nasivin) näsdroppar
|
2.0
|
2021-10-14
|
[2.0 - 2 st.]
|
2076
|
UTGÅR UPPDATERAS EJ Papaverin intravenös inj 0,1 mg/mL (Paveron N licens)
|
2.0
|
2020-10-01
|
[2.0 - 1 st.]
|
1305
|
UTGÅR UPPDATERAS EJ Paracetamol oralt 24 mg/mL (ex Alvedon, Panodil)
|
5.2
|
2020-07-30
|
[5.2 - 1 st.]
|
3401
|
UTGÅR UPPDATERAS EJ Paracetamol rektalt (ex Alvedon, extempore)
|
3.1
|
2018-08-16
|
[3.1 - 2 st.]
|
4841
|
UTGÅR UPPDATERAS EJ Peginterferon alfa-2b subkutan inj 100 mikrog/0,5 mL = 200 mikrog/mL (PegIntron) förfylld injektionsPENNA
|
2.0
|
2024-04-18
|
[2.0 - 1 st.]
|
4826
|
UTGÅR UPPDATERAS EJ Peginterferon alfa-2b subkutan inj 50 mikrog/0,5 mL= 100 mikrog/mL (PegIntron)
|
2.0
|
2024-04-18
|
[2.0 - 1 st.]
|
4840
|
UTGÅR UPPDATERAS EJ Peginterferon alfa-2b subkutan inj 50 mikrog/0,5 mL= 100 mikrog/mL (PegIntron) förfylld injektionsPENNA
|
2.0
|
2024-04-18
|
[2.0 - 1 st.]
|
4966
|
UTGÅR UPPDATERAS EJ Prednisolon oralt 5 mg/mL (Prednisolone Sodium Phosphate 25 mg/5 mL licens) oral lösning
|
3.1
|
2025-03-27
|
[3.1 - 1 st.] [2.1 - 1 st.]
|
4888
|
UTGÅR UPPDATERAS EJ Prometazin intravenös inf 1 mg/mL (Phenergan licens) liten slutVOLYM
|
3.0
|
2020-10-15
|
[3.0 - 1 st.]
|
4732
|
UTGÅR UPPDATERAS EJ Prometazin intravenös inf 2,5 mg/mL (Phenergan licens)
|
3.0
|
2020-10-08
|
[3.0 - 1 st.]
|
1268
|
UTGÅR UPPDATERAS EJ Protrombinkomplex aktiverat, intravenös inf 50 E/mL (Feiba)
|
2.1
|
2020-07-30
|
[2.1 - 1 st.]
|
1194
|
UTGÅR UPPDATERAS EJ Ranitidin intravenös inj 1 mg/mL (Zantac)
|
5.0
|
2021-03-18
|
[5.0 - 1 st.]
|
1195
|
UTGÅR UPPDATERAS EJ Ranitidin oralt (ex Zantac)
|
2.1
|
2020-07-30
|
[2.1 - 1 st.]
|
3412
|
UTGÅR UPPDATERAS EJ Ranitidin oralt (ex Zantac) tabletter
|
4.1
|
2020-07-30
|
[4.1 - 1 st.]
|
4613
|
UTGÅR UPPDATERAS EJ Ranitidin oralt 15 mg/mL (Zantac) oral lösning, spädning från injektionslösning
|
6.0
|
2021-03-18
|
[6.0 - 3 st.] [2.3 - 1 st.]
|
3042
|
UTGÅR UPPDATERAS EJ Remifentanil intravenös inf 20 mikrog/mL (ex Ultiva)
|
2.0
|
2018-05-31
|
[2.0 - 1 st.]
|
3448
|
UTGÅR UPPDATERAS EJ Ribavirin oralt 40 mg/mL (Rebetol) oral lösning
|
3.0
|
2024-02-15
|
[3.0 - 2 st.]
|
5268
|
UTGÅR UPPDATERAS EJ Silibinin intravenös inf 2 mg/mL (Legalon SIL licens)
|
2.0
|
2023-10-12
|
[2.0 - 2 st.]
|
2557
|
UTGÅR UPPDATERAS EJ Sulfametoxazol + Trimetoprim oralt (ex Bactrim/Bactrim forte) tabletter
|
6.0
|
2020-11-12
|
[6.0 - 1 st.]
|
3314
|
UTGÅR UPPDATERAS EJ Teikoplanin instillation (Targocid-lås), barn under 20 kg
|
2.0
|
2022-10-27
|
[2.0 - 1 st.]
|
3280
|
UTGÅR UPPDATERAS EJ Teikoplanin instillation (Targocid-lås), barn över 20 kg
|
3.6
|
2022-10-27
|
[3.6 - 1 st.]
|
1286
|
UTGÅR UPPDATERAS EJ Terbutalin oralt 0,3 mg/mL (ex Bricanyl licens) oral lösning
|
5.0
|
2019-11-21
|
[5.0 - 1 st.]
|
2182
|
UTGÅR UPPDATERAS EJ Tobramycin intravenös inf 0,8 mg/mL (ex Nebcina)
|
2.0
|
2019-09-19
|
[2.0 - 1 st.]
|
3128
|
UTGÅR UPPDATERAS EJ Uppvätskning: Snabb 4 tim, enteralt i sond (Semper Vätskeersättning) oral lösning
|
3.0
|
2024-08-29
|
[3.0 - 2 st.] [2.7 - 3 st.]
|
3222
|
UTGÅR UPPDATERAS EJ Uppvätskning: Vätskeersättning oralt (blandas själv) oral lösning
|
2.0
|
2024-08-29
|
[2.0 - 3 st.] [1.7 - 1 st.]
|
5160
|
UTGÅR UPPDATERAS EJ Vaccin: Comirnaty intramuskulär inj 10 mikrog/dos mot covid-19, barn 5 - 11 år
|
2.0
|
2024-09-25
|
[2.0 - 2 st.]
|
5162
|
UTGÅR UPPDATERAS EJ Vaccin: Comirnaty intramuskulär inj 30 mikrog/dos mot covid-19, barn från 12 år
|
2.0
|
2024-09-25
|
[2.0 - 2 st.]
|
2566
|
UTGÅR UPPDATERAS EJ Valproat rektalt 300 mg (Delepsine licens) suppositorium
|
5.0
|
2021-03-11
|
[5.0 - 1 st.]
|
3348
|
UTGÅR UPPDATERAS EJ Vigabatrin oralt 50 mg/mL (Sabrilex)
|
3.0
|
2019-11-21
|
[3.0 - 1 st.]
|
5363
|
Vaccin: Comirnaty JN.1 intramuskulär inj 3 mikrog/dos mot covid-19, barn 6 mån - 4 år
|
1.2
|
2025-03-13
|
[1.2 - 6 st.]
|
5364
|
Vaccin: Comirnaty JN.1 intramuskulär inj 10 mikrog/dos mot covid-19, barn 5 - 11 år
|
1.3
|
2025-03-13
|
[1.3 - 6 st.]
|
5365
|
Vaccin: Comirnaty JN.1 intramuskulär inj 30 mikrog/dos mot covid-19, barn 12 - 18 år
|
1.2
|
2025-03-13
|
[1.2 - 6 st.]
|
1272
|
Vaccin: Engerix-B intramuskulär inj mot hepatit B
|
2.2
|
2020-03-12
|
[2.2 - 11 st.]
|
5384
|
Vaccin: Fluenz nasalt mot influensa
|
1.1
|
2025-03-13
|
[1.1 - 5 st.]
|
3287
|
Vaccin: Fluenz Tetra nasalt mot influensa
|
4.2
|
2025-03-13
|
[4.2 - 7 st.] [3.1 - 1 st.]
|
4942
|
Vaccin: Hexyon intramuskulär inj mot difteri, stelkramp, kikhosta, polio, Hib, hepatit B
|
2.1
|
2025-01-30
|
[2.1 - 14 st.]
|
3136
|
Vaccin: Infanrix hexa intramuskulär inj mot difteri, stelkramp, kikhosta, polio, Hib, hepatit B
|
3.1
|
2025-01-30
|
[3.1 - 9 st.]
|
3134
|
Vaccin: Prevenar 13 intramuskulär inj, mot pneumokockinfektioner
|
3.5
|
2024-09-25
|
[3.5 - 9 st.]
|
5206
|
Vaccin: Prevenar 20 intramuskulär inj mot pneumokockinfektioner
|
1.1
|
2024-10-03
|
[1.1 - 6 st.]
|
3323
|
Vaccin: Rabipur intramuskulär inj 2,5 E/mL mot rabies
|
4.1
|
2024-10-10
|
[4.1 - 5 st.]
|
3427
|
Vaccin: Rotarix oralt mot rotavirus, oral suspension
|
5.1
|
2023-12-07
|
[5.1 - 11 st.]
|
3312
|
Vaccin: RotaTeq oralt mot rotavirus, oral lösning
|
4.1
|
2023-12-07
|
[4.1 - 10 st.]
|
4941
|
Vaccin: Synflorix intramuskulär inj mot pneumokockinfektioner
|
2.3
|
2024-09-25
|
[2.3 - 12 st.]
|
5283
|
Vaccin: Vaxneuvance intramuskulär inj mot pneumokockinfektioner
|
1.2
|
2024-09-25
|
[1.2 - 8 st.]
|
3308
|
Vaccin: Verorab intramuskulär inj 3,25 E/0,5 mL mot rabies
|
4.3
|
2024-10-17
|
[4.3 - 4 st.]
|
4575
|
valAciklovir oralt (ex Valtrex) tabletter
|
2.2
|
2025-02-20
|
[2.2 - 8 st.]
|
5081
|
valGANciklovir oralt 450 mg tablett
|
1.2
|
2024-08-22
|
[1.2 - 5 st.]
|
3277
|
valGANciklovir oralt 50 mg/mL (ex Valcyte) oral lösning
|
6.3
|
2024-08-22
|
[6.3 - 8 st.] [3.0 - 1 st.]
|
2849
|
Valproinsyra intravenös inf/inj 100 mg/mL (Ergenyl)
|
9.2
|
2025-04-30
|
[9.2 - 7 st.] [8.0 - 3 st.] [7.0 - 1 st.] [5.1 - 1 st.]
|
3402
|
Valproinsyra oralt (ex Ergenyl)
|
6.2
|
2025-05-08
|
[6.2 - 9 st.] [5.8 - 2 st.] [4.5 - 1 st.]
|
3390
|
Valproinsyra oralt 200 mg/mL (Absenor) orala droppar, lösning
|
7.2
|
2025-05-08
|
[7.2 - 7 st.] [4.0 - 1 st.]
|
3385
|
Valproinsyra oralt 60 mg/mL (Absenor) oral lösning
|
6.2
|
2025-05-08
|
[6.2 - 10 st.] [5.0 - 1 st.] [3.0 - 1 st.]
|
3038
|
Vankomycin + Heparin instillation 2,5 mg/mL + 50 E/mL (Vankomycin + HeparinLÅS )
|
4.1
|
2025-03-06
|
[4.1 - 3 st.]
|
4672
|
Vankomycin intravenös inf 10 mg/mL
|
5.3
|
2025-03-06
|
[5.3 - 6 st.]
|
1417
|
Vankomycin intravenös inf 5 mg/mL (ex Extempore)
|
11.3
|
2025-03-06
|
[11.3 - 17 st.] [10.7 - 3 st.]
|
4985
|
Vankomycin oralt (ex Vancocin) kapslar
|
2.1
|
2023-10-05
|
[2.1 - 9 st.]
|
3426
|
Vankomycin oralt 50 mg/mL (ex Extempore) oral lösning
|
4.4
|
2025-03-06
|
[4.4 - 10 st.] [3.7 - 1 st.]
|
4811
|
Varicella Zoster-immunglobulin intramuskulär inj 104 E/mL (Varizig licens)
|
1.2
|
2023-09-07
|
[1.2 - 6 st.]
|
3311
|
Varicella Zoster-immunglobulin intravenös inf 25 E/mL (Varitect CP licens)
|
2.1
|
2023-08-03
|
[2.1 - 7 st.] [1.2 - 1 st.]
|
5399
|
Vedolizumab intravenös inf (Entyvio) dos tillsätts till spädningsvätska
|
1.0
|
2025-01-16
|
[1.0 - 3 st.]
|
4974
|
Vedolizumab intravenös inf 1,2 mg/mL (Entyvio)
|
2.0
|
2025-01-16
|
[2.0 - 6 st.] [1.0 - 3 st.]
|
5174
|
Velaglukeras alfa intravenös inf (VPRIV) dos tillsätts till spädningsvätska
|
1.1
|
2024-08-29
|
[1.1 - 4 st.]
|
4799
|
Venlafaxin oralt (ex Efexor Depot) depotkapslar/depottablett
|
1.7
|
2024-11-14
|
[1.7 - 8 st.]
|
3393
|
Vigabatrin oralt 100 mg/mL (Sabrilex) oral lösning
|
4.0
|
2024-09-05
|
[4.0 - 8 st.] [3.0 - 2 st.] [2.3 - 1 st.]
|
5092
|
Vigabatrin oralt 500 mg (Sabrilex) tablett/granulat till oral lösning
|
1.1
|
2025-01-23
|
[1.1 - 5 st.]
|
2872
|
Vorikonazol intravenös inf 5 mg/mL (ex Vfend)
|
3.4
|
2022-03-31
|
[3.4 - 9 st.]
|
4768
|
Vorikonazol oralt (ex Vfend) tabletter
|
1.6
|
2022-03-31
|
[1.6 - 5 st.]
|
3362
|
Vorikonazol oralt 40 mg/mL (Vfend) oral suspension
|
1.5
|
2022-03-31
|
[1.5 - 6 st.]
|
4906
|
Väteperoxid utvärtes 1 % (Microcid) kräm
|
1.2
|
2022-06-27
|
[1.2 - 5 st.]
|
2899
|
Vätskebehandling enteralt (ex bröstmjölk, majsvälling) underhåll 24 tim
|
2.7
|
2025-04-16
|
[2.7 - 6 st.]
|
3437
|
Vätskebehandling oralt (ex Resorb vätskeersättning) brustablett
|
2.4
|
2025-04-16
|
[2.4 - 7 st.]
|
3425
|
Vätskebehandling oralt (ex Semper vätskeersättning) oral lösning
|
3.4
|
2025-04-16
|
[3.4 - 9 st.]
|
4807
|
Vätsketerapi: Basal underhållsbehandling, långsam rehydrering (ex Plasmalyte-GLUCOS, glukos med tillsatser)
|
1.5
|
2019-11-14
|
[1.5 - 9 st.]
|
4805
|
Vätsketerapi: Chock (ex Ringer-Acetat, Plasmalyte, Natriumklorid 9 mg/mL)
|
4.7
|
2025-02-13
|
[4.7 - 6 st.] [3.0 - 1 st.] [2.0 - 1 st.]
|
4817
|
Vätsketerapi: Ersättning av kvarvarande deficit och förluster, långsam rehydrering
|
2.9
|
2025-01-23
|
[2.9 - 5 st.]
|
4802
|
Vätsketerapi: Hyponatrem encefalopati hyperton Natriumklorid 30 mg/mL=3%, från ex Addex Natriumklorid
|
1.4
|
2020-10-08
|
[1.4 - 6 st.]
|
4806
|
Vätsketerapi: Snabb uppvätskning (ex Ringer-Acetat, buffrad Glukos 25 mg/mL med tillsatser)
|
4.8
|
2025-02-13
|
[4.8 - 9 st.]
|
5226
|
Zanamivir inhalation 5 mg/dos (Relenza)
|
1.0
|
2023-01-19
|
[1.0 - 4 st.]
|
4823
|
Zanamivir intravenös inf 10 mg/mL (Dectova)
|
2.0
|
2023-01-12
|
[2.0 - 5 st.]
|
1229
|
Zidovudin intravenös inf 4 mg/mL (Retrovir)
|
3.0
|
2024-11-14
|
[3.0 - 9 st.] [2.3 - 1 st.]
|
1230
|
Zidovudin oralt 10 mg/mL (Retrovir) oral lösning
|
3.0
|
2024-11-14
|
[3.0 - 9 st.] [2.2 - 3 st.]
|
5405
|
Zink oralt (ex Solvezink)
|
2.0
|
2025-05-08
|
[2.0 - 2 st.] [1.0 - 1 st.]
|
3073
|
Zink oralt 1,5 mg/mL (Solvezink)
|
4.0
|
2025-05-08
|
[4.0 - 2 st.] [3.0 - 3 st.] [2.1 - 8 st.]
|
5144
|
Zolmitriptan nasalt (Zomig Nasal) nässpray
|
3.1
|
2023-11-23
|
[3.1 - 5 st.]
|
4866
|
Zopiklon oralt 5 mg (ex Imovane) tablett
|
2.3
|
2025-04-16
|
[2.3 - 5 st.]
|